Functional analysis of microRNA-130b in bovine oocyte maturation and preimplantation embryo development by Sinha, Pritam Bala
  
 
 
 
Institut für Tierwissenschaften, Abt. Tierzucht und Tierhaltung 
der Rheinischen Friedrich – Wilhelms – Universität Bonn 
 
 
 
 
Functional analysis of microRNA-130b in bovine oocyte maturation and 
preimplantation embryo development 
 
 
 
I n a u g u r a l – D i s s e r t a t i o n 
zur Erlangung des Grades 
 
Doktor der Agrarwissenschaft 
(Dr. agr.) 
der 
Hohen Landwirtschaftlichen Fakultät 
der 
Rheinischen Friedrich – Wilhelms – Universität 
zu Bonn 
 
vorgelegt im Mai 2011 
 
von  
 
Pritam Bala Sinha 
 
aus 
 
Ranchi, Indien 
  
 
 
Diese Dissertation ist auf dem Hochschulschriftenserver der ULB Bonn 
http://hss.ulb.uni-bonn.de/diss_online elektronisch publiziert 
E-mail: diss-online@ulb.uni-bonn.de 
Universitäts- und Landesbibliothek Bonn 
 Landwirtschaftliche Fakultät – Jahrgang 2011 
Zugl.: ITW; Bonn, Univ., Diss., 2011 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D 98 
 
 
 
 
 
Referent:    Prof. Dr. Karl Schellander 
Korreferent:    Prof. Dr. Jens Léon 
Tag der mündlichen Prüfung: 11th July 2011 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedicated 
 
To my Papa, my husband Bimal and my beloved daughter Vaishnawi 
 
 
 
 
 
 
 v  
Funktionelle Analyse der microRNA miR-130b während der bovinen Oozytenmaturation und 
der preimplantativen Embryonalentwicklung 
 
MicroRNAs (miRNAs) sind dafür bekannt, dass sie eine regulatorische Rolle in verschiedenen 
biologischen Prozessen, wie in der Embryonalentwicklung spielen. Es wir angenommen, dass 
das  Expressionsmuster von miRNAs zwischen immaturen und in vitro maturierten bovinen 
Oozyten variiert, wobei gezeigt wurde, da miR-130b in inmaturierten Oozyten hoch reguliert 
ist. Allerdings ist seine funktionelle Rolle in der Zellvitalität, Proliferation und Transkription 
während der bovinen Oozytenmaturation und der Präimplantiationsembryoentwicklung noch 
nicht bekannt. Daher war das Ziel dieser Studie die Bedeutung von miR-130b in der Maturation 
von Oozyten-, Granulosa- und Kumuluszellen und in der präimplantativen Embryoentwicklung 
zu untersuchen. Dafür wurde das Expressionsmuster der miR-130-Familie im bovinen 
embryonalen Präimplantationsstadium erstellt. MiR-130b war in Kumulus- und 
Granulosazellen, in immaturen Oozyten sowie im Morula- und Blastozystenstadium höher 
exprimiert. Die miR-130b Zielgen Identifizierung erfolgte mittels der In silico Analyse und der 
experimentellen Validierung durch den Luciferase-Assay. Dementsprechend konnten MSK1, 
SMAD5, MEOX2, DOC1R und EIF2C4 als Zielgene von miR-130b ermittelt werden. Um den 
Einfluss der miR-130b während der Maturation der Oozyten zu untersuchen, wurden in 
immaturierten Oozyten pre-miR-130b und sequenz-spezifische miR-130b Antisense (Inhibitor) 
mikroinjiziert, während mit scrambled miRNA injizierte und nicht injizierte Oozyten als 
Kontrolle dienten. 24 Stunden nach der Mikroinjektion wurde der Reifungsstatus der Oozyten 
mittels der ersten Polkörper-Extrusion, festgestellt. Sie betrug 86,3, 73, 85, und 84,6% bei 
Oozyten mit injizierter pre-miR-130b, anti-miR-130b, scramble RNA und nicht injizierte 
Kontrolle. Die Mehrheit der anti-miR-130b injizierten Oozyten blieb in der Telophase 1 (22%) 
stehen. Darüber hinaus konnte eine höhere mitrochendriale Aktivität in pre-miR-130b und eine 
niedrigere in anti-miR-130b injizierten Oozyten im Vergleich zu scramble RNA und nicht 
injizierte Oozyten gefunden werden. Dies konnte mit der Zunahme der Proteinexpression der 
miR-130b Zielgene SMAD5 und MSK1 assoziiert werden. Oozyten Companionzellen sind für 
die Oozytenmaturation erforderlich. Der Einfluss der miR-130b konnte bei der Zellproliferation, 
Laktatproduktion und beim Cholesterinspiegel durch die Transfektion der miR-130b Precursor 
RNA oder anti-miR-130b RNA in Kumulus- und Granulosazellen beobachtet werden. Mit der 
Reduktion der miR-130b folgte einen Reduzierung in der Zellproliferation und der 
Laktatproduktion, allerdings keine Änderungen im Cholesterinspiegel in Granulosa- oder 
Kumuluszellen. Neben der Maturation der Oozyten und der Oozyten Companionzellfunktion 
wurde die Rolle der miR-130b während der präimplantations Embryoentwicklung nach einer 
Mikroinjektion der  miR-130b Precursor oder – Inhibitor in Zygoten untersucht. Das Ergebnis 
zeigte, dass die erste Teilungsrate  unbeeinflusst vom Knockdown oder der Überexpression der 
miR-130b war,  jedoch war die Morula/Blastozysten rate der anti-miR-130b injizierten Eizellen 
signifikant reduziert. Diese Studie liefert Hinweise dafür, dass die miR-130b während der 
bovinen Oozytenmaturation, der Granulosazellproliferation und der Morula- und 
Blastozystenformation funktionell beteiligt ist.  
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Functional analysis of microRNA-130b in bovine oocyte maturation and preimplantation 
embryo development 
 
MicroRNAs (miRNAs) are well known to regulate the proteins involved in various biological 
processes including development. The expression pattern of miRNAs is believed to vary 
between immature and in vitro matured bovine oocytes. Among these, miR-130b was reported 
to upregulated in immatured compared to matured oocytes. However, its functional role in cell 
viability, proliferation or transcription during bovine oocyte maturation and preimplantation 
embryo development is not known. Therefore, this experiment was aimed to investigate the 
functional role of miR-130b in oocyte maturation and oocyte surrounding cells and its 
involvement in preimplantation embryo development. For this, the spatiotemporal expression 
pattern of miR-130 family was performed throughout the bovine preimplantation stage 
embryos. Accordingly, miR-130b was found to be highly expressed in cumulus and granulosa 
cells, immature oocyte, morula and blastocyst stage embryos. Once the expression pattern of 
miR-130b was evaluated, its target genes were in silico analyzed and experimentally validated. 
Accordingly, MSK1, SMAD5, MEOX2, DOC1R and EIF2C4 were found to be the real targets 
of miR-130b.  
To investigate the involvement of miR-130b during oocyte maturation, immatured oocytes were 
microinjected with pre-miR-130b (precursor) or sequence specific antisense (inhibitor) of miR-
130b, while scramble miRNA injected and uninjected oocytes were used as controls. The 
maturational status of the oocytes and the level of miR-130b target genes expression were 
assessed 22 hours post microinjection. The result showed that the first polar body extrusion was 
86.3, 73, 85 and 84.6% in oocytes injected with pre-miR-130b, anti-miR-130b, scramble and 
uninjected controls, respectively. Similarly, mitotic staining showed that majority of oocytes 
injected with anti-miR-130b remains arrested at the telephase I stage (22%) and significantly 
reduced to reach Metaphase II compared to other oocyte groups. In addition, the mitochondrial 
activity was higher in pre-mir-130b and lower in anti-miR-130b injected oocytes compared to 
scramble and uninjected oocytes. This was associated with the reduction of miR-130b and 
increase of its target genes SMAD5 and MSK1 expression. Furthermore, oocyte surrounding 
cells are required for oocyte maturation, the involvement of miR-130b in cumulus and 
granulosa cell proliferation, lactate production and cholesterol level was assessed after 
transfection of pre-miR-130b or anti-miR-130b in both cell types. The inhibition of miR-130b 
resulted in reduction of cell proliferation and lactate production. However, knockdown of miR-
130b did not change the cholesterol level in the granulosa or cumulus cells.  
Apart from oocyte maturation and oocyte companion cell function, the role of miR-130b was 
investigated during preimplantation embryo development by microinjecting zygotes with pre-
miR-130b or anti-miR-130b. The result has shown that the first cleavage rate was unaffected by 
knockdown or ectopic expression of miR-130b, but the rate of morula and blastocyst were 
significantly reduced in anti-miR-130b injected zygotes. Therefore this study provides the 
significant evidence that miR-130b may be required during bovine oocyte in vitro maturation 
and granulosa cell proliferation, morula and blastocyst formation, further functional in depth 
studies are necessary to understand whether miR-130b is involved in bovine oocyte in vivo 
maturation or embryo implantation. 
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1 Introduction   
         
MicroRNAs (miRNAs) are non-coding genetically transcribed small molecule which 
post-transcriptionally fine-tunes the protein regulation in the range of living being from 
prokaryotes to eukaryotes (Abrahante et al. 2003, Bartel 2004, Gottesman 2004, Lewis 
et al. 2005, Lim et al. 2003, Wienholds et al. 2005). miRNAs are conserved in 
eukaryotic organisms that are believe to be a dynamic and evolutionarily ancient 
component of genetic regulation (Kren et al. 2009, Lee et al. 2007, Tanzer and Stadler 
2004), which can target about 60% of human genome (Friedman et al. 2009). Mainly it 
down regulates the gene expression in a range of manners, including translational 
repression, mRNA cleavage, and deadenylation. In animals, miRNAs have shown 
diverse biological functions including ovarian function, spermatogenesis, embryonic 
development, abnormal endometrium, organ development, granulose cells proliferation 
and function and stem cells differentiation (Hayashi et al. 2008, Houbaviy et al. 2003, 
Lagos-Quintana et al. 2002, Lei et al. 2010, Otsuka et al. 2008, Pan and Chegini 2008, 
Yao et al. 2010a, Zhao and Srivastava 2007). In addition, evidences indicated that the 
expression pattern of miRNAs is associated with their specific biological process or 
molecular functions.  
Apart from their significant contribution in different biological or cellular process, the 
role of miRNAs during oocyte maturation and preimplantation embryo development has 
been a focus of research. Development of an embryo depends on the proper genetic 
programming during preimplantation period starts even before fertilization during 
gametogenesis. This genetic programming includes mRNA transcription, miRNA 
transcription and degradation of maternal transcripts (Bashirullah et al. 1999, Bushati et 
al. 2008, Tadros et al. 2007). For instance, some reports have showed the importance of 
miRNAs in oocyte maturation and preimplantation embryo development (Giraldez et al. 
2006, Sempere et al. 2003). Furthermore, Byrne and Warner (2008) indicated the 
involvement of miRNA in the regulation of early development in mice. Additionally, a 
report of Tesfaye et al., (2009) showed expressional differences of miRNAs between 
immature and in vitro matured bovine oocytes, using a heterologous miRNA array 
platform. Accordingly the authors indicated that miR-130b was upregulated in 
immatured oocytes compared to matured oocyte. This may suggest being miR-130b as 
one of the candidate miRNA required to play some significant function during oocyte 
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maturation. This miRNA is known to be conserved in vertebrates and belongs to miR-
130 family by sharing similar seed sequence (Houbaviy et al. 2003, Ma et al. 2010b). 
High expression of miR-130b has been reported in different cancerous cells as, mouse 
mammary tumor (Sun et al. 2009), liver cancer (Jiang et al. 2008, Krutovskikh and 
Herceg 2010), and transformation of mouse cells (Watashi et al. 2010). These reports 
suggest the involvement of miR-130b in controlled or uncontrolled cell proliferation. 
Moreover, miR-130b has been found to be involved in different functions in diverse cell 
types including; mesenchymal stromal cells (Gao et al. 2011), fibroblast cells 
(Mosakhani et al. 2010), gastric cells (Lai et al. 2010), human mammary epithelial cells 
(Borgdorff et al. 2010), gliomas cells (Malzkorn et al. 2010). Despite its functional role 
in different cell types, whether this miRNA involves in cell viability, proliferation and 
transcription during bovine oocyte maturation is not yet known. Therefore, the main 
objectives of this study were 
 
1. To investigate the expression pattern of miR-130b and its related miRNAs in 
bovine oocytes, oocyte companion cells and preimplantation embryo. 
2. To identify and experimentally validate the genes targeted by miR-130b during 
oocyte maturation, granulosa cell proliferation and preimplantation embryo 
development. 
3. To highlight the role of miR-130b in bovine oocyte maturation and cultured 
granulosa and cumulus cells. 
4. To uncover the role of miR-130b during bovine preimplantation in vitro 
development. 
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2 Literature review 
 
In this section the discussion of microRNA discovery, biogenesis, mechanism and the 
principle of target binding is focused. The fundamental knowledge on regulation of 
miRNA has been described. A review on the expression and functional aspect of 
miRNA on mammalian embryogenesis, folliculogenesis, maternal and embryonic 
transcript is accumulated. A brief introduction for the fundamental aspects of miRNA in 
gamete formation, fertilization, preimplantation and the role on embryonic stem cell 
development has been discussed. Moreover, a review on embryonic stem cells 
microRNA, miR-130 family and its role is also added in the later section of this chapter. 
The literature focused on the involvement of the miRNA on embryogenesis. In the end 
the research gap and the mission of the research has reviewed. 
 
2.1 MicroRNAs 
 
MicroRNAs (miRNAs) are small single-stranded, noncoding, endogenous with 19-24 
nucleotides (nt) in length which regulates the expression of genes by binding to the 3'-
untranslated regions (3'-UTR) of specific mRNAs. Till date thousands of miRNAs have 
been identified in virus to plants and animals (Abrahante et al. 2003, Besecker et al. 
2009, Gottesman 2004, Jia et al. 2008, Jung et al. 2009, Lewis et al. 2005, Zhang et al. 
2006) . miRNA can form the largest part of ~1% of total genome and can control the 
regulation of more than 30% of protein coding genes (Lewis et al. 2005). miRNAs can 
play important regulatory roles in posttranscriptional gene regulation by regulating their 
targets by translational inhibition and mRNA destabilization. miRNAs comprise one of 
the most abundant classes of gene regulatory molecules in multicellular organisms and 
likely influence the output of many protein-coding genes. These mechanisms are 
conserved in animal from signaling to chromatin remodeling and transcription (Zhao 
and Srivastava 2007). A single miRNA can target numerous mRNAs or a single mRNA 
can be targeted by numerous miRNAs.  MicroRNAs were discovered in 1993 by Victor 
Ambros, Rosalind Lee and Rhonda Feinbaum during a study of C. elegans development 
and the first published description was given by Lee and colleagues in 1993 (Ambros et 
al. 2003b, Bushati and Cohen 2007, Lee et al. 1993), however the term miRNA was 
coined in 2001 (Lagos-Quintana et al. 2001).  
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In higher eukaryotes hundreds of miRNA genes are predicted to be present and a single 
miRNA having the ability to regulate multiple genes (Lim et al. 2003a). These miRNAs 
may act as key regulators for several processes even for early development by 
posttranscriptional modification (Reinhart et al. 2000), cell proliferation and cell death  
(Brennecke et al. 2003), cell differentiation and apoptosis (Carletti et al. 2010, Hirai et 
al. 2010). miRNAs are also found in brain development (Krichevsky et al. 2003), 
chronic lymphocytic leukemia (Calin et al. 2004), colonic adenocarcinoma, Burkitt’s 
Lymphoma (Pfeffer et al. 2004) and some reports have shown the possible links 
between miRNAs and viral disease, neurodevelopment and cancer (Zhang et al. 2007a). 
Now it is clear that miRNA plays a vital role in post transcriptional gene regulation but 
still specific functions of specific miRNAs is an area of research and very few works 
has been done in this field. Although, in silico analysis, based on target predictions 
using a variety of bioinformatics approaches shows several targets of a specific miRNA 
ranging from one to hundreds (Artzi et al. 2008,minutes.and Yoon 2010), still in 
physiological condition targets are largely unknown. 
 
2.1.1 Discovery of miRNAs  
 
The first microRNA was uncovered through classical genetic methods to identify a 
mutation responsible for abnormal development of the nematodes namely, 
Caenorhabditis elegans (C. elegans) by Ambros and coworkers (Ambros et al. 2003a, 
Ambros et al. 2003b, Reinhart et al. 2000, Wightman et al. 1993). They found that the 
gene lin-4 was essential for post-embryonic development in C. elegans and negatively 
regulates the protein Lin-14. Markingly, when the open reading frame of the lin-4 was 
analyzed it didn’t show any encoding of proteins. Further investigation of lin-4 led to 
the conclusion that it has sequence complementarity with the repeated sequence in the 3' 
untranslated region (UTR) of the lin-14 messenger RNA (mRNA) and thus the 
speculation made for lin-4 may function via an antisense RNA-RNA mechanism by that 
an entirely unexpected class of genes and a novel regulatory mechanism was discovered 
(Bagga et al. 2005, Olsen and Ambros 1999). This discovery of posttranscriptional gene 
regulation has given a new apparatus of gene regulation during development. Initially, it 
was believed that miRNA were unique to C. elegans, however, after several years in 
2000, the second miRNA characterized, let-7 (let=lethal) in C. elegans having 22-nt that 
regulates the expression of protein-coding genes, i.e. lin-41, daf-12, lin-14, lin-28, and 
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lin-42 by targeting the 3' UTR target sites during development of C. elegans 
(Pasquinelli et al. 2000, Reinhart et al. 2000). Initially it was believed that the existence 
of miRNA was limited to C. elegans but later on let-7 was found to be conserved in 
many species. In fact, now miRNAs have known to be present in diverse range of 
organisms from bacteria and viruses to plants and animals (Cai et al. 2005, Chen 2005, 
Nielsen et al. 2009, Reinhart et al. 2002, Zhang et al. 2004). 
 
2.1.2 Biogenesis of microRNA 
 
Biogenesis of miRNA is complicated and differs in plant and animal system. In 
mammals miRNA processing pathway leads to a series of several biochemical steps 
from primary miRNA transcripts to mature functional miRNA. The ~22-nt, mature 
forms of miRNAs arise from multiple processing steps of longer substrate RNAs. 
Around 70% of the mammalian miRNAs are located in enumerate transcription units 
(TU) i.e. intronic and exonic miRNAs (Golan et al. 2010, Rodriguez et al. 2004). 
Moreover, 61% of miRNAs are located in protein coding region, the localization rules 
are discussed further in this section. RNA polymerase II is the transcription factor for 
most of the miRNAs, but the miRNAs located within Alu-repetitive elements are 
transcribed by RNA polymerase III (Chen and Rajewsky 2007, Zeng et al. 2003). They 
also apparently undergo 5'-end 7-methyl guanosine capping, 3'-end polyadenylation and 
splicing (Bracht et al. 2004, Bushati and Cohen 2007). The pri-miRNA with RNA 
hairpin structure of 60-120 nt is processed within the nucleus by a multiprotein complex 
called Microprocessor, whose core components are RNase III enzyme (Drosha) and the 
double-stranded RNA-binding domain protein pasha (DGCR8) (Gregory et al. 2004, 
Han et al. 2004, Landthaler et al. 2004). These proteins are conserved in insects upto 
mammalians. Drosha cleaves the pri-miRNA stem from the distance of the single-
stranded/double-stranded RNA junction (Han et al. 2006) and binding protein helps to 
produce a  ~60-70-nt hairpin precursor miRNA (pre-miRNA) 2-nt 3' overhang (Lee et 
al. 2002), which is a specific characteristic of RNase III enzyme. This cleavage 
recognized by Exportin- 5, and transported into the cytoplasm via a Ran-GTP-
dependent mechanism (Han et al. 2006, Lee et al. 1993, Lund et al. 2004) shown in 
(Figure 2.1), presence of Ran-GTP cofactor is important for binding of Expotin- 5 to 
pre-miRNA (Yi et al. 2003). 
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Figure 2.1: miRNA biogenesis: a. Transcription: The primary miRNA transcripts (pri-
miRNA), are transcribed as individual miRNA genes, from different location 
of DNA, b. Nuclear processing: Processing of the nascent transcript to ~70-
nt stem-loop precursor miRNA (pre-miRNA), c. Nuclear exporting: Export 
of the pre-miRNA from the nucleus, d. Cytoplasmic processing: Processing 
of ~22-bp miRNA duplex, e. Release of the ~22-nt mature miRNA and 
assembly of the miRNA-induced silencing complex (miRISC), f. 
Transcriptional repression or mRNA degradation by miRNA binding to the 
3'UTR of target mRNA (adapted from van Rooij and Olson 2007). 
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Now, the one end of mature miRNA is defined by Drosha and the next end crouched by 
another RNase III enzyme, Dicer. Dicer produce the mature ~22-nt miRNA: miRNA* 
duplex, by slicing, which interacts with TRBP/Loquacious, a dsRBD proteins 
(Chendrimada et al. 2005, Forstemann et al. 2005, Lee et al. 1993). Subsequently, 
TRBP binds directly to Dicer through its C-terminal domain and recruits the trimeric 
complex to the assembly of RNA-induced silencing complex a ribonucleoprotein 
complex (Daniels et al. 2009, Forstemann et al. 2005, Gregory et al. 2005, Ketting et al. 
2001). Overall the whole biogenesis is completed in four major steps: 1. Transcription, 
2. nuclear processing, 3. nuclear exporting and 4. cytoplasmic process (Figure 2.1).  
The localization of miRNA genes within genomes are systematically governed and can 
be grouped as: 
• The miRNAs transcribed with there own promoters as pri-miRNAs are 
Intergenic miRNAs. For example: mir-30a, mir-21.mir-10a, let-7, (Griffiths-
Jones 2004, Lee et al. 2004).  
• The miRNAs located in intronic regions of protein-coding genes in the sense or 
antisense orientation like, mir-93, mir-186, mir-126 (Lagos-Quintana et al. 2001, 
Lagos-Quintana et al. 2003, Rodriguez et al. 2004). 
• Intronic miRNAs located out of protein-coding genes, mir-26a-1, mir-26a-2, 
mir-26b, mir-28 and mir-126 are good examples (Kim and Kim 2007, Lin et al. 
2005, Rodriguez et al. 2004). 
• Most of the miRNA genes (about 50%) are polycistronic in nature and transcribe 
in cluster form from the genome. Examples of such clusters are well known such 
as let family, miR-17-92 clusters (Hayashita et al. 2005, Lagos-Quintana et al. 
2001, Lau et al. 2001, Mourelatos et al. 2002). 
• Some miRNA comes in an exon of the non-coding RNA. For example, miR-10, 
is located in the Hox gene cluster in insects, zebrafish, mouse and human 
(Lagos-Quintana et al. 2003).  
 
2.1.3 RNA induces silencing complex assembly  
 
The RNA-induced silencing complex assembles on short interfering (si) RNA 
fragments and cleaves target mRNAs that hybridize with the siRNA RISC forms 
through an ATP-dependent assembly pathway that includes a siRNA-unwinding step 
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(Figure 2.1). The relative thermodynamic stabilities of the ends of the siRNA duplex 
help to specify the strand that will ultimately assemble into RISC. RISC is a multiple-
turnover, divalent-metal-ion-dependent enzyme that hydrolyses the target 
phosphodiester linkage, leaving 3'-hydroxyl and 5'-phosphate perfection (Krol et al. 
2004, Sontheimer 2005).  
The miRNA strand with relatively lower stability of base-pairing at its 5' end is 
incorporated into RISC, whereas the miRNA* strand is degraded (Ambros et al. 2003a, 
Du and Zamore 2005). According to some thermodynamic arguments the selection of 
mature miRNA strand was performed and the 5' end that is more easily peeled away 
from its antisense is incorporated into a stable complex and the other half is unprotected 
and degraded (Khvorova et al. 2003). The position of the stem-loop may also influence 
strand choice (Lin et al. 2005). Finally, the assembly of RISC and miRNA recognize the 
3'UTR site of mRNA and binds to it (Figure 2.2). Argonauts are needed for miRNA-
induced silencing and having two RNA binding domains. These domains are conserved 
and known as PAZ and PIWI (structurally same to ribonuclease-H). PAZ domain 
having the ability to interact the 3' end of a single strand in the mature miRNA and 
PIWI domain which binds to the 5' end of the guide strand. They bind the mature 
miRNA and orient it for interaction with a target mRNA. Among argonautes, Ago2 is 
important for direct cleavage of target transcripts (Cifuentes et al. 2010). Argonautes 
may also activate some other unknown proteins which help to achieve translational 
repression (Pratt and MacRae 2009). In human genome argonaute proteins are eight 
types among that each four have sequence similarities into two families: AGO 
(E1F2C/Ago), and PIWI (Schwarz and Zamore 2002). Here, these proteins make the 
fate of mRNA cleavage of suppression. In the process of mRNA cleavage, the miRNA 
pathway appears to be biochemically very much similar to the RNA silencing pathway 
known as RNA interference (RNAi) (Fire et al. 1998, Zeng et al. 2003). In the last step 
RISC identifies its targets by the perfect complementarily between the miRNA and the 
mRNA and cleaved directly by Argonaute2 (AGO2) protein (Bushati and Cohen 2007, 
Choe et al. 2010). It is assumed that in mammal the most common complementarity is 
imperfect match and leads for translation suppression inspite of mRNA cleavage. These 
uncleaved mRNA accumulates within discrete cytoplasmic foci called Processing 
bodies (P-bodies) where they are inaccessible to the translational machinery and 
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destroyed by RNA-degrading enzymes (Sen and Blau 2005). The RISC binding to 
miRNA and further process to p-body has shown in figure 2.2. 
 
           
 
Figure 2.2: RNA induces silencing complex assembly and binding to siRNA or miRNA. 
siRISC binds to its target mRNA by perfectly matching base pairs, cleaves 
the target mRNA, recycles the complex, and does not require P-body 
structures for its function. Multiple numbers of miRISC bind to target 
mRNA by forming a bulge sequence in the middle that is not suitable for 
RNA cleavage, accumulate in P-bodies, and repress translation by exploiting 
global translational suppressors such as RCK/p54. The translationally 
repressed mRNA is either stored in P-bodies or enters the mRNA decay 
pathway for destruction. Depending upon cellular conditions and stimuli, 
stored mRNA can either re-enter the translation or mRNA decay pathways 
(from Herrera-Esparza et al. 2008). 
 
2.1.4 Principle of miRNA target prediction 
 
The prediction of miRNA targets is critical and several approaches are available to 
predict the miRNA target gene. It is known that a miRNA can able to target a number of 
genes and a single gene can be targeted by a number of miRNAs, but still, identification 
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and validation of the real targets is not an easy task. The efficacy of in silico validation 
to locate and grade the possible genomic binding sites is supported by the relatively 
high degree of miRNA complementarity to experimentally determine the binding sites. 
The prediction of miRNA target is depending upon the sequence binding or 
miRNA/mRNA interaction. This interaction depends upon the 5' seed sequence match 
of miRNA, conservation of the sequence and the thermodynamic stability between 
miRNA and mRNA (Krol et al. 2004, Ni et al. 2010). Several target prediction 
programs are available based on the above mentioned criteria. The most popular site for 
target prediction is miRanda (www.microrna.org/microrna/home.do) which is based on 
the principle of sequence match and binding energy between the miRNA/mRNA and 
the evolutionary conservation of the gene target binding site. The estimated false 
positive rate for this program is approximately 24-39% (Enright et al. 2003). Next 
known target prediction site for mammalian miRNA targets is TargetScan 
(www.targetscan.org). It is based on the 8 mer or 7 mer conserved sites that match the 
seed sequence of the miRNA and also on the free energy using the RNA fold algorithm. 
For this program, the estimated false positive rate is between 22-31% (Enright et al. 
2003). In this site conserved targeting has also been detected within open reading 
frames (Lewis et al. 2005). The third well known target prediction site is PicTar 
(pictar.bio.nyu.edu) which is used to identify miRNA target genes in vertebrates, 
Drosophila and C. elegans (Grun et al. 2005, Krek et al. 2005, Lall et al. 2006). The 
estimated false positive rate for this program is approximately 30%. Moreover, these 
programs identify targets for single miRNA as well as targets that are regulated by 
several miRNAs in a coordinated manner. This suggests that miRNA and target network 
might be more complicated than originally expected and the experimental validation 
should be performed carefully. However, prediction programs don’t account for all of 
the criteria by mutated target binding sites of the 5' seed region of the miRNA. This 5' 
seed, consisting of 2-8 nts, must bind perfectly to the target mRNA sequence. The 
Cohen laboratory reported the minimal target site for miRNA function. They mentioned 
that seven or more sequences that are complementary at the 5' end of the miRNA are 
enough to show function. If the 3' sequence has weaker binding, then the 3' 
compensatory binding is required (Vella et al. 2004). The possibility of miRNA:mRNA 
binding was schematically described in (Figure 2.3). 
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Figure 2.3: The schematic description of the miRNA seed sequence binding to target 
mRNA. The perfect seed binding extended with 3’ site ends with mRNA 
cleavage. Imperfect binding of seed sequence is not enough for mRNA 
degradation but suppress the function. Wobble (G:U) pairing in seed 
sequence don’t allow the complementary binding of miRNA and mRNA. 
 
2.1.5 Regulatory mechanism of microRNA in animals  
 
When the miRNA is incorporated into the miRISC, it interacts with specific sites of the 
3’UTR of target mRNAs and downregulates their expression, either by translational 
repression or by mRNA degradation in animals (Ambros 2004, Bartel 2004). In nearly-
perfect complementarity, the miRNA with nearly-perfect complementarity to target 
sites cleaves the mRNA directly, as like as siRNA. In partial complementarity, the 
miRNA complement to the target site of 3’UTR of the mRNA but not binds to whole 
seed sequence, it can be 7 to 5 nt bond in seed region, which results in translational 
repression without mRNA cleavage (Ajay et al. 2010). Most of the animal miRNA 
binds with partial complementarity and repress the translation of protein (Fabian et al. 
2010). But some miRNA in animals also make near-perfect complementarity, like miR-
196 sequence binds nearly-perfect site to HOXB8 during vertebrate development 
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(Yekta et al. 2004). In some other cases also we show, miRNAs can guide mRNA 
cleavage in animals as in muscle stem cells, the 3’UTR of the Pax3 mRNA has some 
perfect sequence for miR-27b seed sequence, which leads to the initiation of cleavage of 
the Pax3 mRNA (Crist et al. 2009). The mechanism of regulation is determined by the 
degree of miRNA and mRNA binding, reviewed in (Huntzinger and Izaurralde 2011). 
However, the first model is most common for plant gene silencing with mRNA 
cleavage and the second model, translational repression is consider being more 
prevalent in animals. 
Several mechanistic studies of translational repression have led to different conclusions. 
In the original studies of the lin-4/lin14 interaction in C. elegans presented that 
repression occurs after translational initiation. The lin-14 mRNA was found to be stably 
associate with polysomes, suggesting either an arrest of translational elongation 
(ribosomal stalling), or cotranslational peptide degradation (Olsen and Ambros 1999). 
In contrast, Pillai and colleagues have evidenced that inhibition of translational 
initiation occurs by let-7 in human cells. They evaluated that: i) mRNA which is 
targeted by miRNA accumulates in P-bodies. ii) the mRNAs which falls in P-bodies 
unable to undergo translation; and iii) miRNAs don’t allow the mRNA to load into 
polysomes (Pillai et al. 2005). In addition, alteration of translation initiation, can make 
the mRNA resistant to miRNA–induced repression, for example when mRNA binds to 
the translational factors Eukaryotic translation initiation factor 4E or Eukaryotic 
translation initiation factor 4G directly it resist to miRNA repression (Hoeffer et al. 
2011, Valencia-Sanchez et al. 2006). It leaves further some uncovered questions related 
to the target of the miRNA/mRNA complex in P-bodies, whether it is the site of 
translational inhibition by the miRNA machinery, or if P-bodies represent only as a 
storage area for repressed mRNA (Valencia-Sanchez et al. 2006). 
 
2.2 Biological functions of miRNAs in animals 
 
In animals, miRNAs have shown diverse biological functions. There are several 
approaches which lead to the evidence of the function of miRNAs in animals (Figure 
2.4). At first, several miRNAs in C. elegans and D. melanogaster were identified by 
forward genetics (loss- and gain-of-function genetic screens). The study in c elegans 
showed, miRNA effects the early developmental timing (Lee et al. 1993, Moss et al. 
1997, Wightman et al. 1993) where lin-4 targets lin-14 and lin-28, let-7 targets lin-41 
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and daf-12 that affects late developmental timing (Lin et al. 2003, Reinhart et al. 2000), 
miR-273 affects neuronal left/right asymmetry  (Chang et al. 2004). In Drosophila miR-
14 regulates programmed cell death and metabolism (Brennecke et al. 2003, Xu et al. 
2003), miR-7 regulates notch signalling (Lai et al. 2005, Stark et al. 2003), and in 
zebrafish miR-430 affects brain morphogenesis (Giraldez et al. 2005). Some other 
helpful approaches to find the function of miRNAs are reverse genetic approaches and 
computational predictions. Reverse genetic approaches for miRNA includes miRNA 
knockout or knockdown (Hutvagner et al. 2004, Lecellier et al. 2005, Meister et al. 
2004a). Which showed, different roles for argonaute proteins in small RNA-directed 
RNA cleavage pathways (Okamura et al. 2004) and sequence-specific inhibition of 
small RNA function (Hutvagner et al. 2004). By computational predictions, almost all 
miRNAs target genes are analyzed (Huang et al. 2010, Koscianska et al. 2007, Lai 
2004, Mosakhani et al. 2010). According to computational analysis, hundreds of genes 
can be predicted to be targeted by each miRNA (Enright et al. 2003). However, the 
molecular details of the suppression of genes via miRNA-mediated suppression are still 
being investigated using forward and reverse genetic approaches. In addition, the 
miRNA expression profiles using microarray, real-time PCR and in situ localization 
have revealed specific miRNA expression patterns, which can clue the functions of the 
specific miRNA in specific tissue or organ. For example, mir-155, mir-130b, mir-21 are 
highly regulated in cancerous tissues which avail the role of these miRNA as oncomiR 
(Jiang et al. 2010, Medina et al. 2010, Yeung et al. 2008). Whereas, minimization of 
tumour in hepatoma cell lines was observed by miR-199-5p miRNA which targets 
discoidin domain receptor-1 (DDR1) tyrosine kinase. The downregulation of miR-199-
5p allow the DDR1 to deregulate and increase cell invasion (Shen et al. 2010a). Few 
genes responsible for disease have been identified using forward and reverse genetic 
screens approached by experimental validation, such as, miR-155 targets the suppressor 
of cytokine signaling 1 and induces breast cancer in mammals and by targeting SMAD2 
miR-155 modulates the response of macrophages to transforming growth factor-beta 
(Jiang et al. 2010, Louafi et al. 2010), miR-21 blocked NF-κB activity and promoted IL-
10 by regulating PDCD4 expression after LPS stimulation of human peripheral blood 
mononuclear cells (Sheedy et al. 2010). Some recent research shows that miRNAs can 
also potentially bind to complementary sequences in the open reading frame (Borgdorff 
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et al. 2010) or to 5´ UTR of an mRNA (Zhang et al. 2004). The different approaches to 
achieve the function of miRNA in animals are shown in figure 2.4. 
 
 
 
Figure 2.4: Different approaches used to identify the miRNA genes, target genes and 
functions of miRNAs in animals with an example. Ce: Caenorhabditis 
elegans; Dm: Drosophila melanogaster; Dr: Danio rerio; Hs: Homo sapiens; 
Mm: Mus musculus (from Wienholds and Plasterk 2005). 
 
2.3 Expression and role of miRNA in mammalian folliculogenesis and embryogenesis 
 
The following section highlights the accessible information of miRNA in 
fundamentals of mammalian foliculogenesis and preimplantation embryo development. 
 
2.3.1. Involvement of miRNA in follicular development  
 
Early folliculogenesis in mammalian ovary begins with the breakdown of germ cell 
clusters and formation of primordial follicles. Each follicle has immature oocytes 
surrounded by flat and squamous granulosa cells that are separated from the oocyte's 
environment by the basal lamina. Primordial follicles are able to maintain dormant 
phase by few weeks to several years in cattle and shows a little or no biological 
activities (Choi and Rajkovic 2006, Knight and Glister 2001). Later it undergoes for 
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developmental process in which primordial follicle activated and develops to a 
preovulatory size following growth and differentiation of the oocyte (Choi and Rajkovic 
2006, Gougeon 1996, Salama et al. 2010). Throughout puberty, the pools of primordial 
follicles are continuously growing and the primordial follicles from a resting to a 
growing stage can be observed throughout life. After puberty, gonadotrophin-dependent 
growth occurs in a cohort of antral follicles and follicle depletion starts at a very high 
rate. At birth, millions of primordial follicles remain which requites very few follicles to 
reach up to the ovulatory stage, where by most non-ovulatory follicles undergoes for 
atresia. During folliculogenesis atresia is a common phenomenon observed in vivo and 
in vitro (Fujino et al. 1996, Grotowski et al. 1997, Matsuda et al. 2011, Perez et al. 
1997, Wang et al. 2011). During the time of development, it achieves several stages 
namely, primary, secondary, tertiary and graafian (Hutt and Albertini 2007, Smitz and 
Cortvrindt 2002). These stages are characterised according to the follicle and oocyte 
size, development and antrum formation, shown in figure 2.5.   
 
  
 
Figure 2.5: Stages of mammalian oogenesis and folliculogenesis. PGD: primordial germ 
cells, n: chromosomal and C: DNA content (from Picton et al. 1998). 
 
In the process of follicular growth, the oocyte plays an important role in genetically 
programming and coordination of the multiple events during folliculogenesis and 
embryogenesis (Dean et al. 2001, Madan et al. 2003). Similarly, oocyte surrounding 
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granulosa cells also plays a major role for the development and growth of oocyte. The 
granulosa cells are uniform in developing follicles but after the antrum formation 
mostly at preovulatory stage these granulosa cells are differentiated in theca granulosa, 
mural granulosa and cumulus granulosa cells (Gilchrist et al. 2001, Hutt and Albertini 
2007). The cells adjacent to the oocyte during ovulation are known as cumulus cells. 
The cumulus cells and oocytes are tightly connected to each other and facilitate 
heterologous interactions as, metabolites, ions and small signalling molecules exchange 
(Nicholson 2003). Cumulus cells provide metabolites, cholesterols, steroids, epidermal 
growth factor (EGF) and hormones to growing oocytes (Nyholt de Prada et al. 2009, 
Zamah et al. 2010). During this growth granulosa cells are highly proliferated and 
undergo several metabolic changes by the influence of transforming growth factors 
(TGFs) which involves SMADs protein signaling pathway. In oocyte and granulosa 
cells SMAD signaling pathway involves three different ligands (Table 1) with receptor I 
and II and further leads to the phosphorylation of transcriptional factor (Kawabata and 
Miyazono 1999, Myers and Pangas 2010), MSK1 gene has also been reported to be 
involved in the TGF-β activated SMAD signaling pathway. In folliculogenesis gene 
transcription, posttranscriptional modification, protein synthesis and storage play a vital 
role. Several reports indicated that SMAD5 increases granulosa cell mitosis, stimulates 
preantral follicular growth and its function in rodent (Myers and Pangas 2010), but for 
ruminants and also in pigs the SMAD pathway shows mildly or even inhibitory effect in 
respect to both cell proliferation and function (Gilchrist et al. 2008). In bovine, SMAD 
pathway is highly active in preantral follicles and it performs for suppression of 
granulosa cell proliferation and promotes apoptosis (Zheng et al. 2009). Investigation of 
the biological role of SMAD family shows their influence on estradiol (E2) and 
progesterone (P4) biosynthesis in bovine granulosa cells by targeting the steroidogenic 
enzymes and inhibits luteinization in cultured bovine granulosa cells further leads to 
increased apoptosis (Yu et al. 2004, Zheng et al. 2008, Zheng et al. 2009) 
Recently, some evidences showing the presence of miRNA in follicular cells (Carletti et 
al. 2010, Yao et al. 2010b) and the role of miRNA in ovarian function was well 
reviewed by Christenson (2010). Presence of miRNA and small RNA library 
construction was conformed in new born and 2 weeks old mouse ovary (Ahn et al. 
2010, Alvarez-Garcia and Miska 2005, Ro et al. 2007a, Ro et al. 2007b) and also in 
bovine ovaries, the miRNA and small RNA library was constructed with the findings of 
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some novel miRNAs (Hossain et al. 2009, Tripurani et al. 2010). Conditional 
inactivation of Dicer1 in follicular granulosa cells leads to increased primordial follicle 
numbers and increased early follicle recruitment (Huang and Yao 2010, Lei et al. 2010). 
Dicer1 knockout shows female infertility due to impaired growth of new vessels in the 
corpus luteum (Otsuka et al. 2008).  
Regarding the male fertility and folliculogenesis, miRNAs show their importance in 
many aspects; Dicer lacking male (where biogenesis of miRNA was interrupted) shows 
delayed in fertility, reduced proliferation of primordial germ cells and spermatogonia 
leading to spermatogenic arrest (Hayashi et al. 2008, Maatouk et al. 2008). While 
female lacking Dicer is infertile and decreased ovulation (Hong et al. 2008, Nagaraja et 
al. 2008). In regard to the specific cells of follicles, several investigations has done to 
find the factors involved in regulation of miRNA or the factors regulated by miRNA 
during folliculogenesis. A recent report shows that human chorionic gonadotrophin 
(hCG) supplementation and vitamin C status alter the miRNA expression profiles in 
oocytes and granulosa cells during in vitro growth of murine follicles (Kim et al. 
2010b).  FSH-mediated progesterone secretion of cultured granulosa cells has alternated 
the expression of around 31 miRNA showing pleiotropic effects of FSH (Yao et al. 
2010b). There are some other reports which indicated the role of miRNA in granulosa 
cell proliferation by the regulation of SMAD signalling pathway. TGF-β, BMP and 
Activin are the key regulators of SMAD signalling pathway. TGF-β treatment during in 
vitro culture of mouse preantral granulosa cells has shown the up-regulation of 3 
miRNAs and down regulation of 13 miRNAs in  were down-regulated the report also 
shows the regulation of SMAD4 was under the control of miR-224 in granulosa cells 
(Yao et al. 2010a). miRNA can play a role as apoptotic marker as well as these miRNA 
can controls the apoptotic pathway in ovarian cells which is witnessed by the work 
showing increase in the apoptotic markers as, caspase 3 and control of apoptosis in 
ovarian cells and increased ovulation by miR-21 (Carletti et al. 2010). Several other 
reports have shown the regulation of ovarian function, prevention of granulosa cell 
apoptosis, control of hormonal secretion in granulosa cells via some miRNA (Hawkins 
and Matzuk 2010, Hennebold 2010, Sirotkin et al. 2009). Dicer1 plays important roles 
in follicular cell development through the differential regulation of gene expression. 
Recently a report has indicated for the involvement of TGF-β regulates miRNA 
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regulation (Yao et al. 2010a) or vice versa (Davis et al. 2008, Kahata et al. 2004, Rogler 
et al. 2009). 
 
2.3.2. Gametes formation and the involvement of miRNA   
 
Gametes formation is a biological process by which diploid or haploid precursor cells 
undergo cell division and differentiation to form mature haploid gametes. In female it is 
called oogenesis or development of oocyte and in male it is known as spermatogenesis. 
 
2.3.2.1 Expression and role of miRNA in oocyte maturation 
 
Mammalian oocytes are arrested at prophase I of meiosis before induction of maturation 
by the preovulatory luteinizing hormone (LH) surge at the stage of puberty. It is known 
that the oocyte plays an important role in the progression of follicle growth and 
granulosa cell differentiation. The bidirectional communication promotes oocyte to 
secrete soluble paracrine growth factors which are uptaken by companion granulosa 
cells, and help for oocyte development. This oocyte-cumulus cell interacts with each 
other and prevents luteinization of cumulus cells by suppressing luteinizing hormone 
receptor expression and promoting growth factor, steroidogenesis and inhibin synthesis 
(Eppig 1985, Gilchrist et al. 2004). During embryogenesis the maternally-inherited 
RNAs and proteins are stored within the oocyte, these RNAs and proteins are essential 
for completion of the meiotic cell cycle, initial cleavage divisions and the establishment 
of an embryonic genome and regulation of preimplantation embryo development 
(Bilodeau-Goeseels 2003, Lieberfarb et al. 1996, Mtango et al. 2008, Pepling 2010, 
Schier 2007). 
Oocyte maturation is a complex event in which the oocyte break it’s quiescent and 
progress to the MII stage (nuclear maturation) from the stage of diplotene of prophase I. 
The surge of LH evokes the resumption of meiosis in oocytes. The oocytes in meiosis 
were relaxed and structurally forms vesicle known as germinal vesicle. This GV arrest 
is continuing until the puberty and after that the meiosis resumes occurs. In cattle, the 
age of puberty is 7-18 months in males and 18-24 months in heifers. As the meiosis 
revive reductive division starts, the GV disappears and the chromatin is recondensed, 
the pairs of homologous chromosomes are separated in half and a part with reduced 
amount of cytoplasm forming the first polar body. Here again the meiosis interrupted 
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(in metaphase II). The starting of the complex process of maturation attends with GV 
breaking and further follow with several other steps which are discuss further and 
completed by the formation of the first polar body, with the outcome of a mature and 
fertile oocyte (Dekel et al. 1989, Homa 1995), that are able to be fertilized by sperm. 
All mammals having approximate same process of mitotic activation but the timing of 
the cycle differs in each species. In cattle the timing taken for maturation can be divided 
as GVBD: 6 hrs, metaphase I: 12-14hrs, telophase: 18 -20 hrs, nuclear maturation: 22-
24 hrs. Here the oocyte remains arrested at the MII stage until the fertilization takes 
place (Hunter and Moor 1987, Sato et al. 1990). Meanwhile, cytoplasmic maturation 
also takes place which involves organelle reorganization and storage of mRNAs, 
proteins and transcription factors that controls the whole maturation process, 
fertilization and early embryogenesis (Ferreira et al. 2009, Liehman et al. 1986). The 
meiotic maturation depends on a high level of cAMP within the oocyte too, in vitro 
culture of bovine oocyte shows the prominent amount of cAMP is important to regulate 
resumption of meiosis (Lee et al. 2010, Sanbuissho et al. 1992). Once the oocyte gets 
mature it get arrested in MII stage until it gets fertilized within certain timing. The arrest 
is managed by the constantly high activity of cyclin B and the protein kinase p34cdc2 
(MPF) with the entry of M-phase by activation of MPF, (Fan et al. 2004, Gavin et al. 
1999, Palmer et al. 1998, Palmer and Nebreda 2000). MPF is necessary to maintain MII 
arrest and to sustain MPF Cytostatic Factor (CSF) function is required (Dumont et al. 
2005). MAPK plays a crucial role in the activation of CFS (Fissore et al. 1996). The 
MAPK has a role in promoting MPF activation and in assisting meiotic resumption 
(Fissore et al. 1996, Ohashi et al. 2003). The activation of MAPK mediates the 
activation of MPF, a key regulator of the M phase and results in the induction of GVBD 
in xenopus (Gotoh and Nishida 1995, Hehl et al. 2001), mouse (de Vantery Arrighi et 
al. 2000), bovine (Fissore et al. 1996) and porcine (Ohashi et al. 2003). MSK1 
(RPS6KA5) is a downstream protein of MAPK which phosphorylates the 
transcriptional factors. MSK1 is required for CREB and ATF1 phosphorylation after 
mitogenic stimulation of mouse ES cells (Arthur and Cohen 2000) fibroblasts (Wiggin 
et al. 2002).  MSK1 is also involved in TGF-β mediated pathway, here the capability of 
SMAD3 to mediate TGF-β induced transcriptional responses was blocked by 
suppressing the prosphorylation of MSK1 (Abecassis et al. 2004). It also illustrates the 
involvement of MSK1 in SMAD signalling pathway. In the ovulating follicle, oocyte-
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secreted factors also play vital roles in enabling cumulus cell expansion and regulating 
extracellular matrix stability, thus facilitating ovulation. The identity of these oocyte-
secreted growth factors regulating such key ovarian functions remain unknown, 
although growth differentiation factor-9 (GDF-9), bone morphogenetic protein-15 
(BMP-15) are likely candidate molecules, probably forming complex local interactions 
with other related members of the TGF-β superfamily shown in Table 1. 
 
Table 1: The genes involved in SMAD signalling pathway during folliculogenesis and      
oocyte maturation. 
Ligands BMP TGFβ Activin 
Signaling Receptors: ALK2 ALK2 ALK2 
Type I ALK3 ALK5 ALK4 
 ALK6   
Binding Receptors: BMPR2 TGFBR2 ACVR2A 
(Type II)   ACVR2B 
Receptor Smads: SMAD1 SMAD2 SMAD2 
 SMAD5 SMAD3 SMAD3 
 SMAD8   
Common Smad: SMAD4 SMAD4 SMAD4 
Suppressor Smads: SMAD7 SMAD7 SMAD7 
 SMAD6   
 
Oocyte-derived bone morphogenetic protein 15 (BMP15) and growth differentiation 
factor 9 (GDF9) are key regulators of follicular development (Paulini and Melo, Paulini 
and Melo 2011), in the transient of the primary follicle to secondary follicle, growth 
differentiation factor 9 (GDF9) in mouse (Sasseville et al. 2010) and bone 
morphogenetic protein 15 (BMP15) (Galvin et al. 2010) in sheep (Xu et al. 2010) are 
essential and playing an important role in animal fertility. GDF9 and BMP15 are the 
regulation members of the TGF-β superfamily that play crucial roles in mammals 
(Chang et al. 2002, Otsuka et al. 2011). These transcriptions are most closely 
homologous to each other in the family and are synthesized in oocytes beginning of the 
recruitment of primordial follicles (Elvin et al. 2000). The SMAD signalling pathway is 
a key regulator of TGF-β signalling and involved in the regulation of cumulus cell 
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metabolism, particularly glycolysis and cholesterol biosynthesis before the preovulatory 
surge of luteinizing hormone (Gilchrist et al. 2004). The better understanding of the 
relationship between the oocyte and its companion somatic cells are changing as we are 
gaining the appropriate greater understanding of these factors in folliculogenesis (Su et 
al. 2008). The crosstalk between oocyte and its surrounding cells are shown in figure 
2.6.  
 
           
 
Figure 2.6: Crosstalk between the oocyte and granulosa cells (both cumulus and mural) 
is integral for various stages of folliculogenesis. Oocyte-derived factors act 
via SMAD 1/5/8 and SMAD 2/3 respectively, to elicit cellular responses that 
are essential for successful folliculogenesis and ovulation (from Myers and 
Pangas 2010). 
 
Presence of miRNA in oocyte is vital and well known. There are several evidences 
which show the presence and function of miRNA in oocyte. The role of miRNA in 
oocyte was first identified by the group of Nakahara in drosophila and they found that 
the accumulation of 40S ribosomal protein and S2 protein is inhibited by miRNAs 
during oocyte maturation by global suppression of miRNA (Nakahara et al. 2005). 
Identification and expression of miRNA in oocyte were done by adapting RT-PCR 
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based miRNA detection using homologous or heterologous approaches in mouse (Choi 
et al. 2007, Tam et al. 2008) and bovine (Tesfaye et al. 2009). However, Watanabe and 
co-workers managed to clone miRNA with two other small noncoding RNAs, 
retrotransposon-derived siRNAs from mouse oocyte and germline small RNAs in male 
germline (Watanabe et al. 2006). Expression profiling of miRNA in oocyte and the 
surrounding cumulus cells (Giraldez et al. 2006) has shown a differential regulation of 
miRNA in oocyte and its surrounding communicating cells (Hawkins and Matzuk 
2010). 
Cloning of miRNA was been possible during oocyte development in bovine by 
Tripurani et al. in 2010. In which, bta-mir424 and bta-mir-10b showed high expression 
patterns during oocyte maturation and preimplantation development of bovine embryos, 
both the miRNAs were abundant in GV and Metaphase II stage oocytes (Tripurani et al. 
2010). Degradation of maternal transcripts in zebrafish has reported by manipulation a 
single miRNA miR-430 in oocytes (Giraldez et al. 2006). As, the miRNA processing 
genes directly related to the function and biogenesis of miRNA, here an importance of 
maternal transcript argonaute 2 is reported being essential for early mouse development 
is shown by argunate2 knockout mouse (Lykke-Andersen et al. 2008). Dicer is will 
known for the notching of siRNA and miRNA both. The abnormal spindle assembly in 
oocyte and the aberrant chromosomal organization has attended the important and 
markable role during oogenesis and were essential for meiotic completion (Liu et al. 
2010). Dicer1 is highly expressed and functionally important in the oocytes during 
folliculogenesis as well as in the mature oocytes. Dicer lacking in growing oocytes 
shown the importance of maternal miRNA for zygote formation resulted in an arrest of 
zygotic development mice, arrest in meiosis I with multiple disorganized spindles and 
severe chromosome congression defects defective spindle organization and further 
embryonic development. This analysis had also shown the misregulation of several 
transcripts and proteins in Dicer1 knockout oocytes, which demonstrates that the 
maternal miRNAs are essential for the early stage embryonic development in mouse 
(Murchison et al. 2007, Tang et al. 2007, Watanabe et al. 2008). The Dicer-knockout 
models in oocytes are not only evidence the imperative role of miRNAs in the oocyte 
but also indicate that the regulations of maternal transcripts are fine tuned by the 
influence of miRNA. Although there are some recent report which shows the limited 
role of miRNA in oocyte and preimplantation development in mouse (Suh et al. 2010), 
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there is a wide spectrum to analyze a specific miRNA showing role in oocyte 
maturation and further development. Specially the functional characterization for the 
bovine oocyte and corresponding cumulus cells are remains to be articulated.  
 
2.3.2.2 Expression and role of miRNA in spermatogenesis 
 
Spermatogenesis is the process by which male primary germ cells divide and produce a 
number of cells of same type termed spermatogonia. This spermatogonia forms primary 
spermatocytes and end to two secondary spermatocytes. Further, secondary 
spermatocytes divide into two spermatozoa. These spermatozoa develop and mature to 
form sperm cells. Spermatozoa are the mature male gametes in many sexually 
reproducing organisms (O'Donnell et al. 2001). Thus, spermatogenesis is the complex 
biological process tightly regulated with stage-specific genes transcriptions and 
remodelling (Johnston et al. 2008). Identification and function of miRNA in mammalian 
sperms were reported by different researchers (Bouhallier et al. 2010, Hayashi et al. 
2008, Yan et al. 2009). In porcine miRNA has shown a high degree of sequence 
conservation among other mammalian species (Curry et al. 2009). A different study of 
miRNA expression profile using microarray analysis in testis tissues from immature 
rhesus monkey indicate that miRNAs are extensively involved in spermatogenesis (Yan 
et al. 2009). Furthermore, some studies showed the specific gene regulation by miRNA. 
Here, RNA –binding protein, Dead end 1 (Dnd1), is essential for fetal male germ cell 
development which prevents the miRNA-mediated repression of cell cycle-related 
target mRNAs (Cook et al. 2011, Kedde et al. 2007). Recently a study in mouse 
pachytene spermatocytes and round spermatids cells showed the expression of miR-34c 
could enhance spermatogenesis (Bouhallier et al. 2010). Another study of specific 
miRNA member of oncomir-1 cluster family, miR-18 directly targets the heat shock 
factor 2 and affects the transcription factor in spermatogenesis (Bjork et al. 2010). 
Similar study of individual miRNA has shown the regulation of Tnp2 (a gene involved 
in chromatin remodeling) during spermatogenesis by miR-122a (Yu et al. 2005). For the 
study of miRNA function miRNA processing genes also been manipulated. Dicer (a 
cytoplasmic protein function for miRNA and siRNA stemloop cleavage) deletion results 
in a loss of sperm and validates the importance of miRNA for proper proper 
differentiation of the male germline (Hayashi et al. 2008, Maatouk et al. 2008)  
Similarly, the deletion of Argonaute 2 (Ago2), has shown not significant different 
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phenotype of testis (Hayashi et al. 2008). The presence of miRNA in sperm was shown 
by Amanai group (Amanai et al. 2006). Although, the role of miRNA derived from 
sperm was limited in fertilization and embryo formation in comparison to oocyte 
derived miRNAs even miRNAs are playing role for spermatogenesis and there 
regulation.   
 
2.4 Role of miRNAs in fertilization and preimplantation embryo development   
 
In the process of bovine fertilization, the fusion of an oocyte with a sperm occurs either 
in vivo or in vitro, which finally leads to the development of an embryo. In vivo 
fertilization performed by millions of sperms deposited into the vagina during mating. 
The sperms make their way through the cervix into the uterus and then on to the 
fallopian tubes where mature oocyte waits for it. During this all process the number of 
sperm decline and only few hundred sperms get close to the oocyte. Once inside the 
fallopian tube, the sperm attracts towards the oocyte (surrounded by cumulus cells and 
zona pellucida) by releasing a chemical substrate (Krug et al. 2009). Where as, in vitro 
fertilization occur in a petri plate, where a number of sperms are allowed to interact 
with oocyte. The cumulus cells allow the sperm to interact and the zona pellucida 
interrupt polyfertility and allow only one sperm to penetrate it. Head of the sperm 
releases its genetic contents, which fuses with the nucleus of oocyte and the 
fertilization, occurs. The embryo formed is known as zygote. The early embryo 
development starts with eventual cleavage and forming blastomeres (Fields et al. 2011). 
In the early development of bovine embryo the preimplantation period remains from 
day 1 to day 8 surrounded with zona pellucida (Panigel et al. 1975). The embryos enter 
into several divisions after fertilization. The zygote is large cell, having a low nuclear to 
cytoplasmic ratio (Figure 2.6). To attain a ratio similar to somatic cells, cell divisions 
occur without an increase in cell mass. This process is referred as cleavage. The 
cleavage starts 2 days post fertilization and reaches to expended blastocyst by day 9 or 
10 with containing 250 cells. In between day 3 and 4 after fertilization the embryo with 
8-16 cells and by 5 to 6 days it reaches to 32-64 cell stage which known as morula 
stage. It forms early blastocyst in 7 days with ~128 cells (all stages of preimplantation 
embryos are shown in Figure 2.7). 
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Figure 2.7: Schematic diagram of in vitro preimplantation embryo development in 
bovine 
 
Here after the embryo undergoes compaction and forms blastocyst with blastocoelic 
cavities by reaching the day 8.Blastocyst formation (cavitation) is essential for 
implantation and subsequent development and implantation failure is a principal cause 
of early pregnancy loss (Starbuck et al. 2004) in cow (Ealy and Yang 2009, Khatib et al. 
2009, Pretheeban et al. 2009). The blastocoelic cavity and compaction allows the cells 
to differentiate into inner cell mass (ICM) and trofectoderm (TE) cells, the blastomeres 
remaining in contact with the outside are destined to form the TE cells lineage while the 
blastomeres inside the embryo are destined to form the ICM. The ICM later forms the 
fetus, with fated three germinal layers. Early embryonic development is characterized 
by the number of nuclei (blastomere) present within the developing embryo. The initial 
development of the number of nuclei (blastomere) present within the developing 
embryos is controlled by maternally inherited molecules in the oocyte. The minor 
embryonic genome activation which begins at 2-cell stage and major embryonic 
genomic activation starts at 8-cell stage in bovine. During this early embryogenesis an 
eventually developmental control is purchased (Maddox-Hyttell et al. 2003). This shift 
from maternal to zygotic genomic control is referred to as the maternal/zygotic 
transition (MZT). A unique feature of these early embryonic cells is the ability by which 
a single cell can able to form a whole organism, which is termed as totipotency. 
Blastomeres maintain complete totipotency until the 16-cell stage of development, here 
after the differentiation of cell happens in the embryo which prevents the complete 
totipotency of an embryo (Kurosaka et al. 2004). 
For the formation of zygote both the gametes (male and female) are contributing 50-
50% of the nuclear content but approximate whole cytoplasmic content was taken from 
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female. So, the contribution of transcripts are more from female gametes and also the 
cytoplasmic miRNA contribution which known to be abundant in oocyte in comparison 
to sperms. Amanai group has shown that miRNAs derived from sperms plays no role or 
if any, the role is limited in mammalian fertilization or early preimplantation 
development (Amanai et al. 2006). Identification of miRNAs in cattle embryos was 
obtained by cloning, microarray or qRT-PCR profiling (Castro et al. 2010, Coutinho et 
al. 2007, Long and Chen 2009, Tripurani et al. 2010). A total of 390 miRNAs had 
shown temporal expression profiles during prenatal development at specific stages of 
mouse embryonic development (Mineno et al. 2006). The group working in zebra fish 
embryonic development found that the embryos lack let-7 miRNA, phenotypically they 
have shown delay in early growth and after 8 days of fertilization the embryo was 
lethargic and the development was arrested (Wienholds et al. 2003). The effect of 
miRNAs during embryonic development in different embryonic tissues was determined 
by microarray analysis. These identified miRNAs are responsible for development and 
control of stem cell in zebrafish (Wienholds et al. 2005). Expression difference of 
miRNA was shown by Tripurani et al in 2010. They showed the high expression of bta-
mir424 and bta-mir-10b in early stages of preimplantation embryos and some of the 
novel miRNA were relatively less in early stages but higher in blastocysts stage 
(Tripurani et al. 2010). Dicer is a key enzyme in processing of mature miRNA, so lack 
of dicer interrupts the biogenesis of miRNA. Dicer1–/– embryos have shown the drop in 
the expression of miRNAs in mouse development (Bernstein et al. 2003). As the 
knockout of Dicer1 reduces miRNA expression, it leads to the embryonic lethal and 
depletion of stem cell development in mice (Bernstein et al. 2003). Female fertility and 
embryo development were also been affected by the involvement of Dicer1/miRNA 
mediated posttranscriptional gene regulation in reproductive somatic tissues (Hong et al. 
2008). In bovine, nuclear transfer and in vitro fertilized embryo were taken at day 17 to 
find the differentially regulated miRNA in both group using microarray screening and 
qRT-PCR. Additionally, it also has shown the nuclear reprogramming in somatic 
cloning (Castro et al. 2010). A study in human describes the infertility of male and 
female with its transferable quality of blastocysts and correlation of the miRNA 
expression in the male factor infertility and polycystic ovaries (McCallie et al. 2010). 
Further more, functional analysis of microRNA in preimplantation embryo development 
will facilitate the contribution of miRNA in biological processes and disease in 
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embryos. The study specially will help to understand the mystery of the gene expression 
controlled by miRNA in maternal to embryonic gene transition and the study also 
facilitate the knowledge of miRNA expression pattern in different stages of 
development. Some functional work has been done in preimplantation stage of different 
other species but not yet in bovine. This study will lead to prevent the embryo loss in 
bovine and will develop some therapeutic applications which can be useful in future. 
 
2.5.1 MicroRNA miR-130b family in embryonic stem cells   
 
MicroRNA 130 family was first identified in embryonic stem cell (ESC) and known as 
ESC miRNAs (Houbaviy et al. 2003). It has four members in family namely: miR.130a, 
miR-130b, miR-301a and miR-301b. The annotated sequences for all four family 
members of miR-130/301 family in human are shown in (Table 2). miR-130a was 
initially been identified by cloning studies in mouse (Lagos-Quintana et al. 2002). miR-
130b was first identified in mouse embryonic cells (Houbaviy et al. 2003). Later on 
these miRNAs were identified in human embryonic stem cells (hES) and believed to 
serve as molecular markers for the early embryonic stage and for undifferentiated hES 
cells (Suh et al. 2004). Different functions have been found for the family members of 
miR-130. Regarding to other cells miR-130b was verified to be present in human BC-1 
cells (Cai et al. 2005). Additionally, in human disease the expression of miR-130b was 
seen higher in schizophrenic compared with normal individuals (Burmistrova et al. 
2007). Furthermore, reduction of adipogenesis was observed by miR-130 which 
regulates PPARgamma biosynthesis (Lee et al. 2011). In human vascular endothelial 
cells, miR-130a, is a regulator of the angiogenic phenotype by targeting GAX and 
HOXA5 and regulating there expression (Chen and Gorski 2008). miR-130a plays a role 
in the regulation of cardiac development by the regulation of FOG-2, a transcriptional 
co-factor, protein (Kim et al. 2009). A recent report shows the family members of miR-
130 (miR-130/301), binds to a conserved site in the 3′UTR of CD69 mRNA and down-
regulates its expression in activated CD8+ cells (Zhang and Bevan 2010). Furthermore, 
regarding to human disease miR-130b found in the development and progression of 
melanoma (Stark et al. 2010). The family members of miR-130/301 were known to be 
oncomiR (Shi et al. 2011, Yeung et al. 2008). Recently, a report has shown miR-301 is 
located in an intron of the SKA2 gene and act as a novel oncogene in LNN breast cancer 
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and targets Col2A1, PTEN, FoxF2, and BBC3 mRNAs in human breast cancer that acts 
through multiple pathways and mechanisms to promote nodal or distant relapses (Shi et 
al. 2011). 
    Table 2: miRNA sequence of miR-130 family in human 
 
miRNA Family Sequence (seed sequence) 
hsa-miR-130b mir-130 CAGUGCAAUGAUGAAAGGGCAU 
hsa-miR-130a mir-130 CAGUGCAAUGUUAAAAGGGCAU 
hsa-miR-301a mir-130 CAGUGCAAUAGUAUUGUCAAAGC 
hsa-miR-301b mir-130 CAGUGCAAUGAUAUUGUCAAAGC 
 
miR-130b* sequence is the complementary sequence of miR-130b and located in the 
negative strand of chromosome, It was identified as a miRNA candidate using RAKE 
and MPSS techniques (Berezikov et al. 2006). The expression of miR-130b* was later 
confirmed by cloning (Landgraf et al. 2007).  
MicroRNA miR-130a, miR-130b and miR-301 were first known in bovine through the 
web-server for miRNA gene which provides homologous tool for animals (Artzi et al. 
2008, Strozzi et al. 2009). The conserve region of genes are stable and miR-130a, 130b 
are highly conserved in mammalian species (Jin et al. 2009). Expression profiling using 
heterologus approaches of miRNA had shown a high expression of miR-130b in 
immature oocyte in comparison to mature oocyte (Tesfaye et al. 2009). 
 
2.5.2 Impact of miR-130b in different cell types  
 
The miRNA miR-130b was known to be an oncomir regarding various researches (Ma 
et al. 2010b, Watashi et al. 2010, Yeung et al. 2008). The role of miR-130b was been 
observe in Human HTLV-1–transformed T-cell lines for regulating cell proliferation 
and survival in HTLV-1 transformed cells by targeting TP53INP1. Here, miR-130b 
known to regulate cell growth and established by conducting experiments which 
showed that enhanced TP53INP1 expression increased apoptosis in HTLV-1 
transformed cells (Yeung et al. 2008). Functional studies of miR-130b on lentiviral-
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transduced CD133-cells demonstrated high resistance to chemotherapeutic agents, 
enhanced tumorigenicity in vivo, and also provide a better possibility for self renewal of 
cells. So, this report shows increase in miR-130b reduces the expression of TP53INP1, 
a known miR-130b target and regulate CD133+ liver TICs which enhance self renewal 
and tumorigenicity in CD133-cells (Ma et al. 2010b). miR-130/301, were up-regulated 
T-cell and targets to down-regulate CD69 transcript expression via binding to a 
conserved site in the 3′UTR of CD69 mRNA (Zhang and Bevan 2010). A recent study 
shows the tumorigenesis induced by miR-130b can be reprogrammed by some small 
molecules which affects the biogenesis pathway of miRNA targeting two different 
compounds; one impaired Dicer activity and the other blocked small RNA-loading into 
AGO2 complex. These small molecules could potentially reverse tumorigenesis induced 
by miR-130b (Watashi et al. 2010). In a report a specific miRNA can regulate the miR-
130b which can be correlated with the reprogramming during newt regeneration and the 
stem or germ cells reprogramming (Nakamura et al. 2010). This all reports show that, 
miR-130b is an embryonic stem cell specific miRNA. It is a conserved and an important 
miRNA in animal system which also able to induce tumour or proliferation in different 
cell types including stem cells but the function of miR-130b is still uncovered for the 
preimplantation embryos including oocytes and its surrounding cells.   
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3 Materials and methods 
 
3.1 Materials 
 
3.1.1 Embryos 
For this study, bovine oocytes were obtained from local slaughter house and embryos 
were obtained by in vitro production (IVP) technologies after in vitro maturation, 
fertilization and culture. 
 
3.1.2 Materials for laboratory analysis 
 
3.1.2.1 Chemicals, kits, biological and other materials 
Manufacturer/Supplier Chemicals or biological materials 
 
Acris Antibodies GmbH: RPS6KA5 (MSK1) primary antibody anti 
rabbit 
 
Abcam, Cambridge, MA, USA: Fluorescein (FITC)-conjugated donkey anti-
goat antibody, Lactate Colorimetric Assay Kit  
 
Beckman Coulter, Krefeld, Germany: CEQ™ 8000 Genetic Analysis System, Dye 
Terminator Cycle Sequencing (DTCS), 
Sample loading solution (SLS), Glycogen for 
sequencing 
 
BioAssay System, USA: Enzychrom AF Cholesterol Assay Kit 
(E2CH-100) 
Biomol, Hamburg, Germany: Phenol, Phenol/ Chlorophorm/Isoamyl 
alcohol (25:24:1) 
 
Bio-Rad laboratories, Munich, 
Germany: 
 
iTaq SYBR Green Supermix with ROX 
Burlingame, CA, USA: 4', 6'-diamidino-2-phenylindole hydrochloride 
(DAPI) 
 
Clontech, Takara Bio Europe 
/Clontech,  France: 
 
pMJGreen (pBEHpac18 + pEGFP-N1) 
Dako Deutschland GmbH, Hamburg, 
Germany: 
 
Fast Red Substrate System 
Diagnostics GmbH, Mannheim, 
Germany: 
Digoxigenin-AP Roche 
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Eppendorf Biopur, Hamburg: Safe-Lock tubes 0.5 ml, epT.I.P.S. Singles 
0.1-20 µl, 2.5x RealMasterMix/ 20x SYBR 
Solution 
Exiqon, Vedbaek, Denmark: miRNA primer, Precursor, inhibitor, 
miRCURY™ LNA Detection probe 
 
Gibco, Karlsruhe, Germany: GIBCO® Opti-MEM I Reduced-Serum 
Medium (1x) liquid, Fetal Calf Serum (FCS) 
 
Invitrogen Life Technologies, 
Karlsruhe, Germany: 
 
Lipofectamine 2000, DMEM, DPBS, MEM 
NEAA 100x (non- essential amino acids), 
BME EAA 50x (essential amino acids), 
Gentamycin, FCS, Hoechst 33342, 
MitoTracker® Mitochondrion-Selective 
Probes 
 
New England Biolabs Ipswich, MA, 
USA: 
 
Pme1 and Xho1 Restriction Enzymes    
Promega WI, USA : Random primer, BSA, pGEM®-T vector. 
RNasin (Ribonuclease inhibitor), 2X rapid 
ligation buffer, 10x PCR buffer, Bovine 
serum albumin (BSA), T4 DNA ligase, 
pmirGLO Dual-Luciferase miRNA Target 
Expression Vector,  Dual-Luciferase® 
Reporter Assay System (E1910), JM109 
(Escherichia coli) competent cells 
  
Qiagen, Hilden, Germany: mirNeasy® Mini kit, QIAquick PCR 
Purification Kit, Mini EluteTM Reaction 
Cleanup Kit, RNase-free DNase, miScript 
Reverse Transcription Kit, miScript SYBR 
Green PCR Kit  
  
Roth, Karlsruhe, Germany: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acetic acid, Agar Agar, Ammonium 
persulfate (APS), Ampicillin, Boric acid, 
Bromophenol blue, Calcium chloride, 
Chloroform, dNTP, Dimethyl sulfoxide 
(DMSO), Ethylenediaminetetraacetic acid 
(EDTA), Ethanol, Ethidium bromide, DTT, 
Formaldehyde, Hydrochloric acid, Isopropyl -
D-thiogalactoside (IPTG), Kohrsolin® FF 
Pepton, Nitric acid, Peptone, Potassium 
dihydrogen phosphate, Ponceau-S, Proteinase 
K, 2- Propanol, Roti®-Block-10x, 
Rotiphosese Gel 30 (37:5:1), Silver nitrate, 
Sodium acetate, Sodium carbonate, Sodium 
chloride, Sodium hydroxide, Sodium 
carbonate, Sodium chloride, Tris, N, N, N’, 
Materials and methods 
 
32 
N’-Tetramethylendiamine (TEMED), Tris-
HCl, T-octylphenoxypolyethoxyethanol 
(Triton X-100), 5-bromo-4-chloro-3 
indolylbeta-D-galactopyranoside (X-Gal), 
Yeast extract 
  
Santa Cruz Biotechnology, CA, USA:  Primary antibody SMAD1/5 anti goat, 
GAPDH anti goat, horseradish-peroxidase 
(HRP) conjugated donkey anti-rabbit 
secondary antibody, HRP-conjugated mouse 
anti-goat IgG 
  
Sigma-Aldrich Chemie GmbH, 
Munich, Germany: 
 
2-Mercaptoethanol, Acetic anhydride, 
Agarose, Ammonium acetate, anti-goat IgG 
FITC conjugated antibody, Calcium chloride, 
Calcium chloride dehydrate, Calcium lactate, 
Cell Growth Detection Kit MTT based,  
Dulbecco’s phosphate buffered saline (D-
PBS), Fast green,  Formaldehyde, Fetal 
Bovine Serum, FSH, GenEluteTM Plasmid 
Miniprep kit, Heparin, Hepes, Hydroxylamin, 
Hyaluronidase, Hypotaurin, Igepal, 
Isopropanol, Magnesium chloride, 
Magnesium chloride hexahydrate, Medium 
199, Mineral oil, Penicillin, Phenol red 
solution, 10x PCR reaction buffer, Potassium 
chloride, Proteinase inhibitor, RIPA Buffer 
RNA later, Secondary anti-rabbit IgG FITC 
conjugated antibody, Sodium Dodecyl Sulfate 
(SDS), Sodium hydrogen carbonate, Sodium 
hydrogen phosphate, Sodium hydrogen 
sulfate, Sodium lactate solution (60%), 
Sodium pyruvate, Streptomycin sulfate, Taq 
DNA polymerase, Trypan Blue Solution 
(0.4%), Trypsin-EDTA, yeast tRNA 
  
Thermo Scientific, USA: SuperSignal West Pico Substrate 
  
Whatman- Protran®, Schleicher & 
Schuell Bioscience: 
Protran Nitrocellulose Transfer Membrane 
  
USB, Ohio, USA: ExoSAP-IT 
 
Vector laboratories, Burlingame, CA: DAPI 
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3.1.2.2 List of Equipment 
ABI PRISM 7000 SDS Applied Biosystems, Foster city, USA 
4-well, 24-well and 96-well plate  Thermo Fisher Scientific, Nunc, 
Roskilde, Denmark 
Agilent 2100 bioanalyzer Technologies , CA, USA 
ApoTome microscope  Carl Zeiss MicroImaging, Germany 
Carbon dioxide incubator (BB16)    Heraeus, Hanau, Germany  
Carbon dioxide incubator (MCO-17AI)  Sanyo, Japan 
Centrifuge Hermle Labortechnik, Wehingen 
CEQ™ 8000 Genetic Analysis System Beckman Coulter GmbH, Krefeld 
Confocal laser scanning microscope-510  Carl Zeiss, Germany 
Cryotube Nunc  Roskilde, Germany 
Epifluorescence microscope (DM-IRB) Leica, Bensheim, Germany 
Gel-documentation unit BioRad, Munich, Germany 
HERA safe Bioflow safety hood Heraeus Instruments, Meckenheim 
Icycler Bio-Rad Laboratories, München 
Incubator Heraeus, Hanau, Germany 
Inverted microscope  Leica DM –IRB, Germany 
Inverted microscope, ECLIPSE TS100 Nikon, Japan  
Injection capillary (K-MPIP-3335-5) Cook, Ireland 
Luminofluroscent reader Centro LB 960, Berthold Technologies, 
Germany 
Millipore apparatus Millipore corporation, USA 
Multiplate reader Molecular Device, Germany 
NanoDrop 8000 spectrophotometer  NanoDrop, Wilmington, USA 
Nitrocellulose transfer membrane 
(Protran®)   
 BioScience, Germany 
PCR thermocycler (PTC100) MJ Research, USA & BioRad, Germany 
pH meter Kohermann, Germany 
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Power Supply Mini-Protan®  BioRad, Munich, Germany 
Power supply PAC 3000 Biorad, Munich, Germany 
Savant SpeedVac TeleChem International, Sunnyvale 
Slide SuperFrost® Plus  Braunschweig, Germany 
SHKE6000-8CE refrigerated Shaker Thermoscinentific, IWA, USA 
Stereomicroscope SMZ 645 Nikon, Japan 
Thermalshake Gerhardt John Morris scientific, Melbourne 
Trans/Blot® Semi/Dry transfer Cell  BioRad, CA, USA 
Tuttnauer autoclave Connections unlimited, Wettenberg 
Ultra low freezer (-80 ºC) Labotect GmbH, Gottingen, Germany 
 
3.1.2.3 Used softwares 
BLAST program   http://www.ncbi.nlm.nih.gov/BLAST 
ENSEMBL genome browser  http://www.ensembl.org/index.html 
Entrez Gene           www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene      
Gene Ontology        http://www.geneontology.org 
microRNA.org,target prediction  http://www.microrna.org/microrna/home.do 
Mitarget http://cbit.snu.ac.kr/~miTarget/ 
PicTar target prediction http://www.pictar.org/ 
Targetscan, target prediction http://www.targetscan.org/ 
miRBase_12.0  http://microrna.sanger.ac.uk/sequences/ 
Multiple Sequence Alignment                                   http://searchlauncher.bcm.tmc.edu/  
Primer Express software  v2.0                                            Applied Biosystems, Foster city, CA, USA 
SAS (version 9.2) SAS Institute Inc., NC, USA 
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3.1.2.4 Reagents and media 
 
All solutions used in this study were prepared using deionized and demineralised 
millipore water (ddH2O) and when required the pH was adjusted with sodium hydroxide 
(NaOH) or hydrochloric acid (HCl).  For some of the sensitive experiment, the solutions 
or buffers were filtered through 0.2 µm filter and autoclaved at 120 °C for 20 minutes. 
 
General reagents 
DEPC-treated water  DEPC 1.0 ml 
 Water added to 1,000.0 ml 
LB-agar plate Sodium chloride 8.0 g 
 Peptone 8.0 g 
 Yeast extract 4.0 g 
 Agar 12.0 g 
 Sodium hydroxide (40 mg/ml) 480.0 µl 
 ddH2O added to 800.0 ml 
LB-broth Sodium chloride 8.0 g 
 Peptone 8.0 g 
 Yeast extract 4.0 g 
 Sodium hydroxide (40 mg/ml) 480.0 µl 
 ddH2O added to 800.0 ml 
10x TBE buffer Tris base 108.0 g 
 Boric acid  55.0 g 
 EDTA (0.5 M) 40.0 ml 
 ddH2O added to 1,000.0 ml 
50X TAE buffer, pH 8.0 Tris  242.0 mg  
 Acetic acid   57.1 ml  
 EDTA (0.5 M) 100.0 ml 
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 ddH2O added to 1,000.0 ml 
1X TE buffer Tris (1 M) 10.0 ml 
 EDTA (0.5 M) 2.0 ml 
 ddH2O added to 1,000.0 ml 
X-gal X-gal 50.0 mg 
 N, N’-dimethylformamide  1.0 ml 
10X PBS NaCl 8.77 g 
 Na2HPO4 1.50 g 
 NaH2PO4 2.04 g 
 Water added to 1,000.0 ml 
1X PBS 10X PBS 100.0 ml 
 Water added to 1,000.0 ml 
1X PBS-Tween (PBST) PBS  999.50 ml 
 Tween®20  0.50 ml 
PBS + PVA (50 ml) Polyvinyl alcohol (PVA) 300.0 mg 
 PBS upto 50.0 ml 
Physiological saline solution Sodium chloride  9.0 g 
 Water upto 1,000.0 ml 
Agarose loading buffer Bromophenol blue 0.0625 g 
 Xylencyanol 0.0625 g 
 Glycerol 7.5 ml 
 ddH2O added to 25.0 ml 
Lysis buffer                                      Igepal 0.8 µl 
 RNasin   5.0 µl 
 DTT 5.0 µl 
 Water added to                                              100.0 µl 
SDS solution Sodium dodecylsulfat in ddH2O 10% (w/v) 
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Proteinase K solution Proteinase K in 1X TE buffer 2% (w/v) 
dNTP solution dATP (100 mM) 10.0 µl 
 dCTP (100 mM) 10.0 µl 
 dGTP (100 mM) 10.0 µl 
 dTTP (100 mM) 10.0 µl 
 ddH2O added to 400.0 µl 
IPTG solution IPTG 1.2 g 
 ddH2O added to 10.0 ml 
3M Sodium Acetate, pH 5.2 Sodium Acetate  123.1 g 
 ddH2O added to 500.0 ml 
1M EDTA, pH 8.0 EDTA 37.3 g 
 ddH2O added to 1,000.0 ml 
Phenol Chloroform  Phenol : Chloroform 1 : 1 (v/v) 
 ddH2O added to 10.0 ml 
3M Sodium Acetate, pH 5.2 Sodium Acetate  123.1 g 
 ddH2O added to 500.0 ml 
20X SSC  NaCl  87.65 g 
 Sodium citrate 44.1 g 
 Water upto 500.0 ml 
1 M Tris-HCl (1M) Tris 121.14 g 
 Water added to 1,000.0 ml 
4% PFA, pH 7.3 Para-formaldehyde  4.00 g 
 1X PBS  100.0 ml 
 Brought to 65 ºC under ventilation hood. 5 µl of 
5 M NaOH was added for solution to become 
clear. Stored in light protected place upto 2 
weeks. 
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20X SSC, pH 7.0 NaCl 87.65 g 
 Sodium citrate 44.12 g 
 Water upto 500.0 ml 
0.5M Sucrose/PBS (30% 
sucrose)  
Sucrose 85.57 gm 
 1X PBS upto  500.0 ml 
Acetylation solution Triethanolamine  2.33 ml 
 Acetic anhydride  500.0 µl 
 DEPC water upto 200.0 ml 
Yeast tRNA (10 mg/ml) Yeast tRNA  25.0 mg 
 DEPC-treated H2O 2.50 ml 
Hybridization solution Formamide 65% 32.25 ml 
 5X SSC  12.5 ml 
 Tween-20, 0.1% 50.0 µl 
 1M citric acid  460.0 µl 
 Heparin, 50 µg/ml 2.5 mg 
 tRNA, 500 µg/ml 2.5 ml 
 DEPC water upto 50.0 ml 
Hybridization wash solution Formamide, 65% 65.0 ml 
 5X SSC,  25.0 ml 
 Tween-20, 0.1% 100.0 µl 
 1M citric acid 1.2 µl 
 DEPC water upto 100.0 ml 
50% Formamide/SSC Formamide 1,000.0 ml 
 1X SSC 1,000.0 ml 
50% Formamide/Tween-20/ 
SSC   
Formamide, 50% 500.0 ml 
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 Tween-20, 0.1% 1.0 ml 
 1X SSC 499.0 ml 
5X SSC 20X SSC 250.0 ml 
 DEPC water 750.0 ml 
2X SSC 20X SSC 100.0 ml 
 DEPC water 900.0 ml 
1X SSC 20X SSC 100.0 ml 
 DEPC water 1,900.0 ml 
0.2X SSC 20X SSC 10.0 ml 
 DEPC water 990.0 ml 
1X PBST 1X PBS 999.0 ml 
 Tween-20 1.0 ml 
Blocking solution FCS   2.0 ml 
 B1 solution 18.0 ml 
B1 solution 1M Tris, pH7.5 100.0 ml 
 5M NaCl 30.0 ml 
Stop solution EDTA, 1mM 14.61 mg 
 PBS, pH 5.5 upto  50.0 ml 
10N NaOH NaOH 40.0 gm 
 dd H2O upto 100.0 ml 
0.2% Triton-X100 Triton 2.0 ml 
 10X PBS added to 1,000.0 ml  
0.3% BSA in PBS BSA 3.0 g 
 10X PBS added to 1,000.0 ml 
3% BSA in PBS BSA 30.0 g 
DMEM DMEM 129.0 ml 
 Sodium pyruvate, 1%  1.5 ml 
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 Non-Essential amino acid, 1%  1.5 ml 
 L-Glutamine, 1% 1.5 ml 
 PenicillinStreptomycin, 1% 1.5 ml 
 Fungizone/Amphothericin, 1% 1.5 ml 
 2-mercaptomethanol 1.5 µl 
 Fetus Calf Serum, 10% 1.5 ml 
Cryoprotectant FCS, 90% 9.0 ml 
 DMSO, 10% 1.0 ml 
Fertilization medium                      Sodium chloride                        330 .0 mg 
 Potassium chloride           117.0 mg 
 Sodium hydrogen carbonate                   105.0 mg 
 Sodium dihydrogen phosphate                        2.1 mg 
 Penicillin    3.2 mg 
 Magnesium chloride hexahydrate                   5.0 mg 
 Calcium chloride dihydrate                              15.0 mg 
 Sodium lactate solution, 60%                       93.0 µl 
 Phenol red solution, 5% (in DPBS)                100.0 µl 
 Water upto    50.0 ml 
Modified parker medium HEPES 140.0 mg 
 Sodium pyruvate 25.0 mg 
 L-Glutamine  10.0 mg 
 Gentamicin 500.0 µl 
 Medium 199 99.0 ml 
 Hemi calcium lactate 60.0 mg 
 Water upto 110.0 ml 
Permeabilizing solution(10 ml) Triton X-100 5.0 µl 
 Glycine + PBS added 10.0 ml 
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PHE medium Physiological saline, 0.9% 16.0 ml 
 Hypotaurin solution 10.0 ml 
 Epinephrin solution 4.0 ml 
CR1-aa culture medium Hemi-calcium lactate 273.0 mg 
(50 ml) Streptomycin sulphate 3.9 mg 
 Penicillin G 1.9 mg 
 Sodium chloride 315.6 mg 
 Potassium chloride 11.2 mg 
 Sodium hydrogen carbonate 105.0 mg 
 Sodium pyruvate 2.2 mg 
 L-Glutamine 7.3 mg 
 Phenol red solution 100.0 µl 
 Sodium hydrogen carbonate 80.0 mg 
 
3.2 Methods  
 
Functional analysis of miR-130b in preimplantation embryo development is conducted 
in several steps of experiments and beside this cumulus cell culture was conducted for 
the validation of miRNA target. 
 
3.2.1 In vitro embryo production 
 
3.2.1.1 Oocytes recovery and in vitro maturation 
 
Bovine ovaries were obtained from the local abattoirs and transported to the laboratory 
within 2-3 hours in a thermo flask (30-35 ºC) having physiological saline (0.9% NaCl), 
supplemented with 0.5 ml Steptocombin® per liter. Before aspiration of cumulus oocyte 
complex (COC), the ovaries were surface sterilized with 70% EtOH followed with 
twice washing with 0.9% physiological saline and dried with sterile paper. COC were 
aspirated from antral follicles (2-8 mm diameter) using an 18-gauge needle and a 10 ml 
syringe containing ~2 ml aspiration media (Hepes-buffered Tissue Cultured Medium-
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199). This aspirated fluid was collected in 50 ml tubes and kept at 37 ºC for 15 minutes 
to allow the precipitation of COC. The competent COCs were picked out and separated 
using glass-pipette under a stereomicroscope (Nikon) and washed three times in drops 
of pre-warmed maturation medium (Modified Paker Medium, MPM). The medium was 
taken with 12% heat-inactivated oestrus cow serum  (OCS), 0.5 mM L-glutamine, 0.2 
mM sodium pyruvate, 50 µg/ml gentamycin sulphate, and 12% FSH (Sigma-Aldrich 
Chemie GmbH). The COCs were transferred in groups of 50/well in 400 µl maturation 
medium under mineral oil (Sigma) in four well dishes (Nunc). Oocytes with evenly 
granulated cytoplasm and multiple layers of cumulus cells surrounded were in vitro 
matured. During the IVM procedure, these competent COCs were culture in TCM-199 
as basic medium at 37 ºC in incubator with humidified atmosphere of 5% CO2 in air for 
22-24 hours.  
 
3.2.1.2 Sperm preparation and capacitation 
 
According to the oocyte number the semen straws were taken (2-4) from the known 
breeding bull and thawed. To obtain the best quality of motile spermatozoa swim-up 
procedure (Parrish et al. 1988). During the swim-up procedure the frozen thawed sperm 
cell were incubated in a tube containing 5 ml capacitating medium supplemented with 
heparin for 50 minutes under 39 ºC in an incubator with humidified atmosphere of 5% 
CO2 in air. The motile sperm cells found in the upper layer of the solution were 
transferred into new falcon tube. The sperm cells were pelleted by centrifugation at 
10,000 rpm for 10 minutes. The resulting pellet was washed two times and finally 
resuspended in already prepared 3.5 ml capacitating medium for IVF. 
 
3.2.1.3 In vitro fertilization of oocytes 
 
Matured oocytes were washed twice in the fertilization medium and transferred into a 
four-well dish containing 400 µl of fertilization medium supplement with 6 mg/ml 
bovine serum albumin (BSA), 2.2 mg/ml sodium pyruvate and 1 mg/ml heparin. Ten 
microliter of PHE medium was added to each well to initiate sperm motility and 
covered with mineral oil (Sigma). Motile spermatozoa were selected according to the 
procedure explained above in 3.2.1.2. The final concentration of 1x106 spermatozoa/ml 
was taken in the fertilization medium. These diluted spermatozoa were added to a group 
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of 50 oocytes in each well and co-cultured for 18 hrs at standard incubation conditions 
with 39 ºC and humidified atmosphere containing 5% CO2 in air (Tesfaye et al. 2010). 
 
3.2.1.4 In vitro culture of embryos 
 
The mature oocytes were in vitro fertilized and then the presumptive zygotes were 
collected into 15 ml of falcon tube with 1 ml of culture medium (CR1aa) (Rosenkrans 
and First 1994) with 10% OCS, 10 µl/ml BME (essential amino acids) and 10 µl/ml 
MEM (non essential amino acids). The presumptive zygotes were gently vortexed for 
the separation of dead spermatozoa and cumulus cells. The cumulus free zygotes were 
screened and washed twice with culture medium. Then transferred in the group of 50-60 
zygotes each well into four-well dish, each of this well was filled with pre-warmed 400 
µl culture medium cover with mineral oil. The first cleavage rate was observed 48 hours 
post fertilization followed by incubating for the consecutive days of the embryos to 
collect different stages of preimplantation stages embryos. 
 
3.2.1.5 Oocytes denudation and storage 
 
For the separation of oocytes from the cumulus cells, mature and immature COCs were 
taken in 15 ml falcon tube separately in TCM or maturation medium supplemented with 
hyaluronidase (1 mg/ml) (Sigma) and vortexed for 4 minute. Oocytes were carefully 
picked out and corresponding cumulus cells were collected by centrifugation. Oocytes 
and the cumulus cells of each group were washed two times in PBS (Sigma) and frozen 
separately in cryo-tubes containing 20 µl of lysis buffer [0.8% IGEPAL (Sigma), 40 
U/µl RNasin (Promega Madison WI, USA), 5 mM dithiothreitol (DTT) (Promega 
Madison WI, USA). Finally, samples were grouped according to experiment and stored 
at -80 ºC until RNA extraction. 
 
3.2.2 Plasmid DNA preparation 
 
3.2.2.1 Primers design and gene cloning 
 
For this study the genes selected as the target were first quantified in all stages of 
embryos and cells. For that sequence specific primers were designed using Primer 
Express® Software v2.0 (Applied Biosystems, Foster City, CA, USA) or from the 
online software primer 3.0 (http://frodo.wi.mit.edu/primer3/). Used primer sequences, 
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the GenBank accession number, size of amplified products and the annealing 
temperature are shown in (Table 3). For designing 3’UTR primers were constructed 
with restriction digestion sequence. Primers for 3’ UTR were listed in (Table 4). To 
balance the GC content some more bases were added. All primers were purchased from 
Eurofins MWG synthesis GmbH (MWG Biotech, Eberberg, Germany) and diluted at 
100 pmole as a stock solution. The selected gene sequence were amplified from 
genomic DNA or cDNA using Polymerase Chain Reaction (PCR) with 20 µl final 
volume containing 2 µl of 10X PCR buffer (Sigma), 0.5 µl of each primer (10 pmole), 
0.5 µl of dNTP (50 µM), 0.5 U of Taq DNA polymerase (Sigma), 14.4 µl millipore H2O 
which finally added to 2 µl of cDNA templates or 50 ng/µl genomic DNA and 
Milliposre water (2 µl) was used as negative control. The PCR reactions were carried 
out in a PT-100 Thermocycler and the thermal cycling program was set as: denaturation 
at 95 ºC for 5 min, followed by 35 cycles at 95 ºC for 30 sec, annealing at the 
corresponding temperature, as shown in table 3, for 30 seconds and extension at 72 ºC 
for 1 min, final extension step at 72 ºC for 10 minutes. Finally, 5 µl of loading buffer 
were added to PCR products and loaded on agarose gel (2% for cDNA checking; 0.8% 
for PCR product extraction) in 1X TAE buffer by staining with ethidium bromide. The 
amplified PCR products were electrophoresed for 23 minutes at 120 voltages and 
visualized under Gel-documentation unit (BioRad) and the gel that have the DNA 
fragment of interest was cut if needed. The PCR product was extracted using QIAquick 
PCR purification kit (Qiagen) for the qRT-PCR primers using the manufacturer 
protocol. 
Ligation was performed using pGEM-T Vector System I ligation kit for the entire 
specific gene fragment amplified by PCR and purified. According to the manufacturer 
instruction, ligation was performed in a 6 µl reaction mix containing 3 µl of 2X rapid 
ligation buffer, 0.5 µl of pGEM vector (50 ng/µl), 0.5 µl of T4 DNA ligase (3 units/µl), 
and 2 µl of gel purified PCR product. The reaction was then incubated at 4 ºC overnight 
or 1hour at 37 °C. Transformation was performed by combining 3 µl of ligation reaction 
with 60 µl of JM109 (Escherichia coli) competent cells in a 2 ml tube and incubating on 
ice for 30 minutes. After incubation, the mixture was then heat-shocked briefly in a 42 
°C water bath for 60 seconds and immediately returned to ice for 2 minutes. Then, 650 
µl of LB broth was added to the previous mixture and all together was shaken with 
speed of 90 rpm at 37 ºC for 90 minutes in SHKE6000-8CE refrigerated Stackable 
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Shaker (Thermoscinentific, IWA, USA). Meanwhile, plates of LB-agar with ampicillin 
(4 mg / 100 ml) were prepared. About 20 minutes prior to use 20 µl of 0.5 M IPTG and 
20 µl of 50 mg/ml X-Gal was spread over the surface of LB-ampicillin plates with a 
glass spreader. And by 90 minutes of incubation, 300 µl of inoculums were transfered in 
each plate and incubated at 37 ºC overnight till the colonies become visible.   
 
3.2.2.2 Colony screening and sequencing 
 
The positive bacteria having DNA insert in the pGEM-T vectors were screened by the 
presence of β-galactosidase activity. β-galactosidase is an enzyme produced by lacZ 
gene in pGEM-T vector which interacts with IPTG to produce a blue colony. On the 
other hand, the insert of DNA disrupts the lacZ gene which failure to produce β-
galactosidase, which results in white colonies. So the appearance of white colony shows 
the success of cloning. Four white colonies in addition to one blue colony were picked 
up and suspended in 30 µl 1X PCR buffer for M13 reaction for further confirmation of 
transformation and sequencing. At the same time, colonies were also cultured in 600 µl 
LB-broth with ampicillin (4 mg / 100 ml) in a shaking incubator 90 rpm at 37 ºC for 90 
minutes. On the other hand, bacteria that were suspended in 30 µl 1X PCR were lysed 
by heating at 95 ºC for 15 minutes. The colonies were screened for the insert by 
performing a PCR with primers designed in M13 promoter region of the vector. 20 µl of 
reaction volume containing 10 µl of lysate, 0.5 µl dNTPs (10 mM), 0.5 µl of each of 
primer 0.5 U of Taq polymerase (Sigma) in 1X PCR buffer were amplified in PTC 100 
(MJ Research) thermal cycler for 35 cycles at 95 ºC denaturation, 60 ºC annealing and 
72 ºC extension followed by 10 minutes of final extension at 72 ºC. The products were 
electrophoresed in 2% agarose gel. Clones having insert have higher molecular weight 
fragments than the blue clones. And the colonies with insert were then transferred to 15 
ml tube and 5 ml of LB-broth with ampicillin were added and incubation continued 
overnight at the previous conditions for further plasmid isolation. The M13 PCR 
products from white colonies containing inserts were used as a template for subsequent 
sequencing to identify the proper sequence in the vector. A volume of 5 µl of M13 
products was purified by adding 1 µl of ExoSAP-IT (USB Corporation) then incubated 
at 37 ºC for 45 minutes followed by enzyme inactivation step at 80 ºC for 15 minutes. 
The purified DNA product (6 µl) was subsequently used as template for the sequencing 
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PCR which contains 8 µl of millipore water, 2 µl of 1.6 pmole M13 forward or reverse 
primer, 4 µl of DTCS Quick Start Master Mix (Beckman Coulter). The PCR sequencing 
reaction was performed for 30 cycles at 96 ºC for 20 seconds, 50 ºC for 20 seconds and 
60 ºC for 4 minutes, followed by holding at 4 ºC. The stop solution was prepared in a 
volume of 2 µl of 3M NaOAc (pH = 5.2), 2 µl of 100 mM EDTA (pH = 2.0) and 1 µl of 
glycogen (20 mg/ml). The sequencing PCR product was transferred to a 1.5 ml sterile 
tube and mixed with 5 µl stop solution. A volume of 60 µl cold EtOH (98%) was added 
and mixed by vortex and then centrifuged for 15 minutes at 4 ºC. The supernatant was 
removed and the pellet was washed 2 times with 200 µl cold EtOH (70%) then 
centrifuged for 5 minutes at 4 ºC. After removing the supernatant pellet was allowed to 
dry. The obtained pellets were dissolved in 40 µl SLS and transferred to the sequencing 
plate, covered with mineral oil (Beckman Coulter, Krefeld, Germany) and immediately 
loaded to CEQTM 8000 Genetic Analysis (Beckman Coulter, Krefeld, Germany) 
sequencing machine. The sequence similarity of the result was verified by blasting the 
sequence into NCBI/BLAST search tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
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Table 3: List of primers (5´ to 3´) used in this study 
Gene 
NCBI Accession 
No. (Bos Taurus) 
 Sequence of primer 5´ to 3´ 
TA 
(°C) 
F CTTGATTCTAATGGCCACGTGA MSK1 
(RPS6KA5) 
NM_001192023.1 
R CATCAACAGTGAACGGAGATGC 
53 
F CCATCAGCCCAACAACACT 
SMAD5 NM_001077107.2 
R AGGCAGGAGGAGGAGTATCA 
52 
F AGAGTGGAGTATGCAGTGCTCG 
EIF2C1 XM_002686476.1 
R GGGCATCAACATCGTTGTCA 
51 
F CACACATCCATCCGAGTTTG EIF2C4 XM_606455.4 
R ACCGCACATAGGTGTGACAA 
54 
F AGGCAGGAACATCGAAATCGT 
DDX6 NM_001143867.1 
R AAGATGACCAAAGCGACCTGA 
53 
F GCCCTTTCAGACCACTGTTT 
DOC1R NM_001035320.1 
R GGATCTCTTTGCCCATCTCTT 
51 
F GTTTGGAACCGTCGTGAAGT 
MEOX2 NM_001098045.1 
R GCAAGACGAGGAAGAAGTGG 
51 
F GGTCTCATTCCGCTACCATT 
MARCH2 NM_001037589.1 
R TGTCTCCTCAGCCACCTTCT 
54 
F AATGGAAAGGCCATCACCATC 
GAPDH NM_001034034 
R GTGGTTCACGCCCATCACA 
57 
F GCCGTATTCATCGACACCTGA 
Histone NM_174809.2 
R CTCCACGAATAGCAAGTTGCAA 
55 
F GTGGTGTTGTGTTCGTGGAC 
pmirGLO 
R CTTTCGGGCTTTGTTAGCAG 
58 
F TTGTAAACGCGGCCAGT 
M13 
R CAGGAAACAGCTATGACC 
59 
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Table 4: List of 3’UTR primer (5´ to 3´) used for the validation of miR-130b target 
genes 
Gene  Primer for 3’UTR 5´ to 3´  (underline bases shows restriction site) Seq. T A (°C) 
F GTGCGGTTTAAACGCTAGTGACAGTGCGTGCAT SMAD5 
(I. seed match 
sequence) R GTCGGCCTCGAGAGGGGTACCAAGGAAGCAAG 
194 Tdwn 
  66.5 
F CGCTGTTTAAACGATAAGGACTGGGGCTCACA 
SMAD5 
(II. & III.  
seed 
match 
sequence) R CTGTCTCGAGTGAAGCATGTTGCTAGAATTTCA 
325 Tdwn 
 57 
F CGCTGTTTAAACCCATTGGAGATGATGTTGCTT SMAD5 (IV & V.  
seed match 
sequence) R CTGTCTCGAGTGAAGCATGTTGCTAGAATTTCA 
324 62 
F CGCTGTTTAAACAGTTTTGCACTGCTCTTTCC 
MSK1 
R CGTCTCGAGTTGAGCTATACAAGTGCTCTGC 
483 56 
F CGCTGTTTAAACTTCAACAGCGACACTCACTC 
 
GAPDH 
R CGCTCTCGAGGGAAACATGTGGAAGTCAGG 
 
266 56 
F CGCTGTTTAAACCTGTGACACATCGATTTTGG 
 DDX6 
R GCTCTCGAGAGGCACTTCGCACAAATAAG 
 
249 58 
F CGCTGTTTAAACGCAACTCGGAATAGTTGCAC 
 EIF2C4 
R CGTGCTCGAGAATTGCCTGTCTGAATCTGC 
 
551 58 
F CGCTGTTTAAACGCAGAACTGCAACCTTTTGT 
 EIF2C1 
R CGCTCTCGAGTGGCAATGGACTCAGGTTAT 
 
206 57 
F CGCTGTTTAAACCCAGAGGTGTTGGTTGTGTG 
 MEOX2 
R CTGTCTCGAGGCTGGTTCTGTTTGTCATCG 
 
422 65.1 
F CGCTGTTTAAACAGCCGATTCTGTGATTCCTG 
 MARCH2 
R CTGTCTCGAGGGGCTCCTTTTATTCATTCG 
 
324 
Gradient 
PCR 
(52.3-59.6) 
F CGCTGTTTAAACCGACTCCACCTCAGCTTCTGG 
DOCR1 
R CTGTCTCGAGCCTCGCTGCTAACTCTTTCG 
199 Tdwn  59 
T
 A , Aneline  temperature; Seq, Sequence; Tdwn, touchdown 
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3.2.2.3 Plasmid DNA isolation and serial dilution 
 
Once the sequence were conformed for the gene of interest into the plasmid DNA the 
plasmid was isolated from the bacteria by using GenEluteTM Plasmid Miniprep Kit 
(Sigma, Germany) based on the manufacturer’s instructions. Briefly, 5 ml of bacterial 
culture were centrifuged at 12,000 g for 1 minute for harvesting cells. The supernatant 
was discarded and the pellet containing cells were collected. These cells were 
resuspended in 200 µl of resuspension solution under the laminar hood. Then 200 µl of 
lysis solution was added to lyses the bacteria. The mixture was subsequently mixed by 
inversion of tubes until it became clear and viscous. After incubating at room 
temperature (< 4 minutes), cell precipitation was done by adding 350 µl of 
neutralization buffer, mixed gently and centrifuged at 12000 rpm for 10 minutes. At the 
same time, the GeneElute Miniprep column was prepared by washing with 500 µl of 
preparation solution using centrifuge. After that, the clear supernatant of plasmid was 
transferred to this binding column and centrifuged at 12000 rpm for 1 minute. The flow-
through was discarded and the column was washed with 750 µl of wash solution 
followed by centrifugation at 12000 rpm for 1 minute and discarding the flow. Access 
wash buffer was removed from the column by re-centrifuging at 14000 rpm for 1 
minute. DNA was eluted from the column by transferring it into a fresh collection tube; 
30 µl of ddH2O was added and centrifuged at 14000 rpm for 1 minute. The column was 
discarded and the plasmid DNA was then collected. For determination of plasmid size 
and quality, 5 µl of plasmid together with 2 µl loading buffer was checked by agarose 
gel electrophoresis. In addition, the quantity of plasmid was also measured by 
NanoDrop 8000 spectrophotometer (NanoDrop, Wilmington, Delaware, USA) at 260 
nm. An aliquot of plasmid DNA was subjected to sequence check; the rest was stored at 
-20 ºC to be used as template for setting up the standard curve in real-time PCR. The 
copy number per microlitre of plasmid DNA was calculated based on the size and 
concentration. The plasmid serial dilution was prepared by converting concentration of 
plasmid (ng/µl) into numbers of molecules using the website 
(http://molbiol.ru/eng/scripts/01_07.html). Serial dilutions were then prepared from the 
concentration of 109 upto 101 copies /µl and were stored at -20 ºC. To achieve suitable 
standard curve for Real-time PCR the template serial dilution was conformed by PCR.  
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3.2.2.4 Cloning of 3’UTR amplicons in pmirGLO vector 
 
Once the 3’UTR were cloned in pGEM-T Vector it was sequence conformed and 
purified from bacteria as described above. For the 3’UTR amplicons into the pmirGLO 
Vector (Figure 3.1) the plasmid DNA were first digested with 0.5 µl of pme1 and 2 µl 
of Xho1 restriction enzyme with 2 µl of BSA and incubated at 37 °C for 60 minutes. 
Now the restricted plasmid was loaded in 0.8% agrose gel at 120 Voltage for 15 
minutes and the 3’UTR amplicon was extracted from 0.8% (W/V) agrose gel using 
phenol-chloroform. All centrifugation were performed at 4 ºC with 12,000x g speed. 
The gel that have PCR fragment was sliced, heated at 42 °C with 0.5 ml of 1X TE 
buffer until it is completely dissolved. The extraction was carried out by vigorously 
vortexing the gel solution with 0.6 ml of phenol-chloroform. Centrifugation for 15 
minutes allow the mixture to be separated into three phases having, a lower phenol-
chloroform phase, an interphase of precipitated protein, and an upper aqueous phase 
containing the amplified gene product. Upper aqueous phase was transferred into a new 
tube, shaked vigorously with an equal volume of chloroform to remove possibly carried 
over phenol, and re-centrifuged for another 10 minutes. The cleared aqueous phase was 
precipitated by gentle mixing with 50 µl (or 1/10 volume) of sodium acetate solution (3 
M, pH 5.3) and 1.5 ml of 100% EtOH (or 2.5 volume). Precipitation was maximized by 
placing at -20 ºC for 2 hour. The precipitated amplified PCR product was pelleted at 
12,000x g for 30 minutes at 4 ºC in universal centrifuge Z233MK (Hermle 
Labortechnik, Wehingen, Germany). The supernatant was then removed and the pellet 
was washed with 200 µl of 70% ethenol and centrifuged for 5 minutes to remove the 
supernatant. The pellet was air dried and gently dissolved in 20 µl of ddH2O and stored 
at -20 ºC till ligation or ligation was preformed immediately.  
The 3’UTR fragment digested with restriction enzyme was religated with pre-digested 
pmirGLO vector. Ligation was performed in a 6 µl reaction mix containing 3 µl of 2X 
rapid ligation buffer, 0.5 µl of pmirGLO vector (1µg/µl), 0.5 µl of T4 DNA ligase (3 
units/µl), and 50-120 ng of digested and gel purified 3’UTR fragment (according to the 
length of DNA with 3:1 ratio). The reaction was then incubated overnight at 4 ºC. 
Transformation was performed by combining 6 µl of ligation reaction with 80 µl of 
JM109 (Escherichia coli) competent cells in a 2 ml tube and incubated on ice for 30 
minutes. After incubation, the mixture was then heat-shocked briefly in a 42 °C water 
bath for 60 seconds and immediately returned to ice for 2 minutes. Then, 700 µl of LB 
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medium was added to the previous mixture and all together was shaken with speed of 
90 rpm at 37 ºC for 90 minutes in SHKE6000-8CE refrigerated Stackable Shaker 
(Thermoscinentific, IWA, USA). Meanwhile, LB-agar plates were prepared with 
ampicillin (4 µg/100 µl). For each gene two plates were prepared by adding about 400 
µl of inoculums per plate and incubated at 37 ºC overnight till the colonies become 
visible. As pmirGLO vector don’t have lacZ gene it can’t produce β-galactosidase 
enzyme to form blue colony so all about 20 white colonies were randomly been picked 
up and suspended in 30 µl 1X PCR buffer. At the same time, colonies were also 
transformed in 900 µl of ampicillin/LB-broth (4 mg /100 ml) in a shaking incubator 90 
rpm at 37 ºC for 90 minutes. The colonies in plate were stored at 4 °C if needed. The 
bacteria that were suspended in 30 µl 1X PCR were lysed by heating at 95 ºC for 15 
minutes and PCR amplified with gene specific primers and conforms the presence of the 
gene but it don’t conforms the integration of fragment into the vector or the orientation 
of sequence.  
 
                   
 
Figure 3.1: pmirGLO Dual-Luciferase miRNA Target Expression Vector. PGK 
promoter for firefly with multiple cloning site and SV40 promotor for 
renilla luciferase expression. Ampr: ampicillin resistance; MCS: multiple 
cloning site; PKG: phosphoglycerate kinase. 
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3.2.2.5 Sequencing and plasmid isolation of 3’UTR  
 
The conformed colonies with gene specific primers were screened for the insert by 
performing a PCR with primers designed in pmirGLO vector. 20 µl of reaction volume 
containing 10 µl of lysate, 0.5 µl dNTPs (10 mM), 0.5 µl of each of primer, 0.5 U of 
Taq polymerase (Sigma) in 1X PCR buffer were amplified in PTC 100 (MJ Research) 
thermal cycler for 35 cycles at 95 ºC denaturation, 58 ºC annealing and 72 ºC extension 
followed by 10 minutes of final extension at 72 ºC. 5 µl of the pmirGLO PCR products 
was purified by adding 1 µl of ExoSAP-IT (USB Corporation) then incubated at 37 ºC 
for 45 minutes followed by enzyme inactivation step at 80 ºC for 15 minutes. The 
purified DNA product (6 µl) was subsequently used as template for the sequencing PCR 
which contains 8 µl of millipore water, 2 µl of 1.6 pmole pmirGLO forward or reverse 
primer, 4 µl of DTCS Quick Start Master Mix (Beckman Coulter). The PCR sequencing 
reaction was performed for 30 cycles at 96 ºC for 20 seconds, , 50 ºC for 20 seconds and 
58 ºC for 4 min, followed by holding at 4 °C. The stop solution was prepared in a 
volume of 2.0 µl of 3M NaOAc (pH = 5.2), 2.0 µl of 100 mM EDTA (pH = 2.0) and 1.0 
µl of glycogen (20 mg/ml). The sequencing PCR product was transferred to a 1.5 ml 
sterile tube and mixed with 5 µl stop solution. A volume of 60 µl cold EtOH (98%) was 
added and mixed by vortex and then centrifuged for 15 minutes at 4 ºC. The supernatant 
was removed and the pellet was washed 2 times with 200 µl cold EtOH (70%) and 
centrifuged for 5 minutes at 4 ºC. After removing the supernatant pellets were allowed 
for dry. The obtained pellets were dissolved in 40 µl SLS and transferred to the 
sequencing plate, covered with mineral oil (Beckman Coulter, Krefeld, Germany) and 
immediately loaded to CEQTM 8000 Genetic Analysis (Beckman Coulter, Krefeld, 
Germany) sequencing machine. The sequence similarity of the result was verified by 
blasting the sequence into NCBI/BLAST search tool 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). After the confirmation of insert and sequence 
orientation the colonies with insert were then transferred to 50 ml tube and 25 ml of LB-
broth with ampicillin (4 mg / 100 ml) were added and incubation continued more then 
16 hours at the previous conditions for further plasmid isolation (in 3.2.2.3). 
For the determination of plasmid size and quality, 5 µl of plasmid together with 2 µl 
loading buffer was checked by agarose gel electrophoresis. In addition, the 
concentration and quality of plasmid were also measured by NanoDrop 8000 
spectrophotometer (NanoDrop, Wilmington, Delaware, USA) at 260/280 nm. An 
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aliquot of DNA plasmid was subjected to sequencing for conformation as described 
above; the rest was stored at -20 ºC to be used for transfection. 
 
3.2.3 Cell culture 
 
Granulosa/Cumulus cells were cultured using standard protocol of cell culture 
(Gutierrez et al. 1997, Portela et al. 2010) with slight modification. In Brief, Bovine 
ovaries were collected from local abattoirs and transported to the laboratory in a 
thermoflask containing 0.9% physiological saline (0.9% NaCl), at 30-35 °C. Ovaries 
were placed in 70% EtOH for 30 seconds and then rinsed twice with 0.9% physiological 
saline, for surface sterilization. Granulosa cells were harvested from follicular fluid by 
aspiration in 50 ml falcon tube containing 10 ml TCM media. Cells debris was allowed 
to settle down and upper liquid part was taken in 15 ml falcon tube and centrifuged at 
250x g for 4 minute. The pellet containing cells were collected and the suppernatent was 
discarded. The pellet was resuspended in 4 ml in Dulbecco Modified Eagle Medium 
(DMEM), sodium bicarbonate (10 mmol/L), sodium selenite (4 ng/mL), bovine serum 
albuminutes.(BSA), (0.1%; Sigma-Aldrich), penicillin (100 U/mL), streptomycin (100 
mg/mL), transferrin (2.5 mg/mL) without FCS. Where as cumulus cells were collected 
by vortexing the COC in 500 µl tissue culture medium (TCM) 199 supplemented with 
0.1% BSA (A- 3311, Sigma), 0.2 mM pyruvate and 50 µg/ml gentamycin sulphate 
(Sigma) for 4 minute and were washed 3 times in DMEM containing 
penicillin/streptomycin (200 U/mL) and fungizone (100 mg/mL). Cells were 
resuspended in Dulbecco Modified Eagle Medium (DMEM), sodium bicarbonate (10 
mmol/L), sodium selenite (4 ng/mL), bovine serum albuminutes.(BSA), (0.1%; Sigma-
Aldrich), penicillin (100 U/mL), streptomycin (100 mg/mL), transferrin (2.5 mg/mL), 
10% FCS, with essential and nonessential amino acid. Viability of freshly harvested 
cells was 40%–50%, estimated by 0.4% trypan blue staining (Sigma). Cultures were 
maintained at 37 °C in 5% CO2 in air by changing medium every 2 days. After 16 hours 
of culture the medium should be changed to remove red blood corpuscles. Cells were 
cultured according to their demand in each experiment. All experiments were conducted 
in primary cells and miRNA target validation at between 2-3 passage cells.  
According to Sutton et al. (2003) the metabolic activities of cumulus and granulosa cells 
were unaffected by the presence or absence of bovine oocytes so all the experiments for 
cumulus and granulosa cells were performed without co-culture with oocytes.  
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3.2.4 Transient transfection 
 
Prior to transfection the cultured cells were washed twice with perwarmed DPBS or 
phosphate saline buffer (PBS) without calcium and magnesium supplemented and 
transfection was performed for several different experiments:  
 
 1. Validation of miRNA target: The cumulus cells (8 x104 cells/ well) were seeded in 
DMEM medium with 10% FCS in 24 wells plate and incubated at 37 °C in 5% CO2 air 
for 24 hours prior to transfection. At more then 80% confluence, cells were co-
transfected with construct DNA at final concentration of 800 ng /ml and miR-130b 
precursor, inhibitor or scramble control (30 pmole/ml) with 2 µl/ml Lipofectamine 2000 
reagent (Invitrogen) according to the manufacturer’s instructions. In brief, cultured cells 
of 2-3 passage were washed twice in pre warmed DMEM without FCS and 
penicillin/streptomycin. 200 µl of prewarmed Opti-MEM medium IX Reduced Serum 
Media was added and placed into the incubator, meanwhile in RNase-free tube 50 
µl/well Opti-MEM medium was taken with DNA or RNA and in other tube mix was 
prepared with 1 µl Lipofectamine and 50µl/well medium. Both mixes were incubated 
for 5 minute and combined together to mix with each other. Prepared mix was incubated 
at RT for 20 minutes then 100 µl of mix was distributed to each well accordingly and 
the total volume for per well was made upto 500 µl. Transfected cells were incubated 
for 5 hrs at 37 °C in a humidified, 5% CO2 incubator. After 5hrs of incubation the 
transfected cells were washed twice in pre warmed DMEM without FCS and 500 µl of 
DMEM with 10% FCS was added.  
Cell Lysate preparation: After 48 hours of transfection 5X Passive Lysis Buffer (PLB 
Promega) was thawed and 1X PLB was prepared in distilled water. The cells were taken 
from incubator and media was aspirated. Cells were gently washed with PBS and 100 µl 
of 1X PLB was added to each well and gently shaken for 15 minutes at room 
temperature. After centrifugation the pellet was discarded and buffer with protein was 
either directly analyzed or stored in -20 °C for luciferase assay.  
 
2. Cumulus cells were separated from oocytes and cultured as described above. For the 
effect of miR-130b in cumulus and granulose cells the transfection was preformed after 
16 hrs of culture with miR-130b (precursor or inhibitor) and lipofectamin 2000 as 
described above but without any plasmid DNA. The cells were harvester after 24 and 48 
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hours for RNA and protein analysis respectively. The cells were collected in RIPA 
buffer with 1% protease inhibitor (Sigma) for protein analysis.  
 
 3. Cell proliferation assay was conducted using Growth Detection Kit MTT (Sigma) as 
described by manufacturer. In brief, primary granulosa/cumulus cells were seeded in 96 
wells plate in the concentration of 7.5 x 104/ml. For standard curve generation cells 
were seeded as shown in table 5. The transfection process was same as described above. 
 
4. For glycolysis assay granulosa and cumulus cell were cultured as described by Sutton 
et al. 2003 with slight modification. Primary granulose and cumulus cells were co-
cultured (2x105 cells /ml in 24 wells plate) in Dulbecco Modified Eagle Medium 
(DMEM), sodium bicarbonate (10 mmol/L), sodium selenite (4 ng/mL), bovine serum 
albumin (BSA), (0.1%; Sigma-Aldrich), penicillin (100 U/mL), streptomycin (100 
mg/mL), transferrin (2.5 mg/mL), 10% FCS, with essential and nonessential amino 
acid. 16 hrs post seeding transfection was preformed in serum free medium as 
mentioned above. 24 hrs post transfection medium was collected directly and the cells 
were washed twice in PBS and homogenized in the assay buffer. The cell lysate was 
centrifuge to remove the insoluble materials and stored in -80 °C untill use.  
 
5. For cholesterol assay granulosa cells were cultured same as for glycolysis (mentioned 
above). 16 hrs post seeding transfection was preformed in serum free medium. After 24 
hrs of transfection media was collected and the cells were washed twice in PBS and 
collected. After centrifugation PBS was discarded and 1:2 Methanol: chloroform was 
added to 20 volumes for cells and 6 volumes for medium and homogenized strongly. 
The homogenate was, then centrifuged at 800x g for 3 minutes and lower phase was 
collected. The solution containing lipids were dried in vacuum dry (Savant SpeedVac) 
and stored in -80 °C upto use.  
 
 
 
 
 
 
Materials and methods 
 
56 
Table 5: The number of cells taken per millilitre medium to generate standard curve for 
cell proliferation assay using MTT.  
Cells /ml Media in 96wells plate 
1. 8 x 105 100  µl 
2. 4 x 105 100  µl 
3. 2 x 105 100  µl 
4. 1 x 105 100  µl 
5. 5 x 104 100  µl 
6. 2.5 x 104 100  µl 
7. 1.25 x 104 100  µl 
8. 6.25 x 103 100  µl 
For the experiment cells taken 2.5x104/well, with 50 nM/well miRNA concentration 
 
3.2.5 Target validation 
 
MicroRNA targets a number of mRNA in biological system but it always depends on 
the expression of gene and the cell type where the miRNA and the gene can express. To 
clarify it we use the cumulus cells as model cell and computational prediction and 
experimental validation was carried out. 
   
3.2.5.1 miRNA target prediction and site selection 
 
The predicted targets are annotated in miRBase (http://www.microrna.sanger.ac.uk) 
bioinformatic tools namely PicTar (http://www.pictar.org), miRanda 
(www.microrna.org/microrna/home.do) and TargetScan (http://www.targetscan.org) 
(Griffiths-Jones 2004, Grun et al. 2005, Lewis et al. 2005). The selected bovine mRNA 
was uploaded on the software miTarget (http://cbit.snu.ac.kr/~miTarget/) which give the 
support vector machine (SVM) score for the target site (Kim et al. 2006). For 
constructing the vector mRNA secondary structure was also kept in mind and analyzed 
by Mfold (Zuker 2003). By selecting the appropriate site, the primers were designed 
with restriction enzymes (Pme1 and Xhol) for all the genes. Partial segments (200–600 
nucleotides) of the mRNA 3’ untranslated region (UTR) containing the miR-130b-
binding sequences shown in table 8 were PCR amplified from genomic DNA of bovine. 
Gene Ontology (http://www.geneontology.org) analysis of miRNA target genes was 
performed in order to predict the possible biological processes and functions.  
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3.2.5.2 DNA constructs  
 
Validation of mRNA as a target of miRNA was done by pmirGLO Dual-Luciferase 
miRNA Target Expression Vector (Cat.No. E1330, Promega). Although the vector was 
not yet been published even it was selected because of its dual nature of expression of 
luciferase. It had firefly as well as renilla expression genes in the same vector which 
minimize the transfection difference in primary cell system. The amplicons were cloned 
to the downstream of firefly which have the human phosphoglycerate kinase promoter 
and renilla with the promoter of SV40 in the same backbone of vector. The pmirGLO 
Dual-Luciferase miRNA Target Expression Vector is designed to quantitatively 
evaluate microRNA activity by the insertion of miRNA target sites to 3’UTR of the 
firefly luciferase gene. This vector is based on Promega dual-luciferase technology with 
firefly luciferase used as the primary reporter to monitor mRNA regulation and Renilla 
luciferase acting as a control reporter for normalization and selection.  
 
3.2.5.3 Reporter assays and preparation of luminometer 
 
Either the freshly prepared lysate or frozen lysate was taken for luminofluroscent assay. 
The luminescent activity of each sample was measured in an Opticom II luminometer 
(Bretford Instruments) using Dual-Luciferase reporter assay as advised by the 
manufacturer. In brief, 20 µl of cell Lysate was taken in each well of 96 wells plate, 
where untransfected cell lysate was used as blank. The instrument was set with injector 
1 and 2 to dispense 100 µl of LAR II and Stop & Glo reagent respectively. For 
measurement, using 2 second premeasurement delay and 10 second integration to detect 
luciferase for both reagents. Firefly luciferase activity was normalized by dividing 
renilla luciferase activity. All luciferase values represent average SD format with 
performing minimum quadricate transfections using SAS software.  
Injectors were prepared by placing 50 ml Falcon tubes containing ddH2O to both the 
injectors and from the program WASH INJECTORS (1, 2) was selected with (30 
injections) and OK. Continued with 70% EtOH PRIME and left the EtOH for 30 
minutes. Then washed with ddH2O (30 injections). As mentaioned above the reagents 
were plased accordingly to injector 1 and injector 2. After the completion of detection 
the luminometer was washed same as the preparation and the water was returned out to 
dry the injector before leaving it. 
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3.2.6 Microinjection 
 
3.2.6.1 Design and synthesis of precursor, inhibitor and scramble RNA 
 
All the synthetic miRNA- precursors and inhibitors for miR-130b (pre-mir-130b and 
anti-miR-130b) and scramble miRNA were purchased by company from Ambion, USA. 
Precursors are double stranded miRNA resemble the precursor stem-loop of miRNA, 
where inhibitors are single stranded miRNA that makes perfect complementary to 
mature miR-130b and scramble control was the sequence of miRNA which don’t target 
any annotated genes used as negative control. 
 
3.2.6.2 Preparation of miRNA for injection 
 
RNA was prepared to perform microinjection. 50 µM of miRNA precursor or inhibitor 
or scramble were mixed separately with 1% of Fast green (F7258, Sigma) to give the 
final concentration of 45 µM of miRNA and 0.1% fast green in a safe-lock epperndorf 
tubes using epT.I.P.S single tipes. The mix were mixed well and centrifuged before 
injection. Fast green was used for the injection control. 
 
3.2.6.3 Microinjection of oocytes 
 
Competent oocytes were selected on the bases of cumulus compactibility. Once the 
oocytes were selected, the cumulus cells were partially removed by vortexing to avoid 
technical difficulties during microinjection. Stripping of cumulus cells was done by 
vortexing the COC in 500 µl phosphate saline buffer (PBS) without calcium and 
magnesium supplemented with 1 mg/ml hyaluronidase (H-2251, Sigma) for 4 minutes. 
Then, oocytes were kept in a tissue culture medium (TCM) 199 supplemented with 
0.1% BSA (A- 3311, Sigma), 0.2 mM pyruvate and 50 µg/ml gentamycin sulphate 
(Sigma) having humidified atmosphere with 5% CO2 at 39 °C until it was used. Prior to 
injection, immature oocytes were incubated for 20 minutes in TCM-199 medium 
supplemented with cytochalasin B (8 µg/ml) was used to reduce the mechanical damage 
during injection (Paradis et al. 2005). As mentioned above, the immature oocytes were 
categorized into four groups namely: miR-130b precursor, miR-130b inhibitor and 
scramble injected with control uninjected group. Microinjection was performed on an 
inverted microscope (Leica DM-IRB) at 200x magnification. The group of 50-60 
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immature oocytes were placed in a 10 µl droplet of Hepes-buffered tissue culture 
medium 199 (H-TCM) supplemented with 8 µg/ml cytochalasin B under mineral oil. 
Injection was performed by aspiration of the miR-130b precursor, inhibitor, and 
scramble into the separate injection capillary (Cook, Ireland, K-MPIP-3335-5). The 
inner diameter of the injection capillary was 5 µm. The injection volume of ~7 pl 
(picoliter) was estimated from the displacement of the minisque of mineral oil in the 
capillary (Nganvongpanit et al. 2006). The different experimental groups were injected 
one after the other. 
Subsequently, in each injection for three experimental replications, a total of 400 
immature oocytes were categorized for each groups: miR-130b precursor injected (n = 
100), inhibitor injected (n = 100), scramble injected (n = 100) and uninjected control (n 
= 100) in each injection. Likewise, atleast 6 injection has been performed for different 
analysis. After microinjection all groups of ooytes were washed twice in TCM-199 and 
set back into culture (in 3.2.1.4). After 3-4 hours the oocytes degenerated due to 
mechanical injury were separated and remaining oocytes were kept for further culture.  
 
3.2.6.4 Microinjection of zygotes 
 
For the injection in zygote the in vitro fertilized zygotes (3.2.1.3) were selected and 
grouped into 3 about 100 each. Zygotes were placed into injection medium (HTCM) for 
injection with miR-130b precursor, inhibitor or scramble with an uninjected control. 
Microinjection was performed on an inverted microscope (Leica DM-IRB) at 200x 
magnification same as described in (3.2.6.3). After injection all groups of zygotes were 
washed twice in CR1aa medium and set back into culture in (3.2.1.4). The zygotes were 
checked for survival 3-4 hr after injection. For this experiment, zygote were produced 
and injected in the category of miR-130b precursor (100), inhibitor (100) and scramble 
(100) with uninjected control (n = 100) for each injection.  
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3.2.7 Oocytes and embryos collection  
 
In order to calculate the effect of miR-130b the oocytes and embryos were collected 
after specific time of treatment to analyze mRNA and protein using real-time 
quantitative PCR and western blotting analysis, respectively. Immature oocytes were 
cultured and collected after 22 hours of microinjection to observe the role of miR-130b 
in oocyte maturation. Zygotes were injected with miR-130b precursor, inhibitor or 
scramble RNA and uninjected controls were cultured in vitro until day 8 blastocyst 
stages to assess development and resulting blastocysts from each treatment group were 
collected for mRNA and protein analysis to determine the role of miR-130b in 
preimplantation embryo formation. Prior to freezing, all oocytes and embryos were 
washed twice with PBS (Sigma) and treated with acidic Tyrode pH 2.5-3 (Sigma) to 
dissolve the zona pellucida. The zona free embryos were further washed two times in 
drops of PBS and frozen in cryo-tubes containing minimal amounts of lyses buffer with 
1% protease inhibitor (Sigma). Until used for RNA isolation (in 3.2.8) or western 
blotting (in 3.2.13), all embryos were stored at -80 °C. 
 
3.2.8 RNA isolation and cDNA synthesis 
 
Total RNA containing microRNAs was isolated from three independent pools of 
immature and in vitro matured oocytes, corresponding cumulus cells, in vitro produced 
embryos: zygote, 2-cell, 4-Cell, 8-cell, morula, blastocyst and cultured (granulosa and 
cumulus) cells (Table 6) using miRNeasy mini kit (Qiagen, Hilden, Germany) following 
manufacturer’s protocol. In brief, cells or gametes of embryos were homogenated nicely 
using 700 µl chilled QIAzol Lysis Reagent and incubated at room temperature (RT) for 
4-5 minutes. Then to the homogenate 140 µl chloroform was added and mixed gently 
and centrifuged at 12,000x g for 15 minutes at 4 °C after a short incubation at RT. Here, 
after the upper aqueous phase was collected in a new tube and remaining down phase 
was stored at -20 °C for protein extraction. 1.5 volumes of 100% EtOH was added to 
the aqueous phase and pipetted to spin columns to centrifuge. The further procedure 
was followed by washing and oncolum DNA digest using RNase-free DNase (Qiagen). 
The total RNA was eluted with 30 µl of RNase free water. Total RNAs were assessed 
by NanoDrop 8000 spectrophotometer (NanoDrop, Wilmington, Delaware, USA). Total 
RNA isolation from injected oocytes, blastocysts and transfected cells was performed 
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by same method using miRNeasy mini kit (Qiagen, Hilden, Germany). Total number of 
embryos and cells was shown in table 6. Total RNAs (containing miRNA) was reverse 
transcribed using a miScript reverse transcription kit (Qiagen, Hilden, Germany) as 
described by manufacturer's protocol. In brief, 4 µl of 5X miScript RT Buffer (Includes 
Mg2+, dNTPs, and primers) was taken in PCR strips and miScript Reverse Transcriptase 
Mix (1 µl) was added to it. Template RNA was made to the final concentration of 200 
ng with RNase-free water. Total reaction mix (20 µl) was incubated for 60 minutes at 37 
ºC and the mix was inactivated at 95 ºC for 5 minutes and place immediately on ice. 
After synthesis, the cDNA was either used immediately or stored in -20 °C.  
 
      Table 6: Samples and amount taken for RNA isolation 
RNA Isolation Groups No. per replicate 
Oocyte Immature and mature 100 
Embryos Zygote, 2-cell 100 
Embryos 4-cells 75 
Embryos 8-cells 50 
Embryos Morula, Blastocyst 30 
Cells IMCC, MCC, GC 1.0x106 
Injected oocytes  
(after maturation) 
Precursor, Inhibitor, 
Scramble, Uninjected 100-120 
Zygote injected  
(Blastocyst) 
Precursor, Inhibitor, 
Scramble, Uninjected 30 
Transfected cells Precursor, Inhibitor, 
Scramble, Untransfected 1.0x106 
       IMCC: immature cumulus cells, MCC: mature cumulus cells, GC: granulosa cells, No.: Number. 
 
3.2.9 Expression profile of miRNA using qRT-PCR 
 
For the detection of miRNA real-time RT-PCR was carried out in an ABI Prism 7000 
SDS instrument based on the changes in fluorescence proportional to the increase of 
product. SYBR Green, which emits a fluorescent signal upon binding to double 
stranded DNA, was used as a detector. Fluorescence values were recorded during every 
cycle representing the amount of product amplified to a point known as threshold cycle 
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(Ct). The higher the initial transcript amount, the sooner accumulated product was 
detected in the PCR. Triplicate reactions were performed for each miRNA to quantify 
the abundance of miRNA in each sample with miRscript SYBR Green PCR kit (Cat: 
218073, Qiagen, Valencia, CA). miRNAs are amplified using the miScript Universal 
Primer together with the miRNA-specific primer (the miScript Primer Assay). Mature 
miRNA-specific primers were purchased from (Qiagen) and the universal reverse 
primer provided by the manufacturer. In brief, real-time PCR was performed using 2.5 
µL template cDNA with 12.5 µL of SYBRGreen mix, 10X miScript Universal Primer 
and 10X miScript Primer Assay in 25 µl of final volume. The thermocycler was set at 
50 °C for 2 seconds, 95 °C for 10 min, followed by 40 amplification cycles at 95 °C for 
15 seconds and at 60 °C for 1 minute. At the end of the last cycle, dissociation curve 
was generated by starting the fluorescence acquisition at 60 °C following standard 
protocol of the manufacturer in 7000 Real Time PCR system (Applied Biosystem, 
USA) and the Ct were calculated using Sequence Detection Software (SDS v1.2.1, 
Applied Biosystem, USA) using normalization to the geometric mean of U6 and 
Snod48 snRNA. Fold change was calculated as compared with the calibrator after 
normalization of the transcript level to the endogenous control, following the 2-∆∆Ct 
method (Livak and Schmittgen 2001). All experiments were conducted in triplicate.  
 
3.2.10 Quantitative real-time PCR analysis for mRNA 
 
Quantitative RT-PCR was performed for mRNAs using gene-specific primers and iTaq 
SYBR Green Supermix with ROX (Bio-Rad laboratories, Munich, Germany) in ABI 
Prism 7000 apparatus (Applied Biosystems, Foster City, CA). The detection was done 
by emition of fluorescent signal when amplification starts with primer extension. The 
higher the initial transcript amount, the sooner accumulated product was detected in the 
PCR. Prior to quantification, the optimum primer concentration was performed with 
different combinations of primer from 200 nM to 600 nM. Among then the lowest 
threshold cycle and minimum non-specific amplification was selected for subsequent 
reaction. After selection of primer concentration, a final assay consisted of 2 µl cDNA 
as template, up and downstream primers and SYBR Green Universal PCR Master Mix 
containing SYBR Green I Dye, AmpliTaq Gold DNA polymerase, dNTPs with dUTP, 
passive reference and optimized buffer components were performed in a total volume of 
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20 µl reaction. The PCRs were performed in 20 µl reaction volumes containing 10 µl 
SYBR Green universal master mix (Sigma) and 2 µl of template cDNA. A universal 
thermal cycling parameter (initial activation step at 95 °C for 3 min, 45 cycles of 
denaturation at 95 °C for 15 s and 60 °C for 45 s) were used to quantify each gene of 
interest. After the end of the last cycle, a dissociation curve was generated by starting 
the fluorescence acquisition at 60 °C. Genes of each group was quantified in 
comparison with geometric mean of GAPDH and Histone as endogenous control. The 
list of primers was indicated in (Table 3). Standard curves were generated for all genes 
and endogenous control genes using serial dilution of plasmid DNA (101–109) 
molecules. To determine the relative abundance of transcripts as fold change compared 
to the calibrator sample. Finally quantitative analysis was done using the relative 
standard curve method and results were reported as the relative expression or fold 
change as compared to the calibrator after normalization of the transcript level to the 
endogenous control. The quantification of genes was performed based on the relative 
standard curve method. The relative expression data were analyzed using General 
Linear Model (GLM) of the Statistical Analysis System (SAS) software package 
version 9.2 (SAS Institute Inc., NC, USA). Differences among the mean values were 
tested using ANOVA followed by a multiple pair wise comparison using t-test. A 
probability of P ≤ 0.05 was considered to be expressed with significant difference. 
 
3.2.11 Localization of miRNA in ovary and embryos 
 
Whole mount in situ hybridization of miRNAs was conducted with at least 5 COC or in 
vitro produced embryos (zygotes, 2-cell, 4-cell, 8-cell, morula and blastocyst) of each 
stage were taken. The embryos were collected and washed twice in PBS then fixed 
overnight in 4% paraformaldehyde. For hybridization embryos were rehydrated in series 
of methanol/PBS. Acetylation (2.33 ml triethanolamine, 500 µl acetic anhydride, H2O 
up to 200 ml, readily prepared and treated for 10 minutes) and proteinase K treatment 
(10 µg/ml, 10 minutes) were preformed with 3 times brief washing (10 minutes) in PBS 
for each step. Two hours of pre-hybridization was performed at 52 °C in hybridization 
solution (50% formamide, 5× SSC, 0.1% Tween-20, 50 µg/ml heparin, and 500 mg/ml 
yeast tRNA). Embryos were incubated overnight with 3'-Digoxigenin (DIG) labeled 
LNA-modified oligonucleotide probes (1 pM) for miR-130b and scramble RNAs 
Materials and methods 
 
64 
(Exiqon, Vedbaek, Denmark) in hybridization buffer in a humidified chamber at the 
temperature 20 °C below the Tm of probes. After overnight incubation, embryos were 
washed briefly in wash buffer (similar to hybridization buffer but without tRNA) and 
serial wash in 2X SSC/wash buffer (each time 10 minutes) to final three washes in 0.2X 
SSC each for 30 minutes at hybridization temperature was performed. Blocking, 
incubation with anti-DIG-AP antibody, washing and color development (Fast Red 
substrate reaction) was performed as described previously (Obernosterer et al. 2007). 
Embryos were mounted individually with VectaShield containing DAPI (Vector 
laboratories, Burlingame, CA) and analyzed by confocal laser scanning microscope 
(CLSM LSM-510, Carl Zeiss, Germany).  
Localization of miRNA in cryosections of ovary was performed with chopped ovary 
serially in 10 µm sections at -20 ºC using rapid sectioning cryostat (Leica microsystem 
Nussloch GmbH, Heidelberger, Germany) which were prior embedded in Tissue-Tek 
(Sakura Finetek Europe, Zoeterwoude, Netherlands). The sections were mounted on 
poly-L-lysine coated slides (Menzel GmbH & Co. KG, Braunschweig, Germany) then 
directly fixed in 4% (w/v) paraformaldehyde in PBS for 15 minutes at room 
temperature. The fixed specimens were washed three times in PBS for 5 minutes of 
each. The sections were incubated in an ascending alcohol series of 50%, 70%, 90% and 
100% EtOH (v/v) for 5 minutes each (prepared fresh in DEPC-treated H2O), followed 
by a descending alcohol series of 90%, 70%, 50% EtOH (v/v) for 5 minutes each, 
respectively. The sections were washed in 1X PBS for 5 minutes, blocked in 0.6% (v/v) 
H2O2 diluted in 1X PBS for 1 hour washed twice with 1X PBS for 5 minutes of each. 
The acetylation was performed by incubation of sections in 0.1 M TEA buffer with 
0.25% acetic anhydride for 10 minutes. The samples were equilibrated in 2X SSC for 
10 minutes. Blocking, incubation (with anti-DIG-AP antibody), washing and color 
development with Fast Red substrate reaction were performed as described previously 
(Obernosterer et al. 2007). Specimen were mounted with VectaShield containing DAPI 
(Vector laboratories, Burlingame, CA) and analyzed by confocal laser scanning 
microscope (CLSM LSM-510, Carl Zeiss, Germany). 
 
3.2.12 Protein detection in oocyte and ovary cryosection 
 
The ovarian sections were taken from the same serial number taken for miR-130b 
detection. The specimens were brought to room temperature for 10 to 15 minutes to dry 
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and washed twice in PBS for 5 minutes then fixed in 4% (w/v) paraformaldehyde in 
PBS for 45 minutes at room temperature. The slides now were permeabilized with 0.2% 
(v/v) Triton-X100 (Sigma) in PBS for 5 minutes and washed thrice in PBS. Non-
specific binding was minimized by blocking in 3% (w/v) bovine serum albumin (BSA) 
in PBS for 1 hr at 37 °C. Meanwhile, anti-SMAD1/5 (1:100) and anti-MSK1 (1:100) 
were prepared in 0.3% (w/v) BSA in PBS and covered over tissue section and were 
incubated overnight at 4 °C. To remove the unbound primary antibody specimens were 
washed three times with PBS. Secondary antibody fluorescein (FITC)-conjugated goat 
anti-rabbit antibody (Sigma) and fluorescein (FITC)-conjugated donkey anti-goat 
antibody (Abcam) in 0.3% (w/v) BSA /PBS with dilution 1:100 used for 1 hr at 37 °C 
and negative controls were processed in the same manner by omitting the primary 
antibody. The specimen were washed three times with PBS and mounted with 
VectaShield containing DAPI (Vector laboratories, Burlingame, CA) and analyzed by 
confocal laser scanning microscope (CLSM LSM-510, Carl Zeiss, Germany). 
For the detection of protein in COCs and oocytes atleast 20 COCs or oocytes were 
taken. After washing with PBS with PVA the specimen were fixed in 4% 
paraformaldehyde overnight at 4 °C. The COCs or oocytes were washed in Glycin-PBS 
(G-PBS) for twice and permeabilized with 0.5% (v/v) Triton-X100 (Sigma) in PBS for 
2 ½ hrs at room temperature. The washing was continued for three times with PVA in 
PBS. The samples were blocked in 3% (w/v) bovine serum albumin (BSA) with 0.3% 
(v/v) donkey serum in PBS for 1 hr at 37 °C. The primary antibody was prepared in 10 
times diluted blocking solution with anti-SMAD1/5 (1:100) or anti-MSK1 (1:100). 
COCs and oocytes were incubated overnight with primary antibody at 4 °C. Unbound 
antibody was removed by washing with G-PBS three times. Secondary antibody 
fluorescein (FITC)-conjugated goat anti-rabbit antibody (Sigma) and fluorescein 
(FITC)-conjugated donkey anti-goat antibody (Abcam) in ten times diluted blocking 
solution with dilution 1:100 prepared. COCs and oocytes were incubated for 1 hr at 37 
°C and negative controls were also processed but without primary antibody. The COCs 
and oocytes were washed three times with PBS and mounted with VectaShield 
containing DAPI (Vector laboratories, Burlingame, CA) and analyzed under confocal 
laser scanning microscope (CLSM LSM-510, Carl Zeiss, Germany). 
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3.2.13 Western blot 
 
3.2.13.1 Protein extraction 
 
As the injected embryos were limited the total RNA and protein were isolated with the 
same sample. Protein was extracted using miRNeasy mini kit (Qiagen, Hilden, 
Germany) from the embryos after the isolation of total RNA, although the adapted 
protocol was not mentioned by manufacturer. As per the manufacturers protocol the 
upper aqueous phase used for RNA isolation and the lower, red, organic phase was 
discarded. But here, the lower phase was been collected and proceeded for protein 
isolation. To the lower organic phase 150 µl of 100% EtOH was added and allowed to 
stand for 2 to 3 minutes at room temperature then centrifuged at 12,000x g for 5 
minutes. After centrifugation the supernatant was transferred to a new 2.0 ml tube and 
750 µl of isopropanol was added then allowed to stand 10 minutes at room temperature 
followed by centrifugation at full speed for 10 minutes. The protein pellet was washed 
three times in 1 ml of 0.3 M guanidine hydrochloride prepared in 95% EtOH solution 
and each wash had an incubation period of 20 minutes at room temperature and then 
was centrifuged at 7,500x g for 5 minutes. Afterward again three times washing was 
preformed with 100% EtOH. 1 ml of 100% EtOH was added and the mixture was 
allowed to stand for 20 minutes continued with centrifugation at 7,500x g for 5 minutes 
(all centrifuge was at 4 °C). Finally, the protein was air dried and dissolved in 200 µl of 
sample buffer containing 1% protease inhibitor cocktail and stored at -20 °C for 
westernblot analysis. The transfected cultured cells 48 hours post transfection were 
washed two times with PBS without calcium and magnesium supplemented and 100 µl 
RIPA buffer (Sigma) was added with 1% protease inhibitor cocktail (Sigma) and whole 
cells lysate was vortex by incubating on ice. The lysate was centrifuged and supernatant 
was collected as protein and stored at -20 °C for westernblot analysis.  
 
3.2.13.2 Protein separation and transfer 
 
The protein loading buffer was added to each sample and was boiled at 95 °C for 5 
minutes. Proteins were separated by 10% Polyacrylamide gel and then transferred onto 
nitrocellulose transfer membrane, pore size 0.45 mm (Whatmen Protran Nitrocellulos 
Membrane). The membrane was stained with Ponceau S to evaluate the transfer quality 
and blocked for 1 hr in 1X Roti-Block (Roth GmbH) with 1×TBS containing 0.1% 
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Tween-20. The membrane was then incubated at 4 °C overnight using the required 
antibody. The primary antibodies used were as follows, Rabbit polyclonal anti-
RPS6KA5 (1:1000) (Acris Antibodies GmbH), goat polyclonal anti-SMAD1/5 (1:500), 
and goat polyclonal anti-GAPDH (1:500) (Santa Cruz Biotechnology) was prepared in 
0.1X of Roti-Block buffer. After incubation with the primary antibody, the membrane 
was washed six times for 5 minutes in PBST and the hybridization with the appropriate 
secondary antibody at room temperature for 1 hour was performed. The horseradish-
peroxidase (HRP) conjugated donkey anti-rabbit secondary antibody (Santa Cruz 
Biotechnology) and HRP-conjugated donkey anti-goat (Santa Cruz Biotechnology) 
were used with dilution factor 1:20000 in 0.1X Roti-Block buffer. The membrane was 
finally washed 6 times for 5 minutes in PBST. The protein and antibody binding was 
detected using the SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Scientific) following the manufacturer’s instructions and visualized using Kodak 
BioMax XAR film (Kodak) or BioRad (Germany).  
 
3.2.14 Mitochondrial assay 
 
Mitochondrial probe detection was performed according to the manufacturer 
instruction. In brief, all groups of oocytes (miR-130b precursor or inhibitor or scramble 
and uninjected) were collected after 22hrs of injection and washed in maturation 
medium then incubated with 300 nM of mitochondrion-specific dye (MitoTracker® 
Mitochondrion-Selective Probes, invitrogen) for 10 minutes and washed thrice in 
maturation medium. After washing all oocytes were fixed with 4% paraformaldehyde 
for 30 minutes (Oubrahim et al. 2001) and washed three times in PBS for collecting the 
image on confocal laser scanning microscope (CLSM LSM-510, Carl Zeiss, Germany) 
at 579 nm to 599 nm wavelength.  
This probe is cell-permeate mitochondrion-selective dyes which passively diffuse across 
the plasma membrane and accumulate in active mitochondria and remains associated 
with the mitochondria even after fixation. 
 
3.2.15 Cell proliferation assays 
 
Cell proliferation was determined using a modified 3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium, bromide (MTT) assay on live cells. As described in 3.2.12 
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cells were seeded in 96 wells plate and transfected 24 hours post seeding. MTT activity 
was assayed with Cell Growth Detection Kit (Sigma) according to manufacturer's 
instruction after 24 or 48 hours of treatment. In Brief, 24 hours and 48 hours post 
transfection the culture plate was taken and aseptically 10 µl MTT SOLUTION was 
added in each well of culture and incubated 4 hours in incubator. Now the dead cells 
with media were removed carefully and 100 µl of MTT SOLVENT was added to each 
well. Plate was gently stirring in a gyratory shaker in dark and the absorbance was read 
at 570 nm on a multiplate reader spectrophotometer (Molecular Device, Germany), with 
a 690 nm reference filter. All readings were taken within 30 minutes to 1 hrs and 
average was calculated. The ±SEM (standard error of the mean) was calculated with the 
absorbance (OD) of the transfected wells with untransfected wells (Pregel et al. 2007).  
The viability of transfected cells were checked using (0.4%) Trypan Blue Solution 
(Sigma). The cells seeded by 8 x 104 each well of 24 well plate and 50 nM of miR-130b 
precursor, inhibitor and scramble. After 24 hours and 48 hours of transfection the 
transfected cell were washed with were stained with tryphan blue solution and live cells 
were observed in haemocytometer under microscope (ECLIPSE TS100, Nikon).  
 
3.2.16 Cholesterol assay 
 
Primary granulose and cumulus cells were cultured in 24 wells plate in the 
concentration of 2 x 105/ml. The cells and the medium were dried stored at -80 °C. 1 
hour prior to use the samples was resuspended in 1:1 Methanol: Chloroform solution 
with 20 µl volume (Miah et al. 2011). 80 µl Assay buffer was added to the solution 
from the EnzyChrom AF Cholesterol Assay Kit (E2CH-100). Further experiment was 
done according to the manufacturer. In brief, standard was prepared and 50 µl of each 
standard and unknown samples were distributed in 96 will plate with about 5 replicates 
of each transfected group (precursor, inhibitor, scramble and control). Enzyme 1 µl, 
Dye Reagent 1 µl and Assay buffer 55 µl pre well were mixed and aliquoted 50 µl in 
each well. The plate was incubated at room temperature in dark for 30 minutes. 
Meanwhile, all setup was completed for the fluorescence reader. The reading was 
preformed with fluorescence at lex = 530nm and lem = 585nm. Standard prepared with 
highest at 100 mg/dl, with different dilution and blank with 0. 
Cholesterol (mg/dL) = [FSample – Fblank] / Slope, 
Where F stands for Fluorescent 
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3.2.17 Determination of glycolytic rate  
 
The high glycolysis shows high metabolic activity. To determine the role of miR-130b 
in glycolysis the experiment was conducted using primary cell culture of granulosa and 
cumulus cell. The cells were transfected with 100 nM/ml of miR-130b precursor, 
inhibitor or scramble in 24 wells plate in serum free medium. After 24 hours of 
transfection the cells were collected in assay buffer and glycolytic rate was measured by 
using the Lactate Colorimetric Assay Kit (Abcam, Cambridge, MA, USA). All the 
reagents were preparation and stored as described by the manufacturer. Lactate assay 
was performed in 96 wells plate in multiplate reader (Molecular Device), The OD was 
taken at 450 nm and calibrated with untransfected cells. Standard was generated with 
assay buffer and provided standard from manufacturer, taken as: 0, 2, 4, 6, 8, and 10 
nmol/well of the Lactate Standard. Plot was made with standard curve of nmol/well vs. 
OD 450 nm for the standard curve. Lactate concentrations were calculated for the test 
samples:  
C = La/Sv (nmol/µl or mM) 
Where: La is the lactic acid amount (nmol) of the sample from standard curve. Sv is the 
sample volume (µl) added into the well. Lactate concentration was normalized by 
sample cell number. 
 
3.2.18 Statistical analysis 
 
The general linear model procedure of General Linear Model (GLM) of Statistical 
Analysis System (SAS) version 9.2 was used to test the significant variation in the 
polarbody extrusion, cleavage rate, morula and blastocyst rates between the pre-miR-
130b injected, anti-miR-130b injected, scrambled injected and uninjected oocytes or 
zygotes, cholesterol level, lactate concentration, cell proliferation in transfected cells 
and the list significant difference t-test was employed to separate means between all 
treatment groups. Moreover, the relative expression of miRNA and gene between the 
treatment groups was performed of t-test. A probability of p ≤ 0.05 was considered to be 
expressed with significant difference. 
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4 Results 
 
4.1 Expression profile of miR-208 and miR-130b in oocyte and surrounding cells 
 
The expression of miR-208 and miR-130b was preformed in granulosa cells, mature and 
immature cumulus cells. U6 and Snord48 were used as endogenous control and Ct value 
was calculated. The results were according to figure 4. miR-130b was significantly high 
in granulosa cells and cumulus cells compared to miR-208 (p < 0.01).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4: The expression profile of miR-130b and miR-208 in granulosa, immature 
cumulus and mature cumulus cells. The vertical axis indicates the fold 
change of miRNA using the minimum value as one and normalized to the 
geometric mean of U6 and Snod48. Error bars show each miRNA mean ± 
SD. Significant differences (a:b – p < 0.05). GC: granulosa cell; ICC : 
immature cumulus cell; MCC : mature cumulus cell. 
 
4.2 The expression pattern of miR-130 family  
 
MicroRNA miR-130 family shares same seed sequence and mostly have same targets. 
So, further, to verify the biogenesis of the miR-130 family members (miR-130a, miR-
130b, miR-301a and miR-301b) in silico chromosomal analysis was performed. 
According to miRBase Version 15 database, miR-130b and miR-301b were located at 
chromosome 17 within 10kb and miR-130a and miR-301a were located at different 
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chromosomes of bovine genome (Table 7).  
 
Table 7: List of microRNA in bta-mir-130 family and their similarity to bta-mir-130b. 
miRNA Acc No. Family Sequence Ch Sr (%) 
bta-miR-130b MIMAT0009224 mir-130 CAGUGCAAUGAUGAAAGGGCAU 17 100% 
bta-miR-130a MIMAT0009223 mir-130 CAGUGCAAUGUUAAAAGGGCAU 15 90.9% 
bta-miR-301a MIMAT0009276 mir-130 CAGUGCAAUAGUAUUGUCAAAGCAU 19 44% 
bta-miR-301b MIMAT0009277 mir-130 CAGUGCAAUGAUAUUGUCAAAGCAU 17 48% 
Acc No, Accession number; Ch, chromosomal location; Sr, similarity.  
 
4.2.1 Expression of miR-130 family in oocytes and surrounding somatic cells 
 
After chromosomal localization of miR-130 family, the expression profiling was 
performed for the verification of transcription similarity in immature and mature 
oocytes and their surrounding cells (cumulus and granulosa). The expression profiling 
was conducted in triplicate using real time PCR and geometric mean of U6 and Snord48 
was used as endogenous control. Accordingly, the expression result showed that the 
members of miR-130 family don’t have any tendency to regulate in same pattern 
together (Figure 4.1- 4.2). The expression of miR-130b was significantly (p < 0.05) high 
in granulosa and cumulus cells compared to other members of the miR-130 family 
(Figure 4.1).  
The expression of miR-301a was the lowest in all cell type among the family members. 
miR-130a was about 3-fold high in immature cumulus cells and granulosa cells (p < 
0.05) when compared to mature cumulus cells. The expression of miR-301b was about 
5-fold higher in granulosa cells compared to immature and mature cumulus cells (p < 
0.05). In granulosa cells miR-130a was 3-fold higher (p < 0.05), miR-301b was 5-fold 
higher (p < 0.05) and miR-130b was about 18-fold higher than compared to miR-301a 
(p < 0.05). In immature cumulus cells miR-130a was 3-fold higher, miR-301b was 2-
fold high and miR-130b was 13-fold higher (p < 0.05) compared to 301a. Compared to 
all indicated miRNA miR-130b was significantly high in cumulus and granulosa cells. 
In mature cumulus cells miR-130a and miR-301a both expressed in low level where as 
miR-301b was 2-fold high compared to miR-301a (p ≥ 0.05). miR-130b was 
significantly high (p < 0.05) with (> 12-fold) in mature cumulus cells compared to miR-
301a (Figure 4.1).   
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Figure 4.1: The expression profile of miR-130 family in granulosa cells, mature and 
immature cumulus cells. The vertical axis indicates the fold change of 
miRNA using the minimum value as one and normalized to the geometric 
mean of U6 and Snod48. Error bars show miRNA mean ± SD. Significant 
differences (a:b – p < 0.05). IM: immature; M: mature. 
 
The expression pattern of miR-130 family in immature and mature oocytes showed that 
miR-301a was relatively low expressed in both oocyte groups. miR-301a and miR-130a 
were no differentially regulated in both immature and mature ooytes (p ≥ 0.05). 
Similarly, miR-301b was not differentially regulated in both mature and immature 
oocytes but 4-fold higher (p < 0.05) than miR-301a. Whereas, miR-130b was 
significantly (p < 0.05) higher compared to miR-301a in immature and mature oocytes. 
Coming to the comparison of miR-130 family in each group of oocyte, the expression of 
miR-301a was lowest in immature oocyte and used as calibrator. Whereas, miR-130a 
was 2-fold high, miR-130b was 10-fold (p < 0.005) high and miR-301b was 5-fold high 
(p < 0.05) compared to miR-301a in immature oocyte. And in mature oocyte miR-130a 
was 1.5-fold high and 130b was 5.5-fold (p < 0.05), whereas, miR-301b was 5-fold 
higher (p < 0.05) than miR-301a (Figure 4.2A). When miR-130b was compared among 
granulosa cells, cumulus cells, immature oocyte and mature oocyte, it was abundant in 
granulosa and cumulus cells with 59- and 54-fold respectively compared to mature 
oocytes (p < 0.001) (Figure 4.2B). Additionally, when miR-130b expression compared 
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between immature and mature oocytes, it showed 2.8-fold high expression of immature 
than mature oocyte (p < 0.05), as showed in figure 4.2B.  
 
 
Figure 4.2: The expression pattern of miR-130 family in immature and mature oocytes 
(A), miR-130b across the cumulus cells, granulosa cells, immature and 
mature oocyte (B). The vertical axis indicates the fold change of miRNA 
using the minimum value as one and normalized to geometric mean of U6 
and Snod48. Error bars show the miRNA mean ± SD. Significant differences 
(a:b:c – p < 0.05), and (**p < 0.001). Significantly different (a:b:c – p < 
0.05) and (**p < 0.001). GC: granulosa cell, CC: cumulus cell, IMO: 
immature oocytes, MO : mature oocytes. 
 
4.2.2 In situ detection of miR-130b in different stages of follicular cells 
  
The expression of miR-130b was higher in granulosa and cumulus cells compared to 
oocyte, so further detection of miR-130b was conducted in different stages of follicular 
cells in ovarian section using 3'-digoxigenin labelled locked nucleic acid (LNA) 
microRNA probes and U6 was used as positive and scramble as negative controls. The 
in situ localization of miR-130b shows the detection of miR-130b in the granulosa cells, 
cumulus cells and oocytes of antral follicles in association with the early stages 
(preantral) follicles and other ovarian tissues (Figure 4.3).  
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Figure 4.3: In-situ detection of miR-130b in the ovarian sections using 3'-digoxigenin 
labelled locked nucleic acid (LNA) microRNA probes for miR-130b, U6 and 
scramble miRNA. A and B: miR-130b, C: U6 (positive control) and D: 
scramble (negative control). A: preantral follicle, B, C and D: antral follicle, 
Red signal stands for miRNA (miR-130b, U6 and scramble) and blue signal 
represents nuclear staining, DAPI: 4',6-diamidino-2-phenylindole. Scale bar 
represents 20 µm. 
 
4.2.3 The expression profiling of miR-130 family in preimplantation embryo 
 
The expression pattern of miR-130 family was investigated in different stages of 
embryos (Zygote, 2-Cell, 4-Cell, 8-Cell, Morula and Blastocyst) using qRT-PCR with 
equal amount of cDNA for all stages of embryos. The experiment was performed in 
appropriate biological replicates and geometric mean of Snord48 and U6 were used as 
endogenous control. The result indicates the expression of each miRNA of miR-130 
family was different at each stage. At the zygote stage, 301a was 1.5-fold higher 
compared to miR-130a. miR-130b was 4.7-fold higher where as miR-301b was 5.2-fold 
higher in association to miR-130a. At 2-cell embryo miR-130a was used as calibrator 
and expression of miR-130b, miR-301b and miR-301a were 2.4-fold, 2.5-fold and 2-
fold high respectively. In 4-cell stage embryo, miR-130a, miR-130b and miR-301b 
were 2-fold, 13-fold and 17-fold high expressed respectively compared to miR-301a. At 
8-cell embryo, miR-130a was 8-fold, miR-130b was 35-fold and miR-301b was 10-fold 
higher compared to miR-301a and the expression differences were significant (p < 0.05) 
for all. At morula stage embryo, miR-301a and miR-130a were less expressed, where 
Results 
______________________________________________________________________ 
75 
as, miR-301b was 10-fold (p < 0.05) higher and miR-130b was 87-fold (p < 0.001) 
higher compared to miR-301a. Similarly, at blastocyst stage, miR-130a, miR-301a and 
miR-301b were expressed in low level but miR-130b was 60-fold higher (p < 0.001) 
compared to miR-301a. However, when each miRNA of miR-130 family was compared 
across the preimplantation stage, the expression of miR-130a and 301a were limited 
through out preimplantation stage. Although, the expression of miR-130a was slightly 
increased in zygote, 2-cell, and 4-cell with 8-fold, 16-fold, and 6-fold respectively 
compared to the expression at blastocyst stage. Similarly, miR-301a was higher in 
zygote and 2-cell stage embryo compared to blastocyst stages embryo. Additionally, the 
expression patter of miR-301b was relatively higher in zygote, 2-cell and 4-cell (p < 
0.05) compared to blastocyst stage. Whereas, the expression of miR-130b was high 
throughout the implantation stage compared to other members of miR-130 family. 
However, the expression of miR-130b was comparatively low at zygote, 2-cell and 4-
cell but increased after embryonic genomic activation. Expression of miR-130b at 
morula was 8-fold higher compared to zygote stage with significant difference (p < 
0.05) (Figure 4.4).     
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: The expression pattern of miR-130 family across the preimplantation stage 
embryos. The vertical axis indicates the fold change of miRNA using the 
minimum value as one and normalized to the geometric mean of U6 and 
Snord48. Error bars show miRNA mean ± SD. Significant differences 
(a:b:c – p < 0.05), and (*p < 0.001). 
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4.2.4 In situ localization of miR-130b in preimplantation embryo development 
 
The microRNA miR-130b was more imperative when compared to other family 
members as it shows the transcription at maternal as well as embryonic gene activation. 
Hence, this microRNA was further localization in all stages of embryos conducting 
Whole-mount in-situ detection. The result showed the high detection of miR-130b in the 
cumulus cells of mature and immature oocytes, immature oocytes and further at 8-cell, 
morula and blastocyst stage (Figure 4.5).  
 
 
 
Figure 4.5: Whole-mount in-situ detection of miR-130b in COCs and preimplantation 
embryo stage using 3'-digoxigenin labelled locked nucleic acid (LNA) based 
microRNA probes for miR-130b and scramble miRNA and nucleus was 
stained with DAPI. 2D, 2 dimensional; 3D, 3 dimensional; scr, scramble; 
miR, miR-130b; DAPI, 4',6-diamidino-2-phenylindole. Red and blue colours 
indicate miRNA expression and nuclear staining respectively. 
 
 
 
Results 
______________________________________________________________________ 
77 
4.3 In silico analysis and experimental validation of target gene 
 
4.3.1 Identification of the appropriate gene as a target of miR-130b in oocyte maturation 
and preimplantation 
 
In order to dissect the mechanisms of miR-130b in preimplantation development and 
function, it was necessary to determine the endogenous mRNA potential targets that are 
known to play a major role in function of granulosa cell, oocyte maturation and in 
preimplantation embryo development. To identify the direct target genes of miR-130b 
in oocyte maturation and granulosa cell function, PicTar, miRanda and TargetScan were 
used as a target prediction tool. The mentioned algorithms annotated on the database of 
the miRBase::Sequences program (http://microrna.sanger.ac.uk), on the bases of strong 
free thermodynamic energy and its SVM scoring. The function of the selected gene 
further analysed using Gene Ontology (GO) analysis associated with signal 
transduction, oocyte maturity, follicular growth and preimplantation development 
transcription factors. Accordingly, the selected genes were SMAD1, SMAD5, MEOX2, 
MARCH2, DDX6, EIF2C1, EIF2C4, RPS6KA5 and DOCR1. Furthermore, the selected 
genes were blasted using NCBI software to evaluate the sequence similarity in bovine. 
And, the result found were SMAD5, MEOX2, MARCH2, DDX6, EIF2C1, EIF2C4, 
RPS6KA5 and DOCR1 having the same target site as in human or mouse except 
SMAD1. SMAD1 is a target in human and mouse but the 3'UTR sequence was not 
similar to bovine. The selected target sequences were uploaded in miTarget with the 
bovine miR-130b to observe the specificity of target and sequence difference to each 
target site shown in (Table 8). The number of target sites at single gene by miR-130b 
was shown in figure 4.6.  
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Table 8: List of selected bta-mir-130b target genes with its target sites. 
RPS6KA5     Alignment 
 
Position 
cloned  
Free Energy 
(total) 
SVM 
Score 
3'             - UACGGGAAAGUAGUAACGUGAC-5' 
       ||: : ||| :| : |||||||| 
5' ----GUUAUUGUUUUUAAUU---UUGCACUG-3' 
1st vector 
30  -14.20  0.531  
3'        - ACGGGAAAAUUGUAACGUGAC-5' 
            ||:::|   |||:|||||||| 
5'   -----UGUUUUAAGUAAUAUUGCACU-3' 
1st vector 
108 -12.50  0.759  
3'  --UACG-G-GAAAGUA— GUA-ACGUGAC-5' 
          ||     ||:::| |  ||:|||:||||  
 5'-GUGCACUCUUUAAAGCAUAUGUACUG-3'  
1st vector 
173 -15.00  2.602  
3'--- -UACGGGAAAGUAGU--AACGUGAC-5' 
    ||||||:| ||    |||||:|| 
5'----UUGCCCUCACACCCCCUUGCGCUU-3'  
1st vector 
234 -17.30  2.300  
     3'--UACGGGAAAGUAGUAACGUGAC-5'  
            |||||   ||:     |||||| 
     5'--CGGCCC- - -  CAGAG -  -  GCACUG-3'  
1st vector 
291 -15.30  1.071  
3'-UACGGGAA- AGUAGUAACGUGAC-5'  
            ||:::| ||:| : ||||||| 
5'-GCGCUGUGCUCGUGGCUGCACUG-3'  
1st vector 
346 -18.30  3.769  
SMAD5    
 3'--UACG - - - -GGAAAGUAGUAACGUGAC-5'  
      ||||          : ||: |   ||||||| 
 5'--AUGCAUUAAUCUUUUAUUUGCACUU-3'  
1st vector 
860 -15.80  0.417  
 3'- UACGGGAAAGUA- GUAACGUGAC-5' 
      | ||:|| |  ::||| ||| 
 5'-GUACCUGUUUAAGUGUUGUACUU-3'  
2nd vector  
3480 -11.10  0.402  
  3'- UACGGGAAAGUAGUAACGUGAC-5'  
             || |::||| |:|||| :|| 
    5 AUACUUUUUCUA--GUUGC-U-UG-3'  
2nd vector 
3545 -10.50  0.229  
3' -----UACGGGAAAGUAGUAACGUGAC-5'  
     || ::| || ||:||||||:| 
5'-- -  GUGGUUGGUUAAAGUUGCAUUU-3'  
3rd vector 4842 -11.00  0.238  
'--UACG--GGAAAG—  UAGU--AACGUGAC-5'  
    || : |||  |  ||:||||||:| 
5'-UUGCAUUUUGAAAAUCGCUUGCAUUA-3'  
3rd vector 4860 -11.60  0.039  
3'--UACGGGA-AAGUAGU-AACGUGAC-5'  
   | | |: ||  | |||||:||| 
5'--AGGUCUGCUUC-UUACUUGUACUU-3'  
3rd vector 4999 -12.20  0.530  
MEOX2    
3'—UACGGG------ AAAG-----UAGUAACGUGAC-5'  
     :::    |||| |  |  |||||||| 
5'----GCCUUUGUGUUUGCUUUGCUUGCACUG-3'  
1st vector 
281 -16.10  1.174  
3'--UACGGGAAAGUAGUAACGUGAC-5'  
   |||:||  |    :|||||||| 
5'--UUGCUCUCGC---------UUGCACUG-3'  
1st vector 
433 -16.60  5.365  
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MARCH2 Position cloned  Free Energy (total) 
SVM 
Score 
3'-UACGGGAA-AGUAGUAA--------CG--UGAC-5'  
   ||:::|          ||: || |||| 
5'---GCUUUCCUCAUCCAACACCAGCUACUG-3'  
1st vector 
537 -10.70  0.160  
3'---UACGGGAAAGUAGU-AACGUGAC-5'  
   :|||| |   :    ||||| || 
5'---GUGCCAUA-CAGAGUUUGCAGUG-3'  
1st vector 
565 -13.50  1.274  
3'----UACGGGAAA---GUAGUAACGUGAC-5'  
   | | :||      |:  ||||||| 
5'---AGGCUCUGCAGGCUUC-UUGCACUU-3'  
1309 -15.50  1.964  
EIF2C1    
3'-UACGGGAAAGUAGUAA-CGUGAC-5'  
 |   :|| ||   |||||||||| 
5'-AAAUCCAUUGA-CAUUUGCACUU-3'  
1st vector 
281 -10.40  0.398  
3'-UACGG-GAAAGUAGUA------ACGUGAC-5'  
   ||   ||||| ||     ||| ||| 
5'--UCCCCGCUUUCUUCCCACCUGC-CUG-3'  
1st vector 
380 -10.50  2.510  
EIF2C4    
3'---UACGGGAAAGUAG---UAACGUGAC-5'  
  | |   |     ||: :|||||||| 
5'-CAGCAAC-UCGGAAUAGUUGCACUG-3'  
1st vector 
69 -14.80  1.401  
3'---  UACGGGAAAGUAGUAACGUGAC-5'  
    ||||     ||  |||||||| 
5'- --- CUGCCAGG-CA-----AUUGCACUA-3'  
1st vector 
569 -15.40  3.712  
DDX6    
3'--UACGGGAAAGU--AGU----------AACGUGAC-5'  
     :::|||:|      :|| |||||||| 
5'----CCUUUUUUGUUCCACUUGUUUGCACUG-3'  
1st vector 
244 -13.40  1.018  
3'-UACGG--GAAA--GUAGU----AACGUGAC-5'  
   ||||   |      :   ||||||| 
5'-GUGCUGACUGAACAUUAGUUGCACUA-3'  
1st vector 
271 -15.70  3.095  
DOC1R (CDK2AP2)     
3'--UACGGGAAAGUAG---UAACGUGAC-5'  
     ||| |  |  ||: ||||||| 
5'--UGGCCUUCACCCCGAGUUGCACUU-3' 
523 -15.64  4.160  
SVM: Support Vector Machine 
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Figure 4.6: bovine miR-130b and predicted 3'UTR of the target gene. Blue: target gene, 
Red: miR-130b. A: DDX6; B: RPS6KA5; C: EIF2C1; D: EIF2C4; E: 
MARCH2; F: SMAD5; G: MEOX2; H: DOC1R. 
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4.3.2 Expression profiling of selected target genes in preimplantation embryo 
 
Once the targets were selected; the expression profiling of selected genes (EIF2C1, 
EIF2C4, DDX6, MARCH2, RPS6KA5 (MSK1), MEOX2, DOC1R and SMAD5) was 
conducted in preimplantation embryo using qRT-PCR. The expression was normalized 
to GAPDH transcript, an endogenous control. The mRNA abundance of EIF2C1, 
EIF2C4, DDX6, MARCH2, MSK1 and SMAD5 in all the stages (mature oocyte, 
zygote, 2-cell, 4-cell, 8-cell, morula and blastocyst) of preimplantation embryo was 
shown in (Figure 4.7). However the expression of MEOX2 and DOC1R were not 
detected in all stages of embryo except very low in morula and blastocyst.  The 
expression of DDX6 was low at mature oocyte but increased at 2-cell followed by 
significantly decline expression at 8-cell and increase at morula stage (p < 0.05). 
MARCH2 and SMAD5 were low at oocyte and zygote but increased at 2-cell upto 8-
cell stage significantly (p < 0.05). Where as, the detection reduced significantly (p < 
0.05) at morula and blastocyst stage EIF2C1 didn’t show any significant difference (p ≥ 
0.05) in expression among all stages of embryo but little increase at zygote and 2-cell 
stage embryo. Transcript of EIF2C4 was low from oocyte upto 8-cell stage but was 
significantly increased (p < 0.05) at morula and blastocyst stage. RPS6KA5 was low at 
oocyte but significantly increased (p < 0.05) at zygote which remains about constant 
upto 8-cell embryos and decrease of mRNA was detected at morula and blastocyst stage 
embryos (p < 0.05). 
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Figure 4.7: Expression profiling of selected transcripts across the preimplantation stage 
embryos. MO: Mature oocyte; Z: Zygote; 2C: 2-Cell; 4C: 4-cell; 8C: 8-Cell; 
Mo: Morula; Bl: Blastocyst. Error bars show the mean ± SD. 
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4.3.3 Transfection of cells with different concentration of construct plasmid and miR-
130b for further experimental validation 
 
To generate pmirGLO target vector, about 200 to 600bp of 3’UTR (according to the 
target site present) were cloned to the pmirGLO vector. As mentioned in materials and 
method. However, the procedure of miRNA target validation was done first time in our 
institute so optimization was needed for the transfection efficiency, DNA and miRNA 
optimal concentration. MSK1 (RPS6KA5) construct, a single construct with several 
target site was been selected for optimization. With different number of cells different 
concentration of vector-construct plasmid and different concentration (15 nM, 30 nM 
and 50 nM precursor) of miR-130b mimic or inhibitor were used. 24 hours and 48 hours 
post-transfection the luciferase activity was observed by firefly luciferase (F-luc) 
activity normalised with renilla luciferase (R-luc) activity. The cell concentration was 
selected where less cell death and more than 80% cell confluency was observed. 
Additionally, all wells showed uniform growth of cells at the concentration of 8 x 104. 
All concentration was used with same number of cells optimised. miR-130b 15 nM, 30 
nM and 50 nM shows significantly decreased in the signalling of MSK1mirGlo 
construct vector compared the cells without miR-130b or with anti-miR-130b (p < 0.05) 
(Figure 4.8A). The cumulus cells were co-transfected with 500 ng of PMJGreen vector 
to visualise transfection efficiency and the transfection efficiency was more then 60% 
(Figure 4.8C-D). Next experiment was done using several controls for cotransfection. 
The controls used were (1) mismatch construct, (2) mismatch vector with miR-130b, 
MSK1 without miR-130b (4) scramble RNA and (5) PMJGreen vector visible control 
The result shows the cells cotransfected with 800 ng/ml MSK1mirGlo vector with 30 
nM/ml of miR-130b precursor was significantly (p < 0.05) reduced in the ratio of F-
luc/R-luc activity compared to all the other controls (mismatch vector control, MSK1 
without miR-130b control and scramble control). Where as cells transfected with 
MSK1mirGlo vector with 30 nM/ml miR-130b inhibitor showed significant (p < 0.05) 
increase in F-luc/R-luc activity compared to MSK1mirGlo without miR-130b control 
(Figure 4.8B).     
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Figure 4.8: (A) The miR-130b concentrations (15 nM, 30 nM and 50 nM) transfected 
with 800 ng/ml MSK1Glo construct plasmid. (B) Different controls used to 
validate the target accuracy. (C-D) Cotransfection of 500 ng pMJGreen 
vector with miR-130b shows transfection efficiency > 60%. Forty-eight 
hours post transfection the activity of F-luc was normalized by R-luc 
expression and the error bar show mean ± SD of four independent 
experiments. Significant differences (a:c – p < 0.05), and (*p < 0.01) versus 
cumulus cells transfected with mismatch vector construct control. RE, 
relative expression; FL, firefly luminescent; RL, renilla luminescent. 
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4.3.4 Experimental validation of cloned genes EIF2C1, EIF2C4, DDX6, SMAD5, 
MEOX2, MARCH2 and DOCR1 
 
The validation result shows that miR-130b triggered a strong and specific silencing 
effect on the target but not to all of the predicted genes. The 3’UTR of the SMAD5 gene 
contains all the predicted binding sites for miR-130b in 3 different clones and 3’UTR of 
the MSK1 gene with 3 sites with highly conserved regions was cloned in single vector. 
MEOX2, MARCH2, EIF2C1, DOCR1, DDX6 and EIF2C4 were constructed with one 
or two target site in single vector (Figure 4.6). To validate whether these genes are the 
real target of miR-130b, sites were cloned into the downstream of the firefly luciferase 
site of the pmirGLO vector and transient transfected with minimum 4 individual 
replicate. The transfection was grouped in mismatch vector with miR-130b transfected 
cells, construct vector transfected cells, construct vector or miR-130b transfected cells 
and construct vector and inhibitor transfected cells.  
The result shows MSK1 was reduced by 40% (p < 0.05) in firefly luciferase expression 
in miR-130b precursor cotransfected with MSK1Glo vector cells compared to mismatch 
mirGlo vector and precursor cotransfected, where as miR-130b inhibitor was 30% high 
signal in MSK1Glo co-transfected cells (Figure 4.8B). 
The cells cotransfected with SMAD5Glo vector and miR-130b precursor with two 
target sites shows 60% reduction (Figure 4.9A) which was highly significant (p ≤ 0.005) 
and SMAD5_site1Glo cotransfected with miR-130b inhibitor showed increase in firefly 
luciferase expression (20%). And the SMAD5_site2 Glo construct cotransfected with 
miR-130b precursor showed reduction in signal (p ≥ 0.05) but the third construct 
SMAD5_site3 didn’t show any change in the signal (Figure 4.9B-C). DOCR1mirGlo 
cotransfected with miR-130b precursor showed reduction in signal by 35% in firefly 
luciferase expression compared to mismatch vector transfected with precursor (p < 
0.05) was significant (Figure 4.9D). EIF2C4 was constructed with 2 strong site and 
cotransfected with miR-130b precursor was 35% reduced in firefly luciferase 
expression compared to mismatch vector transfected with precursor (p ≤ 0.05), where as 
miR-130b inhibitor transfected with EIF2C4mirGlo increased by 20% high signal of 
firefly luciferase compared to EIF2C4mirGlo alone transfected (Figure 4.10E). MEOX2 
was constructed with two strong target sites and gave about 30% reduction (p ≤ 0.05) in 
firefly luciferase signalling in miR-130b precursor transfected cells compared to 
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mismatch vector transfected with mir-130b precursor transfected cells, where as miR-
130b inhibitor increased by 20% of firefly luciferase signal compared to mismatch 
cotransfected with miR-130b precursor (Figure 4.10C). EIF2C1, MARCH2 and DDX6 
didn’t show any reduction in firefly signal (Figure 4.10A-B, D). All transfection was 
controlled using PMJGreen vector with 70- 80% confluent and 50-60% transfection 
efficiency.   
 
Figure 4.9: Validation of genes as target of miR-130b with luciferase reporter activity. 
Cumulus cells were cotransfected with pmirGLO vector construct with 30 
nM miR-130b/ml precursor or inhibitor. Forty-eight hours post transfection 
the activity of F-luc was normalized by R-luc expression and the error bar 
show mean ± SD of four independent experiments. Significant differences 
(*p < 0.05) and (**p ≤ 0.005) versus cumulus cells transfected with 
mismatch vector construct control. RE, relative expression; FL, firefly 
luminescent; RL, renilla luminescent. 
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Figure 4.10: Validation of genes targeted by miR-130b using luciferase reporter 
activity. Cumulus cells were cotransfected with pmirGLO vector construct 
with 30 nM miR-130b/ml precursor or inhibitor. Forty-eight hours post 
transfection the activity of F-luc was normalized by R-luc expression and the 
error bar show mean ± SD of four independent experiments. Significant 
differences (*p < 0.05) versus cumulus cells transfected with mismatch 
vector construct control). FL, firefly luminescent; RL, renilla luminescent. 
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The results shows MSK1, SMAD5, MEOX2, EIF2C4 and DOC1R were experimentally 
validated as target of miR-130b where as EIF2C1, MARCH2 and DDX6 were not been 
validated as target by experimental analysis. Among the validated target MSK1 and 
SMAD5 were selected for further investigation  
 
4.3.5 Expression of SMAD5 and MSK1 transcript in oocyte and companion cells 
 
The transcript abundance of SMAD5 and MSK1 was measured in mature and immature 
oocytes and its corresponding cumulus cells to observe there expression pattern which 
was as figure 4.11, high regulation of SMAD5 as well as MSK1 were observed in 
oocytes compared it its corresponding cumulus cells (p < 0.05).  
 
Figure 4.11: Relative abundance of SMAD5 (A) and MSK1 (B), in mature and 
immature oocyte and its corresponding cumulus cells. The error bar show 
mean ± SD of three independent experiments. Significant differences (*p < 
0.05) related to corresponding cumulus cells. MO, mature oocyte; IMO, 
immature oocyte; MCC, mature cumulus cells; IMCC, immature cumulus 
cells. 
 
4.3.6 Localization of selected target proteins in follicular cells and COC 
 
The spatial protein expression of MSK1 and SMAD5 were further investigated in 
ovarian tissue section and COCs using immunohistochemisty. Accordingly strong 
protein florescence signals were detected in oocyte and cumulus cells for MSK1. 
However, its signal was relatively lower in granulosa cells. On the other hand, the 
Results 
______________________________________________________________________ 
89 
protein signalling of SMAD5 was higher in cumulus cells and follicular granulosa cell 
(Figure 4.12).   
   
 
Figure 4.12: Immunofluorescent analysis of SMAD5 and MSK1 in ovarian section 
shows the localization of protein. Green colour indicates the protein 
(SMAD5 and MSK1), where as, blue colour indicates the nucleus staining 
with DAPI. Scale bar represents 20 µm. 
 
4.4 Effect of miR-130b in oocyte maturation and its surrounding cell function 
 
The role of miR-130b was investigated in oocyte maturation and its surrounding 
somatic cells by overexpression and suppression of miR-130b.  
 
4.4.1 Direct regulation of SMAD5 and MSK1 by miR-130b during oocyte maturation  
 
To observe the effect of miR-130b on its target gene function during oocyte maturation, 
miR-130b precursor and inhibitor were injected to the immature oocyte. Scramble 
injected and uninjected oocytes groups were used as a control. The result showed that 
after 22 hrs of injection, the expression of miR-130b was significantly (p < 0.001) 
increased by 8000-fold in precursor injected group compared to uninjected oocyte group 
(Figure 4.13A). Furthermore, the gene expression analysis indicated that the mRNA (p 
< 0.05) and protein expression of MSK1 and SMAD5 were significantly increased in 
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inhibitor injected compared to uninjected group (Figure 4.13B, 4.13C, 4.13D). 
Moreover, immunohistochemistry localization showed that the protein signal of MSK1 
gene was reduced in precursor injected group and remarkable increased in inhibitor 
injected group compared to scramble injected and uninjected control groups (Figure 
4.13C, 4.13D) 
 
 
Figure 4.13: Expression levels of miR130b (A), MSK1 (B), and SMAD5 (C), in miR-
130b precursor, miR-130b inhibitor and scramble injected oocytes and 
uninjected oocyte control. (D) Western blot analysis showing the protein 
expression of MSK1 and SMAD5 genes in miR-130b precursor, miR-130b 
inhibitor and scramble injected oocyte groups. (E) Immunofluorescent 
indicating spatial localization of MSK1 protein in different injected groups 
of oocytes. Scale bar represents 20 µm. (**p < 0.001, *p < 0.05) 
E 
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4.4.2 Role of miR-130b on oocyte maturation  
 
The oocytes injected with miR-130b precursor, miR-130b inhibitor, scramble and 
uninjected control group were observed during oocyte maturation to understand the role 
of miR-130b on oocyte maturation.  
 
4.4.2.1 Polar body extrusion in miR-130b injected oocyte groups 
 
miR-130b was over-expressed or suppressed during oocyte maturation in vitro to 
understand the role of miR-130b during oocyte maturation. The results have showed 
that the ectopic expression of miR-130b in oocyte has increased the polar body 
extrusion and the suppression of endogenous miR-130b resulted in significant reduction 
of polar body extrusion (Table: 9). The comparative difference between inhibitor 
injected with other injected and uninjected groups was (p ≤  0.01). 
 
Table 9: The polarbody extrusion rate of injected and uninjected oocytes groups. 
 
Injected groups No. of oocytes First polar body 24 h after injection (%) 
miR-130b precursor 408 86.30 ± 4.02 a 
miR-130b inhibitor 467 73.39 ± 6.59 b 
Scramble 489 85.13 ± 3.91 a 
Uninjected 401 84.65  ± 7.8 a 
Different letters of superscripts in the same column indicate significant difference (p ≤ 0.01) 
between injected groups. 
 
4.4.2.2 Effect of miR-130b in mitotic division of oocytes 
 
A group of oocyte injected with miR-130b precursor, inhibitor, scramble and uninjected 
(150 oocytes /group) were stained after 22 hours of injection with Hoechst to investigate 
the chromosomal position in the oocytes. The results have shown that 10-12% oocytes 
remains in GV stage in all injected groups, 22% of inhibitor injected and 8% precursor 
injected groups were arrested in Telophase l stage. On the other hand, the proportion of 
oocytes reached to MII stage were lower significantly (p ≤ 0.05) in inhibitor injected 
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compared to the control groups (Figure 4.14). But the proportion of oocytes reached to 
MII stage was high in miR-130b precursor injected oocytes compared to uninjected 
oocyte groups but not significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14: Mitotic divisions of oocyte observed 22 hours post injection.  
GV: Germinal vesicle; MI: Metaphase I; TI: Telophase I; MII: Metaphase II. 
 
4.4.2.3 miR-130b affects the mitochondrial activity during oocyte maturation  
 
As mitochondria are a powerhouse of cells, loss of mitochondrial activity shows the loss 
of cellular metabolism which leads to apoptosis. Hence, to understand whether loss of 
miR-130b was associated with loss of mitochondrial activity, mitochondrial activity 
assay was performed using MitoTracker probes. At least 20 oocytes per group were 
taken for microscopy and the experiment was done in triplicate. The staining has shown 
a clear reduction in the fluorescent quenching, in miR-130b inhibitor injected groups 
where as the miR-130b precursor injected groups has shown strong fluorescent signal 
compared to scramble or uninjected groups (Figure 4.15).  
 
     GV                  MI                 TI                  MII 
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Figure 4.15: The fluorescent quenching in mitochondria of injected oocytes with miR-
130b precursor, miR-130b inhibitor, scrambled and uninjected after 22 hours 
of injection. Scale bar represents 20 µm. 
 
4.4.3 Effect of miR-130b in oocyte surrounding cells  
 
The granulosa cells and cumulus cells were transfected with miR-130b precursor, miR-
130b inhibitor, scramble and untransfected control were observed after 24 and 48 hours 
of transfection for cell proliferation, cholesterol and glycolysis.  
 
4.4.3.1 Regulation of SMAD5 and MSK1 by miR-130b in cumulus cells 
 
The cumulus cells were transfected with miR-130b precursor, miR-130b inhibitor or 
scramble control. QRT-PCR analysis showed the significantly high level of miR-130b 
with 45-fold and 2-fold low in inhibitor transfected compared to untransfected group 
(Fig: 4.16A). Consequently, the mRNA level of MSK1 was significantly reduced in 
precursor transfected cells (Figure 4.16B). Similarly, the SMAD5 mRNA expression 
was reduced in miR-130b precursor transfected and also increased in inhibitor 
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transfected group when compared to control groups (Figure 4.16C). The protein level of 
MSK1 and SMAD5 has slightly been increased in inhibitor transfected and also slight 
reduction in precursor transfected cumulus cells (Figure: 4.16D). 
 
 
  
Figure 4.16: (A) The ectopic expression of miR-130b showed significantly high level of 
miR-130b after 24 hrs in transfected cumulus cells. (B) MSK1, (C) SMAD5, 
expression in 130b precursor, miR-130b inhibitor and scramble transfected 
cumulus cells after 24 hours. Significant difference (*p < 0.05). (D) The protein 
level of MSK1 and SMAD5 in miR-130b precursor, miR-130b inhibitor and 
scramble control groups after 48 hrs of transfection. GAPDH was used as 
loading control. 
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4.4.3.2 Effect of miR-130b in cumulus cell proliferation   
 
The cumulus cells were cultured and transfected with miR-130b precursor, miR-130b 
inhibitor or scramble miRNA to observe the viability of cells at different time points. 
Live cell count was preformed in triplicates and the cell count showed relatively higher 
cell number in precursor transfected cells and cell viability was less (p ≤ 0.05) in 
inhibitor transfected cells after 24 hours compared to untransfected control group. 
Where as after 48 hours of transfection the cell count in precursor transfected  cells was 
significantly high (p < 0.05) and relatively low in inhibitor (p < 0.01) transfected cells 
compared to scramble transfected as well as untransfected control cells (Figure: 4.17). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17: The number of live cells was determined in cumulus cells by trypan blue 
vital cell count after 24 hours and 48 hours of transfection. . Error bars 
represent the mean ± SD for three independent experiments. Significant 
differences (*p ≤ 0.05) and (** p < 0.01). 
 
4.4.3.3 Regulation of SMAD5 and MSK1 by miR-130b in granulosa cells 
 
The granulosa cells were transfected with pre-miR-130b, anti-miR-130b and scramble 
control and untransfected control. QRT-PCR analysis showed the mRNA level of 
MSK1 was reduced in precursor where as increased in inhibitor transfected cells (Figure 
4.18A). Similarly, mRNA of SMAD5 was reduced in miR-130b precursor transfected 
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and slight increased in inhibitor transfected group when compared to control groups 
(Figure 4.18B). The protein level of MSK1 and SMAD5 has slightly been increased in 
inhibitor transfected and also slight reduction in precursor transfected granulosa cells 
(Figure: 4.18C). 
 
 
 
Figure 4.18: Relative abundance of MSK1 (A) and SMAD5 (B) mRNA in miR-130b 
precursor, miR-130b inhibitor and scramble transfected granulosa cells. 
Significant difference (*p < 0.05). (C) The protein level of MSK1 and 
SMAD5 in miR-130b precursor, miR-130b inhibitor and scramble control 
transfected granulosa cells. GAPDH was used as loading control. 
 
4.4.3.4 Granulosa cell proliferation is influenced by miR-130b  
 
The granulosa cells were cultured and transfected with miR-130b precursor, miR-130b 
inhibitor or scramble miRNA to observe the viability of cells at different time point 24 
and 48 hours post transfection. Live cell count was performed under the microscope 
Results 
______________________________________________________________________ 
97 
using haemocytometer with minimum 4 replicates The cell count showed relatively 
higher cell number in precursor transfected cells (*p < 0.01) after 48 hrs of transfection 
where as lower in inhibitor transfected cells (*p < 0.01) in both 24 and 48 hrs after 
transfection compared to scramble transfected and untransfected control cells (Figure 
4.19). 
 
 
 
 
 
 
 
 
 
 
          
           
 
Figure 4.19: The live cell count in granulosa cells was determined by trypan blue vital 
cell count after 24 hours and 48 hours of transfection. . Error bars represent 
the mean ± SD for three independent experiments. Significant differences 
(*p < 0.01). 
 
Following this, the result of the cell count was further validated by the cell proliferation 
assay using MTT assay. The primary granulosa cells were transfected with 50 nM/ml 
miR-130b precursor, miR-130b inhibitor or scramble and after 24 and 48 hours of 
transfection, the cell proliferation assay was performed. The result showed that miR-
130b precursor transfected cells significantly (p ≤ 0.05) increased the level of cell 
proliferation potential after 48 hrs and the miR-130b inhibitor transfected cells were 
declined in the proliferation potential immediate after 24 hrs post transfection and 
continued upto 48 hrs post transfection significantly compared to scramble as well as 
untransfected control (Figure 4.20). The cell concentration was calculated by standard 
curve generated by OD verses cell number. Moreover, after 48 hours, granulosa cell 
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transfected with miR-130b precursor exhibited a higher proliferation potential of cells 
(p ≤ 0.05), where as miR-130b inhibitors transfected groups showed lower cell 
proliferation compared to untransfected cells (p ≤ 0.05).  
  
                      
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.20: Effects of miR-130b overexpression and suppression on granulosa cell 
proliferation using MTT assay. Error bars represent the mean ± SD for four 
replicates. Significant differences (*p ≤ 0.05), hrs: hours. 
 
4.4.3.5 miR-130b controls glycolysis in oocyte surrounding cells 
 
To understand the role of miR-130b in glycolysis the primary granulosa and cumulus 
cells were transfected and lactate assay was performed 24 hours post transfection in 96 
wells plate in ELISA reader. Addition of miR-130b to cultured cells lead to a significant 
elevation in lactate production (p < 0.005) where as, inhibitor transfected cells showed a 
decreased (p < 0.01) in lactate production compared to untransfected cells (Figure 4.21). 
Concentration of lactate was calculated using standard curve which was generated by 
OD verses dilution.  
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Figure 4.21: Lactate production in miR-130b precursor, inhibitor and scramble RNA 
transfected cells. The OD was taken at 460 nm calibrated with 
untransfected cells. Error bars represent the mean ± SD for four replicates. 
Significant differences (*p < 0.01) and (**p < 0.005). 
 
4.4.3.6 Influence of miR-130b in cholesterol biosynthesis 
 
The transfected cells and medium were collected 24 hours post transfection with miR-
130b precursor and inhibitor with scramble and untransfected control. The fluorescent 
reading showed the cholesterol concentration to be very low in all groups of cells. 
Moreover in precursor transfected cells and medium the cholesterol level was less 
compared to untransfected cells and medium but not significant (Figure 4.22).  
 
Figure 4.22: The graph shows cholesterol concentration in transfected and untransfected 
groups of cells and medium. Concentration was calculated by referring 
standard curve. RFU: Relative Fluorescence Units. 
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 4.5 Effects of miR-130b on in vitro embryos development  
 
After microinjection the first cleavage rate obtained was 75% to 81% for all the 
embryos injected with miR-130b precursor, inhibitor, and scramble with uninjected 
control group (Table 10). However, these differences were not statistically significant (p 
> 0.05). 
 
Table 10: First cleavage of the zygote injected with miR-130b precursor, inhibitor and 
scramble compared to the uninjected control group. 
 
Injected group No. of cleaved embryo/total First cleavage rate (%) 
miR-130b precursor 664/878 75.66 ± 5.22 
miR-130b inhibitor 623/814 75.45 ± 7.70 
Scramble 676/837 80.79 ± 4.85 
Uninjected 498/613 81.38 ± 6.16 
hpi: hour post insemination. There was no significant difference among all injected groups (p > 
0.05).  
 
72 hours post insemination, 68% embryos derived from precursor injected zygotes 
reached to 8-cell stages, and 16% were remains at 4-cell stage. On the other hand, 
embryos derived of inhibitor injected zygote reached to 8-Cell was 58% and 4-cell stage 
28%, whereas 65% of scramble injected and 69% uninjected controls reached to 8-cell 
(Figure 4.23A). Moreover, 19% of scramble and 18% uninjected controls were at 4-
cells (p > 0.05). Similarly, the day 5 morula formation was 33% in precursor injected 
zygotes, 18% in inhibitor injected, 27% in scramble injected and 32% in uninjection 
control . However, the morula rate was (p ≤ 0.05) reduced in the suppression of miR-
130b embryos compared to uninjected zygote derived morula (Figure 4.23B)  
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Figure 4.23: (A) The proportion of 4-Cell and 8-Cell stage embryos 72 hours post 
insemination in different zygote injected groups (B) The proportion of day 
5 morula in different zygote injected groups. Error bars represent the mean 
± SD for four replicates. Significant difference (*p < 0.05). 
 
4.5.1 Effect of miR-130b on in vitro blastocyst formation 
 
The embryos reached to blastocyst stage were 22%, 14% 19% and 20% in miR-130b 
precursor, miR-130b inhibitor and scramble injected and uninjected zygote groups 
respectively (Figure 4.24). However, there was no significantly increase in blastocyst 
rate in precursor injected zygote groups (p > 0.05), but suppression of miR-130b 
showed significant reduction of blastocyst formation (p ≤ 0.05). 
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Figure 4.24: The proportion of day 7 blastocyst formation rate derived from miR-130b 
precursor, inhibitor and scramble injected and uninjected zygotes groups. 
Error bars represent the mean ± SD for four replicates. Significant 
difference (*p < 0.05). 
 
4.5.2 Effect of miR-130b on expression of SMAD5 and MSK1 in blastocyst derived 
from injected zygotes 
 
To observe the effect of miR-130b on the target genes regulation at blastocysts stage 
embryos derived from zygotes injected with miR-130b precursor or miR-130b inhibitor 
and scramble injected and uninjected zygotes were used as controls. The results showed 
that the expression of miR-130b was (>55-fold) increased in miR-130b precursor 
injected whereas inhibitor injected showed reduction of miR-130b expression (Figure 
4.25A). The expression of MSK1 mRNA was lower in blastocysts derived from miR-
130b precursor injected zygotes. On the other hand, the expression of MSK1 was higher 
in blastocysts derived from inhibitor or scramble injected zygotes compared to 
blastocysts derived from uninjected zygotes groups (Figure 4.25B). Similarly, the 
mRNA and protein level of SMAD5 was found to be higher in blastocysts derived from 
miR-130b inhibitor injected zygotes and tended to be decreased in blastocysts derived 
from miR-130b precursor injected zygotes (Figure 4.25C, 4.25D). The SMAD5 protein 
was markedly increased in miR-130b inhibitor injected group blastocysts. 
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Figure 4.25: (A) The expression of miR-130b in blastocysts derived from miR-130b 
precursor, inhibitor and scramble injected and uninjected zygotes groups. 
The relative expression level of MSK1 (B) and SMAD5 (C) mRNA 
transcript in blastocysts derived from miR-130b precursor, miR-130b 
inhibitor, scramble injected and uninjected zygotes. (D) Western blot 
analysis showing the expression difference of SMAD5 in 130b precursor, 
inhibitor and scramble injected, where as GAPDH used as endogenous 
control. 
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4.5.3 Apoptotic effect of miR-130b  
 
Staining of DNA fragmentation was performed by TUNEL assay at blastocyst derived 
from the zygotes injected with miR-130b precursor, miR-130b inhibitor, scramble 
miRNA and uninjected groups. The staining of nuclei were recorded and calculated as 
apoptotic index (API) divided with the total cell number as shown in figure 4.26. No 
significant difference was observed in the total cell number and neither in TUNEL 
positive cells among all injected groups. 
 
 
 
              
Figure 4.26: The total number of blastocyst cell and apoptotic index of blastocysts stage 
derived from zygote injected with different treatment groups.     
  
 
Discussion 
 
105 
5 Discussion 
 
5.1 Functional analysis of miRNA in bovine preimplantation  
 
Functional analysis of miRNA is becoming a focus of research in different fields (Chen 
et al. 2005, Hennebold 2010, Lagos-Quintana et al. 2002, Rosa et al. 2009, Shen et al. 
2010b, Xia et al. 2010) but still it leaves a huge area that needs to be explored. In 
addition, the role of microRNAs in gametogenesis has been evidenced in several reports 
(Giraldez et al. 2006, McCallie et al. 2010, Tang et al. 2007). Parallel to this, dicer 
knockout studies showed the importance of the miRNA in oocyte maturation and 
preimplantation embryo development in mammals (Bernstein et al. 2003, Luense et al. 
2008, Ohnishi et al. 2010, Wienholds et al. 2003). But there is no or little research has 
been conducted to understand the function of specific miRNAs during bovine oocyte 
maturation or preimplantation embryo development. Therefore, this study was 
conducted to find the role of miR-130b in bovine oocyte maturation and 
preimplantation development. 
 
5.2 Selection of miRNA for functional analysis study 
 
The oocyte is the gamete contains the half of genetic material and complete cytoplasmic 
material for an embryo for development (Schultz 2002). These oocytes surrounded with 
somatic cells and bidirectional communication between the oocytes and their associated 
follicular somatic cells is essential for the development of both oocytes and cumulus 
cells (Eppig 2001). For the study of functional analysis of miRNA in oocytes and 
preimplantation embryo development, miR-130b was selected by referring its 
expressional pattern between matured and immature oocytes (Tesfaye et al. 2009). 
According to the authors miR-130b and miR-208 were the miRNAs highly expressed in 
immature oocyte were selected for further studies. The expression profile of both miR-
208 and miR-130b in oocyte companion cells showed the high expression of miR-130b 
in granulosa and cumulus cells (Figure 4). The focus for study was narrowed to miR-
130b due to known bidirectional communication of oocytes and cumulus cells. It is well 
known that the cumulus cells plays a vital role during maturation (Gilchrist et al. 2004, 
Gilchrist et al. 2008, Zhang et al. 1995), fertilization and subsequent embryo 
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development to the blastocyst stage in mammals including bovine (Aparicio et al. 2011, 
El-Raey et al. 2011, Ge et al. 2008, Huang and Wells 2010, Jin et al. 2006, Wang et al. 
2006, Yeo et al. 2009). 
  
5.3 Differentially regulation of miR-130 family in oocyte, oocyte surrounding somatic 
cells and preimplantation embryos 
 
The expression of microRNAs is spatiotemporal, the high expression or reduced 
expression of some miRNA acts as a marker in different tissue type (Yamamoto et al. 
2009, Zubakov et al. 2010). Where as, some prediction of targets specificity was based 
on the seed sequence which is common for the miRNA family members (Lewis et al. 
2003, Lewis et al. 2005) and was validated with the demonstration of reduction in 
mRNA level in by these family members in a tissue type (Farh et al. 2005, Krutzfeldt et 
al. 2005, Neilson et al. 2007). Likewise, the let-7 miRNA family was demonstrated to 
target RAS gene in same tissue (Johnson et al. 2005). To perceive the transcription 
pattern of the family members of miR-130 (miR-130a, miR-130b, miR-301a and miR-
301b), chromosomal localization of the family members was done. miR-130b and miR-
301b were located in same chromosome 17 within 10kb where as miR-130a was located 
on chromosome 15, and miR-301a located at chromosome 19 in bovine according to 
(miRBase 15) database (Table 8). Although the members of this miRNA family are not 
located in same chromosome, it was assumed that their regulation may together. To 
verify this, screening the expression level of miR-130 family was conducted in 
immature, mature cumulus cells and granulosa cells, immature and mature oocytes and 
preimplantation embryo. The result has evidenced that miR-130 family don’t have any 
tendency to regulate in same pattern and all miRNA were having its own expression 
pattern in bovine preimplantation embryo (Figure 4.1, 4.2, 4.4). Although miR-301b 
was upregulated in zygote to 4-cells stage is required to address the question of 
functional consequences in early preimplantation stage. It was acknowledged that 
among the family of miR-130, only miR-130b was abundantly expressed in cumulus 
cells and granulosa cells (Figure 4.1). Keeping this in mind, miR-130b was further 
localized in ovarian section, with different stages of follicles. The signal of miR-130b in 
granulosa cells of antral follicles was predominantly higher compared to the preantral 
follicular cells and the other ovarian tissues. The high expression of miR-130b by real 
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time analysis as well as in situ hybridization at granulosa and cumulus cells of antral 
follicles shows the possible role in regulation of granulosa cell secreted factors 
necessary for granulosa cell function, proliferation, cumulus-oocyte communication and 
oocyte maturation. The detection of miR-130b was further analyzed for preimplantation 
stages of bovine embryo. The expression was spatiotemporal and high expression of 
miR-130b was in 8-cell to the blastocyst stage of preimplantation embryo (Figure 4.4, 
4.5). This may suggest that miR-130b could be involved in controlling maternal mRNA 
and embryonic transcripts. Moreover miR-130b is known to be an embryonic stem cells 
specific miRNA (Houbaviy et al. 2003, Ma et al. 2010b). This study is the first evidence 
to localize miR-130b in bovine follicular cells and preimplantation embryo. Taken 
together, this finding indicates the expression difference of certain miRNA in tissue-
specific or cell-specific manner thus emphasizing the intricacy of miRNA-associated 
regulatory networks and the significance of miRNA functional validation.  
 
5.4 Recognition of miR-130b target genes and their validation  
 
Target genes of miR-130b were selected based on their strong thermodynamics and 
high score according to in silico analysis and their role in cell proliferation, oocyte 
maturation and embryogenesis. Accordingly, SMAD5, MEOX2, MARCH2, DDX6, 
EIF2C1, EIF2C4, MSK1 and DOC1R were selected and were experimentally validated. 
The validation result showed that miR-130b triggered a strong and specific silencing 
effect on the SMAD5, MEOX2, EIF2C4, MSK1 and DOC1R but no effect on 
MARCH2, DDX6 and EIF2C1 suggesting in silico predicted targets are not always 
validated experimentally. Interestingly, Insilco analyzed clone of MSK1, EIF2C4 and 
MEOX2 were consist of 2 sites with strong 8nt seed complementary from 1-8 but even 
the luciferase activity was different for each individual gene. The 3′UTR of SMAD5, 
MARCH2, DOC1R and DDX6 was taken with 2-8 seed sequence (7nt) complementary, 
here the result showed suppression of SMAD5 and DOC1R by miR-130b but not for 
MARCH2 and DDX6. It has been already demonstrated that seed sequence sites with as 
few as 7bp of complementarity to the miRNA 5′ end are sufficient to regulate the 
biologically relevant targets in vivo (Doench and Sharp 2004). The experimental 
validation showed strong reduction of firefly with the clone of MSK1 and SMAD5 
(although it has 7bp complementary) where as EIF2C4, DOC1R and MEOX2 were 
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reduced but comparatively lower than MSK1 and SMAD5. Additionally, MARCH2 and 
DDX6 (both with 7bp complementary) didn’t show any reduction in firefly expression. 
Similarly, in a study which showed, the 3′UTR of hAT1R was computationally 
validated as a target of several miRNAs including miR-124a, miR-155 and miR-365. To 
identify the translational repression by each individual miRNA luciferase reporter assay 
was conducted. Interestingly, only miR-155 could efficiently reduce luciferase activity 
with specific interaction of the 3′UTR of hAT1R mRNA and inhibit translation, where 
as miR-124a and miR-365 do not interact with the 3′UTR of hAT1R mRNAs (Martin et 
al. 2006). This suggests that validation of target gene computationally is not always 
applicable for experimental condition, as there are several physiological factors within 
the cells which work for the complementary of miRNA and its target gene. 
Following identification and validation of the target genes of miRNA 130b, the 
expression pattern of those genes were further investigated during oocyte maturation 
and preimplantation development stage. Accordingly, the endogenous level of SMAD5 
and MSK1 genes were reduced in cumulus cells, morula and blastocyst stage embryos 
(Figure 4.7, 4.11A-B). These expression patterns of genes with miR-130b were 
antagonistic. Further protein expression of SMAD5 and MSK1 were estimated in 
follicular cells and oocytes that showed the same antagonistic pattern with miR-130b in 
oocytes and companion cells (Figure 4.12). This may imply that endogenous expression 
of miR-130b involves in the degradation of mRNA. Similarly, antagonistic expression 
of miRNA and its target genes been described previously by Nielsen et al. they showed 
during neuronal progenitors about nearly half of the expressed miRNAs were negatively 
correlated with the expression of their predicted target mRNAs (Nielsen et al. 2009). 
Another study in C. elegans showed lin-4 and let-7 the well known miRNA could lead 
to significant degradation of their target transcripts of their respective targets that is, lin-
14, lin-28, and lin-41 (Bagga et al. 2005). Degradation of mRNA in preimplantation 
embryo development by miRNA in Zebrafish, showed turnover of maternal mRNAs 
during early embryogenesis was affected by a single microRNA miR-430. Here they 
suggested that miR-430 promote the deadenylation and decay of hundreds of target 
mRNAs that increase the transition between developmental states (Giraldez et al. 2005, 
Giraldez et al. 2006). This provides more support for the degradation mechanism under 
physiological conditions. Here, the findings of this study provide the first evidence 
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experimentally that MSK1, EIF2C4, SMAD5 and MEOX2 are the real target of miR-
130b in physiological condition of bovine cumulus cells. 
Among EIF2C4, MSK1, MEOX2 SMAD5 and DOC1R the selection of MSK1 and 
SMAD5 was done on the bases of target validation where high reduction of firefly 
expression was observed for MSK1 and SMAD5. Furthermore, by peering several 
reviews MSK1 and SMAD5 were found to be involved in signalling pathway of 
folliculogenesis, oocyte maturation and cell proliferation (Hirshfield 1991, Hsueh et al. 
1984, Knight and Glister 2003). In addition SMAD is the central gene in the TGF- 
superfamily signalling (Abecassis et al. 2004, Kawabata and Miyazono 1999). SMAD 
signalling is also well known for GDF9 and BMP15 in oocyte growth and maturation 
(Gilchrist et al. 2004, Hussein et al. 2006, McNatty et al. 2007). Implication of SMAD 
signalling pathway in follicular development, granulosa cell proliferation, terminal 
differentiation and function is well known (Gilchrist et al. 2004, Hsueh et al. 1984, 
Hussein et al. 2006, McNatty et al. 2007, Myers and Pangas 2010). SMAD signalling 
pathway has also been reported for inducing apoptosis in bovine granulosa cells (Zheng 
et al. 2009, Gilchrist et al. 2003) and in several other cells (Bravo et al. 2003, de Luca et 
al. 1996, Jang et al. 2002) in human cancer cell lines and inducing G1 arrest (Lynch et 
al. 2001, Stuelten et al. 2006). Moreover, MSK1 believed to regulates SMAD signalling 
pathway by phosphorylating SMAD3 (Abecassis et al. 2004, van der Heide et al. 2011).  
Other reports showed that MSK1 is reported to induce G1/S arrest during neuronal 
differentiation and neuronal cell death (Hughes et al. 2003, McCoy et al. 2005, Wong et 
al. 2004). Localization pattern of SMAD5 relatively higher in granulosa cells compared 
to cumulus cells and oocytes where as MSK1 protein was relatively higher in oocyte 
compared to follicular granulosa cells and cumulus cells although both SMAD5 and 
MSK1 protein are located into the nucleus. Therefore the cell specific expression of 
SMAD5 and MSK1 may suggest that the former may play role in oocyte surround cell 
proliferation and the later function in oocyte maturation.  
The ectopic expression of mir-130b has shown the degradation of mRNA of MSK1 and 
SMAD5 and also the markable reduction of target protein in oocyte, cumulus cells, 
granulosa cells and blastocyst. Similarly, there are several evidence which shows the 
degradation of target mRNA by inducing ectopic miRNA as during retinal development 
over-expression of miR-124; miR-125 and miR-9 with significant predicted effects 
upon global mRNA levels resulted in a decrease in mRNA expression of five out of 
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ACCN2, ETS1, KLF13, LIN28B, NFIB and SH2B3 (Djuranovic et al. 2011). In 
addition, a report showed in A549 cells the ectopic expression of miR-200c cleaves the 
mRNA of TCF8 and reduced the endogenous transcript in the cell (Hurteau et al. 2007). 
In mouse granulosa cells overexpression of miR-224 had shown suppression of SMAD4 
where as protein was reduced (Yao et al. 2010a).  
 
5.5 The role of miR-130b in oocyte maturation 
  
During oocyte development, synthesis and storage of mRNA was conducted to guide 
embryo development earlier to the embryonic genomic activation. Oocyte maturation 
are affected by several factors which is already indicated elsewhere (Amiri et al. 2009, 
Kren et al. 2004, Vaknin et al. 2001, Wang et al. 2009a, Wang et al. 2009b). To 
synchronize the stability and activation of these transcriptoms many post-transcriptional 
regulation also been conducted in oocyte. These ends with several control mechanism at 
different stages of maturation (Heikinheimo and Gibbons 1998, Luna et al. 2001). Role 
of miRNA during oocyte maturation was also been studied by many researches 
(Giraldez et al. 2005, Tang et al. 2007). The predominance of genes was strongly 
control by miRNAs at the onset of fertilization for the global protein abundance 
(Nakahara et al. 2005). The Dicer, a protein require for miRNA biogenesis, knockout 
mice oocytes demonstrated the arrest in meiosis, suggests the importance of miRNA in 
very earliest stages of development (Murchison et al. 2007). Elsewhere, exhibited the 
deletion of Dicer from the oocyte blocks cell division in mouse shows the maternal 
miRNA contribute for zygotic development (Tang et al. 2007). In this study, 
microinjection of miR-130b precursor in immature oocytes shows the increase of 
polarbody extrusion where as suppression of miR-130b function significantly (p < 0.01) 
reduction on the first polarbody extrusion (Table 9 and Figure 4.14). The chromosomal 
staining showed the high number of oocytes arrested at telophase I stage in the 
inhibition of miR-130b in oocytes but the apparent mechanism was not clear. 
Microtubule organization and meiotic spindle formation has been shown to be 
controlled through the MAPK (mitogen activated protein kinase) pathway by 
phosphorylation of DOC1R protein (Terret et al. 2003). It is well known that MSK1 is a 
downstream protein of MAPK pathway in oocyte maturation (Hauge and Frodin 2006) 
which phosphorilates DOC1R protein while oocyte maturation (Terret et al. 2003). The 
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high regulation of DOC1R protein in young oocyte compared to matured oocyte 
(Grondahl et al. 2010, Terret et al. 2003) leads to conclude the high amount of the 
phosphorylated of DOC1R can delays the polarbody extrusion or maturation of oocyte.   
Mitochondria are known to be the powerhouse of cells which regulates cellular 
metabolism. Active cell has high cellular metabolism and apoptotic cells drops the 
activity for the functioning of normal metabolic process and also reduction in the 
mitochondrial membrane potential (Kroemer et al. 1997). In embryos mitochondria 
maternally inherited and provide the principal sites for oxidative damage and provide 
energy production in all embryonic cells leading to regulation of preimplantation 
embryo development. The current outfinding showed the notably high mitochondrial 
membrane potential in the oocytes performed with ectopic expression of miR-130b, 
where as, drop on the fluorescent quenching in miR-130b inhibition injected oocytes 
(Figure 4.15). Similar work was conducted, to see mitochondrial dysfunction in oocytes 
was found to be directly responsible for the early arrest of preimplantation embryos in 
vitro (Thouas et al. 2004). Moreover, oocyte mitochondrial damage effects on there 
development and blastocyst formation (Thouas et al. 2004, Thouas et al. 2006). 
According to Thouas et al. (2006) blastocyst development in vitro is relatively resistant 
to low levels of mitochondrial injury induced but was intended to identify any delayed 
developmental effects of this treatment after implantation where as another says that the 
oocytes with mitochondrial damage can caused for pre- and postimplantation 
developmental competence and resulted in inhibited zygote formation after fertilization, 
reduced blastocyst survival and developmental damage for in vitro blastocysts 
generation (Thouas et al. 2004, Thouas et al. 2006).  
Although recent reports show the limited role of miRNA in oocyte (Ma et al. 2010a), 
but our current finding has witnessed the role of miRNA in oocyte maturation and 
maternal transcript regulation. The injection of miR-130b precursor, inhibitor and 
scramble has shown a new definition for the presence and regulation of miRNA in 
preimplantation. The central dogma of gene regulation shows the transcription of gene 
in any cell type or stage of cell when it require, the same regulation pattern should be 
for miRNA too, here we have seen a bunch of experiments has shown the different 
trend of miRNA regulation in oocyte or in preimplantation of several animals (Giraldez 
et al. 2006, McCallie et al. 2010, Tesfaye et al. 2009, Yang et al. 2008) which witness 
the regulatory requirement of the miRNA at these stages. Maternal genes are higher in 
Discussion 
 
112 
immature oocyte compared to mature oocyte (Bettegowda and Smith 2007, Fair et al. 
2007, Mamo et al. 2011) the signal within the oocyte to regulate the degradation of the 
excess loaded genes can be miRNA (Giraldez et al. 2005, Ramachandra et al. 2008). 
The observation of oocyte maturation showed that miR-130b is essential for oocyte 
maturation. This is the first demonstration for any miRNA functions during bovine 
oocyte maturation and metabolic activity.   
 
5.6 Influence of miR-130b in oocyte surrounding cells proliferation and cholesterol 
biogenesis 
 
In this study, it was shown miR-130b promotes primary granulosa cell proliferation. To 
investigate the roles of miR-130b in granulosa cell proliferation, miR-130b was 
functionally characterized in granulosa and cumulus cells. Ectopic expression of miR-
130b significantly increases the proliferation potential of granulosa cells; where as 
inhibition of miR-130b reduces the proliferation potential. This may indicate that miR-
130b could involve in follicular development and granulosa cell proliferation. Parallel 
to this result, a report showed the overexpression of miR-130b increased cell viability, 
reduced cell death and decreased expression of Bim in TGF-β mediated apoptosis, by 
downregulating the RUNX3 protein expression (Lai et al. 2010). Additionally, a report 
was showed that miR-130b target TP53INP1 in MT4 cells. The report shows, the 
knockdown of miR-130b increases TP53INP1 which leads to decreased MT4 cell 
viability (Yeung et al. 2008). Another work for the same protein showed, the increase of 
miR-130b decreased TP53INP1 in CD133− cells that improve the self renewal and also 
tumorigenicity in vivo (Ma et al. 2010b). Similar to these findings, a recent study has 
shown that the ectopic expression of miR-224 also promotes mouse granulosa cells 
proliferation in mouse by targeting SMAD4 (Yao et al. 2010a).    
Regulation of cholesterol was not been much affected in cell but cholesterol efflux was 
comparatively low in miR-130b induced cells. Similar, affect has been found by Lee et 
al., that miR-130 prevents the unscheduled differentiation of adipocytes by potent 
repression of PPARgamma, a master regulator of adipogenesis (Lee et al. 2011). 
Another report showed miR-27 repress PPARgamma in human multipotent adipose-
derived stem cells, as well as in mouse preadipocyte model systems, where it was linked 
to a blockage of adipogenesis (Karbiener et al. 2009, Kim et al. 2010a, Lin et al. 2009). 
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PPARgamma may play a role in the regulation of granulosa-lutein cells functions 
through inhibiting proinflammatory factors (Chen et al. 2009). These data suggested 
that PPAR gamma may be involved in follicular atresia and FSH-stimulated 
steroidogenesis during follicle development influenced by MAPK signalling pathway 
(Zhang et al. 2007b). The outfinding has shown high cholesterol level may leads to 
follicular atresia. Whereas, correlation of the result with these references showed the 
low expression of cholesterol in media indicates low cholesterol efflux and high cell 
survival and proliferation in the ectopic expression of miR-130b.  
 
5.7 Influence of miR-130b in glycolysis of oocyte surrounding cells 
 
Glycolysis is a metabolic process can be regulated by oxidative and other cellular 
stresses, fast growing cells or in cancer cells (Elstrom et al. 2004, Shi et al. 2009). 
Although in cumulus cells high glycolysis is performed for the metabolic requirement 
for oocytes resumption of meiosis (Biggers et al. 1967, Eppig et al. 2000). In this study, 
oocyte companion cells transfected with miR-130b showed high lactate production 
where as inhibition of miR-130b significantly reduced the glycolysis by the reduction of 
lactate production. It is possible that in bovine presence of endogenous miR-130b in 
oocyte companion cells induce proliferation through promoting glycolysis. Similarly, 
lactate levels was measured for the effect of miR-210 on HCT116 cells targets ISCU 
and COX10 expression which shows the high regulation of lactate in miR-210 treated 
group compared to negative control (Chen et al. 2010) showed the high metabolic 
activity and proliferation by the influence of miR-210. Another study shows the 
metabolic control of cardiomycytes by miR-133 which regulates the expression of 
GLUT4 by targeting KLF15 (Horie et al. 2009). In oxidative and cellular stresses, 
glycolysis was regulated by constitutive activity of the serine/threonine kinase, where 
both MSK1 and SMAD5 are the members (Elstrom et al. 2004) shows the involvement 
of miR-130b in direct regulation of lactate production, although the appropriate 
pathway affected was unclear. 
Hence the findings of this study provide the first evidence that miR-130b participates in 
regulation of bovine antral granulosa cell proliferation and the function of glycolysis by 
targeting SMAD5 and MSK1.  
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5.8 Effect of miR-130b on blastocyst formation and apoptosis 
 
Selecting embryos with high implantation potential is one of the most important 
challenges in the field of assisted reproduction. Embryo quality has traditionally been 
evaluated based on cleavage rate and blastomere morphology (Puissant et al. 1987)). In 
the present study quantitative expression profiling of miR-130b throughout the 
preimplantation embryonic stages evidenced that miR-130b is activated from both 
maternal and embryonic genome. Transcript abundance for miR-130b was high at 
immature oocytes but down-regulated from mature oocytes until 4-cell stage (but 
detectable). The amount of miR-130b was relatively increased by 8-cell and reached the 
peak at the morula and blastocyst stages. The aim was to evaluate the effect of the miR-
130b on in vitro blastocyst development. Therefore, injection of miR-130b precursor at 
zygote stage was conducted which didn’t show any markable effect on the cleavage rate 
or development of embryos upto blastocyst formation. Where as suppression of miR-
130b at zygotes show arrested embryos at 4-cell by 72 hpi and didn’t reach to 8-cells. 
The blastocyst rate too was affected by suppression of miR-130b at zygote stage and 
significant reduction of blastocyst was observed. Similar studies in zebrafish 
development was done, where no endogenous let-7 miRNA expression found in first 48 
hours of development observed a specific phenotype upon injection of a double 
stranded let-7 miRNA in one-cell stage zebrafish embryos. At 26 hours post-
fertilization (hpf), the embryos found to be retarded in development. Moreover lack of 
proper eye development and reduced tail with yolk sac extension was observed. The 
embryonic death was observed after 2 days (Kloosterman et al. 2004). However a report 
shows the limited role of miRNA in mouse preimplantation embryo (Ma et al. 2010a, 
Suh et al. 2010). Similarly, the result shows ectopic expression of miR-130b didn’t 
show any notable changes in preimplantation embryos development and in the 
phenotype of the embryos. Likewise, the suppression of miR-130b at zygote stage 
shows no effect on the cleavage rate but post embryonic genomic activation, blastocyst 
formation was significantly reduced in the miR-130b suppressed embryos. Endogenous 
expression of miR-130b was high at morula and blastocyst stage which hypothesis the 
functional role or miR-130b at the late stages of preimplantation stage of bovine 
embryos. Similarly, the observation shows suppression of miR-130b reduces the 
formation of morula and blastocyst. Although, total number of blastocyst formation was 
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reduced in miR-130b inhibitor injected zygotes but there was no significant difference 
in total cell number in blastocyst and apoptotic index among the blastocysts derived 
from zygote injected.  
The present study has shown the endogenous expression of miR-130b was required for 
oocyte maturation, granulosa and cumulus cell proliferation and function, and 
development of embryos after embryonic genome activation. However, further study 
may be required to understand the involvement of miR-130b in implantation or 
postimplantation development. 
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6 Summary 
 
The maternal factors associated with the aberrant gene expression in the oocyte 
maturation and preimplantation embryo development has been one of the major causes 
of pregnancy failure in cattle. The period of preimplantation development occurs with 
different timing in various species and been marked by many molecular events 
including maternal to zygotic transition, morula compaction and the turning point of cell 
differentiation into the inner cell mass and trophectoderm at the blastocyst stage. 
Normally, preimplantation development of an embryo relies on the proper genetic 
programming during preimplantation period starts from the gametogenesis and 
continues to the zygotic genomic activation. The genetic programming includes the 
posttranscriptional modification where miRNAs has merged as a major class to fine 
tune the genomic messengers. Hence, investigating the miRNA in oocyte maturation 
and preimplantation embryos provides a unique opportunity for generating molecular 
marker that may be associated with oocyte maturation and embryo preimplantation 
development. Therefore, in the current study, role of miR-130b was investigated in 
oocyte maturation and preimplantation embryo development in bovine. As reported, 
miR-208 and miR-130b were differentially expressed in bovine immature and mature 
oocytes, both miRNAs were further expression profile in cumulus and granulosa cells 
using qRT-PCR. The result has shown relatively high expression of miR-130b in 
granulosa and cumulus cells compared to miR-208. Keeping in mind, the importance of 
oocyte companion cells in oocyte maturation miR-130b was selected for further study. 
Additionally, miR-130b share same seed sequence to its family members required to 
expression profile the miR-130 family in oocyte, cumulus cells, granulosa cells and 
preimplantation embryos. The expression profiling resulted with the high expression of 
miR-130b in both cell types as well as in immature oocytes and late preimplantation 
stage after zygotic genome activation. Furthermore, miR-130b was localized in ovarian 
section and preimplantation embryos, where it was strongly detected at the granulosa 
cells of antral follicles compared to the primordial, primary, secondary follicles and 
other ovarian tissues. The detection of miR-130b was high in cumulus cells of mature 
and immature oocytes, morula and blastocyst compared to mature oocyte, zygote, 2-
cell, 4-cell and 8-cell embryo. High expression of miR-130b indicates that it may have 
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some role in granulosa cells proliferation or function, oocyte maturation or in 
scavenging the maternal transcripts.  
To identify the appropriate target of miR-130b in silico analysis was done and with all 
threshold criteria RPS6KA5 (MSK1), SMAD5, EIF2C1, EIF2C4, MARCH2, MEOX2, 
DDX6 and DOC1R were selected for experimental validation. Prior to validation all 
selected genes were quantified on in vitro produced bovine embryos using qRT-PCR. 
The EIF2C4 and DDX6 were detected at higher level at morula and blastocyst stage 
embryos compared to early stages of embryo. Expression of MSK1, SMAD5, 
MARCH2 and EIF2C1 genes were found to be highly abundant at early developmental 
stages in oocytes to 8-cell compared to morula and blastocyst stage embryos. MEOX2 
and DOCR1 were not been detected from mature oocyte to blastocyst stage. The 
experimental validation was conducted using pmirGLO Dual-Luciferase miRNA Target 
Expression Vector. Firefly and renilla activity was observed 48 hours post transfection. 
The results validated that MSK1, SMAD5, EIF2C4, DOCR1 and MEOX2 are the real 
targets of miR-130b where as EIF2C1, DDX6 and MARCH2 were not validated to be 
the target of miR-130b.  
The high reduction in luciferase efficiency of MSK1 and SMAD5 among the above 
validated targets and the antagonistic expression relation between miR-130b and gene in 
preimplantation was kept in mind for the selection of MSK1 and SMAD5 for further 
studies. MSK1 and SMAD5 were found to be involved in signalling pathway of 
folliculogenesis, oocyte maturation and cell proliferation. The transcript abundance of 
MSK1 and SMAD5 in oocyte maturation and corresponding cumulus cells showed both 
genes were higher in oocytes compared to its corresponding cumulus cells. The protein 
localization showed SMAD5 and MSK1 were present in oocyte, granulosa cells and 
cumulus cells.  
To analyse the role of miR-130b during oocyte maturation, good quality immature 
oocytes were categorized into four groups precursor, inhibitor and scramble (injected) 
and uninjected. From each group after 22 hours of injection (n = 300) oocytes were 
collected for molecular analysis, (n = 50) oocytes for mitochondrial assay and (n = 150) 
oocytes for Hoechst staining. To observe the effect of miR-130b in preimplantation 
development (n = 700) zygotes were categorized for each injected (precursor, inhibitor 
and scramble) and uninjected groups for investigation. Zygotes were injected and in 
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vitro cultured upto blastocyst stage. Day 8 blastocyst were collected for mRNA and 
protein expression analysis.  
To assess the effect of miR-130b in mRNA transcript abundance and protein 
expression, oocytes were collected after 22 hours of injection and phenotype was 
observed. The first polarbody was accounted for all injected groups where, precursor 
showed the higher polarbody extrusion with (86.3%), inhibitor (73.3%) which was 
significantly reduced compared to scramble (85.13%) and uninjected (84.65%) oocytes. 
Similarly, 22 hours post injection between (10-12%) of the oocytes were remain at GV 
stage in all injected groups of oocytes, (22%) of inhibitor injected and (8%) precursor 
injected groups arrested at Telophase l stage. On the other hand, the proportion of 
oocytes reached to MII stage was significantly lower in inhibitor injected (60%) (p ≤ 
0.05) compared to the uninjected control group (75%). Where as, miR-130b precursor 
injected oocyte reached to MII stage was (80%). The mitochondrial fluorescent 
quenching was observed 22 hours post injection in oocyte which showed a very strong 
signal in miR-130b precursor injected oocytes where as low in inhibitor injected 
oocytes compared to scramble or uninjected oocyte groups.  
The observation of the transcripts in injected oocytes showed a significant high 
expression (8000-fold) of miR-130b in precursor injected compared to other groups of 
injected and uninjected oocytes. However, miR-130b precursor injection was resulted in 
decreased in MSK1 and SMAD5 transcript abundance where as miR-130b inhibitor 
injected has significantly (p < 0.05) increased compared to uninjected control group. 
Moreover, immunohistochemistry localization was preformed for all injected and 
uninjected group oocytes and the result indicated that MSK1 protein expression was 
reduced by miR-130b overexpression where as suppression of miR-130b has 
remarkable increased the protein level compared to scramble injected and uninjected 
control oocytes. Similarly, westernblot analysis showed the reduction of both MSK1 
and SMAD5 in precursor injected oocytes where as high expression in inhibitor injected 
oocytes. 
Importance of bidirectional communication between oocytes and surrounding somatic 
(granulosa and cumulus) cells was well known. The cells (2 x 105) were cultured in 24 
wells plate and transfected with 30 nM/ml miR-130b precursor, inhibitor and scramble 
miRNA. Cell viability was observed in 4 replicates using Trypan blue at 24 and 48 
hours of transfection. Live cell count was performed under the microscope in 
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haemocytometer and the live cell count was relatively higher in precursor transfected 
cells and lower in inhibitor transfected cells compared to scramble and untransfected 
control groups (p ≤ 0.05). Following this, cell proliferation assay was conducted to 
determine the proliferation of cells using MTT assay. Primary granulosa cells were 
cultured in 96 wells plate (7.5 x 104) and transfected with 50 nM/ml of either of miR-
130b precursor, inhibitor or scramble. The assay was preformed after 24 and 48 hours 
of transfection. The result showed significant (p ≤ 0.05) increase in proliferation of cells 
transfected with miR-130b precursor and reduction in cells tranfected with miR-130b 
inhibitor (p ≤ 0.05) compared to scramble transfected as well as untransfected cells at 
24 and 48 hours time point. 
To understand the role of miR-130b in glycolysis the primary granulosa and cumulus 
cells were transfected and lactate assay was performed 24 hours post transfection in 96 
wells plate using multiplate reader. Accordingly, the precursor transfected cells have 
shown higher (p < 0.005) lactate production (nmole) where as inhibitor transfected cells 
showed a decreased (p < 0.01) in lactate production (nmole) compared to scramble and 
untransfected controls. Effect of miR-130b on cholesterol biosynthesis in granulosa and 
cumulus cells did not show any significant difference although miR-130b precursor 
transfected cells showed low cholesterol efflux. The molecular analysis showed 
reduction of mRNA and protein in miR-130b precursor transfected cells where as high 
expression in miR-130b inhibitor transfected cells compared to control groups. 
The effect of miR-130b in preimplantation embryos was observed by overexpression 
and suppression of miR-130b at zygote stage. Embryos were collected at 8 days 
blastocyst and phenotype was collected on specific time intervals. The first cleavage 
rate was about 75% to 81% for all embryos derived from miR-130b precursor, inhibitor, 
scramble and uninjected zygotes (p > 0.05). After 72 hours, 68% of precursor 58% 
inhibitor, 65% scramble and 69% uninjected zygotes reached to 8-cell stages. On the 
other hand, 16% precursor, 28% inhibitor, 19% scramble injected and 18% uninjected 
controls were at 4-cells. However, the morula rate was (p ≤ 0.05) reduced in inhibitor 
injected zygotes compared to uninjected zygotes. The embryos reached to blastocyst in 
precursor injected zygotes were the highest 22%, inhibitor injected zygotes were 14%, 
scramble injected 19% and uninjected 20%. A significant reduction was observed in the 
formation of blastocyst derived from inhibitor injected zygotes (p ≤ 0.05).  
Summary 
 
120 
In conclusion, the present study shows the functional importance of miR-130b during 
bovine oocyte maturation and granulosa cell proliferation. The high regulation of miR-
130b in granulosa cells of antral follicle leads to the granulosa cell proliferation and 
increases the metabolic activity by increasing lactate production in oocyte surrounding 
cells, which may helps the oocytes for maturation and further development. During in 
vitro oocyte maturation miR-130b was analyzed to be an important transcript present in 
abundance and helps the oocytes to undergo maturation and blastocyst formation. The 
data highlights the potential involvement of miR-130b in oocyte metabolic activity 
which increases the mitochondrial activity. The overall data provides the significant 
evidence that transcription of miR-130b is needed during bovine oocyte maturation and 
granulosa cell proliferation. High expression of miR-130b at morula and blastocyst 
stage embryo may be influence the further embryo implantation. However, in functional 
depth studies are required whether miR-130b is involved during bovine embryo 
implantation. 
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7 Zusammenfassung  
 
In der vorliegenden Studie wurde die Rolle der miR-130b in der Oozytenmaturation und 
in  der embryonalen Präimplantationsentwicklung beim Rind untersucht. Die 
Expression von miR-130b wurde mittels RT-PCR in Kumulus- und in Ganulosazellen 
untersucht. Dabei konnte bei miR-130b sowohl in Kumulus- als auch in 
Granulosazellen eine höhere Expression detektiert werden als im Vergleich zur miR-
208.  
Das Expressionsergebnis zeigte eine hohe Expression von miR-130b in beiden 
Zelltypen sowie in immaturierten Oozyten und im späten Präimplantationsstadium nach 
zygotischer Genomaktivierung. Darüber hinaus wurde die miR-130b in Bereichen des 
Eierstockes und in Präimplantationsembryonen lokalisiert. Am stärksten wurde sie in 
den Granulosazellen des Antrum follikuli im Vergleich zu den primordialen, primären 
und sekundären Follikeln sowie anderen Ovariengeweben nachgewiesen. Die miR-130b 
konnte bei Präimplantationsembryonen am stärksten in den Kumuluszellen vom 
maturierten und immaturierten Oozyten sowie Morula und Blastozyten detektiert 
werden. Ebenfalls zeigten sich in maturierten Oozyten, Zygoten, 2-Zeller, 4-Zeller und 
8-Zeller Embryonen Expression, aber im geringeren Ausmaß. Eine hohe Expression der 
miR-130b läst ihre Bedeutung in der Proliferation oder Funktion von Granulosazellen, 
in der Maturation von Oozyten oder bei der Abfrage von maternalen Genen vermuten. 
Zur Identifizierung der genauen Ziel Gene der miR-130b wurden In silico Analysen 
durchgeführt. Dafür wurden unter Berücksichtigung der Threshold-Kriterien zur 
Validierung die Gene RPS6KA5 (MSK1), SMAD5, EIF2C1, EIF2C4, MARCH2, 
MEOX2, DDX6 und DOC1R ausgewählt. Zur Validierung wurden die Gene in in vitro 
erzeugten Rinderembryonen mittels RT-PCR quantifiziert. EIF2C4 und DDX6 zeigten 
im Morula- und Bastozystenstadium ein hohes Expressionsmuster, während sie im 
frühen Embryonenstadium runter reguliert waren. Bei der Expressionsanalyse der Gene 
MSK1, SMAD5, MARCH2 und EIF2C1 konnte ein hohes Expressionsniveau im frühen 
Entwicklungsstadium von Oozyten bis zum 8-Zeller beobachtet werden, während im 
Morula- und Blasozystenstadium ein niedriges Expressionsmuster detektiert wurde. Die 
Gene MEOX2 und DOCR1 konnten nicht während der gesamten Präimplantation (von 
der maturierten Oozyte bis zur Blastozyste) detektiert werden. Die experimentelle 
Validierung wurde unter Verwendung des pmirGLO Dual-Luciferase miRNA Target 
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Expression Vektor durchgeführt. 48 Stunden nach der Transfektion wurde die Firefly 
und Renilla Aktivität beobachtet. Die Ergebnisse der Validierung erbrachten das MSK1, 
SMAD5, EIF2C4, DOCR1 und MEOX2 Ziel Gene von miR-130b sind, während dieses 
für EIF2C1, DDX6 und MARCH2 nicht beobachtet werden konnte.  
Von den validierten Genen führte die hohe Reduktion der Luciferase Effizienz von 
MSK1 und SMAD5 und die antagonistische Beziehung zwischen der miR-130b mit den 
Genen während der Embryonalentwicklung zu dem Resultat  MSK1 und SMAD5 für 
weitere Untersuchungen auszuwählen. Für die Gene MSK1 und Smad5 konnte 
festgestellt werden, dass sie in den Pathways der Follikulogenese, Oozytenmaturation 
und Zellproliferation von Bedeutung sind. Der Vergleich der Expressionsniveaus von 
MSK1 und SMAD5 während der Oozytenmaturation und ihren dazugehörigen 
Kumuluszellen zeigte, dass beide Gene in den Oozyten ein höheres Expressionsniveau 
im Vergleich zu den entsprechenden Kumuluszellen haben. Bei der Proteinlokalisation 
konnte eine Expression von MSK1 in Oozyten und Kumuluszellen und für SMAD5 
eine höhere Expression bei follikulären Granulosazellen beobachtet werden.  
Zur Analyse der Funktion von miR-130b während der Oozytenmaturation, wurden 
immaturierte Oozyten mit guter Qualität in vier Gruppen Precursor, Inhibitor, Scramble 
und nicht behandelt eingeteilt. In jeder Gruppe wurden 22 Stunden nach der Injektion 
Oozyten für die molekulare Analyse (n = 300), Oozyten für mitochondriale Analyse (n 
= 50)  und Oozyten für die Hoechst-Färbung (n = 150) gesammelt. Zur Beobachtung der 
Wirkung von miR-130b in der Präimplantationsentwicklung (n = 700) wurden Zygoten 
für jede Behandlungsgruppe (Precursor, Inhibitor und scramble) kategorisiert sowie in 
injizierte und nicht injizierte für die folgenden Untersuchung eingeteilt. Die Zygoten 
wurden injiziert, in vitro kultiviert und an Tag 8 des Blastozystenstadiums für die 
Transkriptions- und Proteinexpressionsanalysen gesammelt. 
Um den Effekt von miR-130b auf die RNA- und Proteinexpression beurteilen zu 
könnnen, wurden Oozyten 22 Stunden nach der Injektion gesammelt und der Phänotyp 
beobachtet. Die ersten Polkörper konnten für alle injizierten Gruppen nachgewiesen 
werden. Die Precursor injizierten Oozyten zeigten die höchste Polkörper Extrusion mit 
(86,3%), die Scramble injizierten mit (85,13%), die nicht injizierten Oozyten mit 
(84,65%)  und die Inhibitor injizierten mit (73,3%), was deutlich niedriger war. Ebenso 
konnte 22 Stunden nach der Injektion bei 10–12 % angefärbten Oozyten aller 
Behandlungsgruppen das GV Stadium beobachtet werden, während 22 % der Inhibitor 
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injizierten und 8 % der Precursor injizierten Gruppen in der Telophase I verblieben. Ein 
siginifikant (p ≤ 0,05) geringerer Anteil der Inhibitor injizierten Oozyten (60%) 
erreichte die MII Phase im Vergleich zur nicht injizierten Kontrollegruppe (75%) und 
Precursor injizierten Oozyten (80%). Die mitochondriale Aktivität wurde 22 Stunden 
nach der Injektion der Oozyten beobachtet. In miR-130b Precursor injizierten Oozyten 
war ein stärkeres mitochondriales Fluorezsenssignal und ein niedrigeres bei Inhibitor 
injizierten Oozyten im Vergleich zu Scramble oder nicht injizierte Oozyten sichtbar.  
Die Transkiptionsanalyse der injizierten Oozyten zeigte, dass die Precursor miR-130b 
injizierten Oozyten signifikant höhere Expression (8000 fache) im Gegensatz zu den 
anderen Oozytengruppen aufweisen. Die miR-130b Precursor injizierten hatten eine 
niedrigere Expression des MSK1 Transkriptes. Die miR-130b Inhibitor injizierten 
hatten eine signifikant höhere MSK1 Expression im Vergleich zur nicht injizierten 
Kontrollgruppe (p < 0,05). SMAD5 zeigte in der Precursor injizierten Gruppe eine 15% 
verringerte Expression, hingegen zeigten die Inhibitor injzierten Oozyten eine 
signifikant höhere Expression nach der Maturation als die Kontrollgruppe. Zudem 
wurde eine immunohistochemische Lokalisierung für alle injizierten und nicht 
injizierten Oozytengruppen durchgeführt. Die Ergebnisse zeigten, dass die 
Proteinexpression von MSK1 durch die hohe Expression von miR-130b reduziert 
wurde. Ebenfalls konnte durch das Ausschalten der miR-130b ein bemerkenswerter 
Anstieg des MSK1 Proteinlevels im Vergleich zur Scramble injizierten und nicht 
injizierten Kontrolloozyten ermittelt werden. Durch Westernblot Analysen konnte 
ebenfalls eine geringere Expression von MSK1 und SMAD5 in Precursor injizierten 
Oozyten und eine höhere Expression dieser bei Inhibitor injizierten Oozyten ermittelt 
werden.  
Die bidirektionale Kommunikation zwischen Oozyten und ihrer umgebenen 
somatischen Zellen (Granulosazelllen und Kumuluszellen) ist für ihre bedeutende Rolle 
bekannt. In 24 Wellplatten wurden 2 x 105 Zellen kultiviert und mit 30 nM/ml miR-
130b Precursor, Inhibitor und Scramble miRNA transfiziert. Die Lebensfähigkeit der 
Zellen wurde mittels Trypanblau in 6 Wiederholungen 24 und 48 Stunden nach der 
Transfektion überprüft. Die Zellzahlbestimmung erfolgte unter dem Mikroskop mittels 
Hämocytometer. Dabei konnte eine höhere Zellzahl bei den Precursor transfizierten 
Zellen und eine geringere Zahl bei Inhibitor behandelten Zellen im Vergleich zu 
Scramble und nicht transfizierten Zellen (p ≤ 0,05) ermittelt werden.  
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Im Zellproliferationsassay zeigte sich bei beiden Zeitpunkten, 24 und 48 Stunden nach 
der Transfektion, eine signifikant (p ≤ 0,05) höhere Zellproliferation in miR-130b 
Precursor tranzfizierten und eine reduzierte Zellproliferation in Inhibitor transfizierte 
Zellen (p ≤ 0,05), im Vergleich zu Scramble sowie auch in nicht transfizierten Zellen.  
Um die Rolle der miR-130b während der Glykolyse besser zu verstehen, wurden 
sowohl primäre Granulosa- und Kumuluszellen transfiziert und anschließend 24 
Stunden nach der Transfektion in 96 Wellplatten mittels eines Multiplate Readers ein 
Laktat-Assay durchgeführt. Das Resultat zeigte bei Precursor behandelte Zellen eine 
höhere Laktatproduktion (p < 0,005). Bei Inhibitor transfizierte Zellen konnte  im 
Vergleich zur Scramble und der nicht transfizierten Gruppe eine geringere 
Laktatproduktion beobachtet werden (p < 0,01). Es konnten keinen signifikanten 
Unterschiede zum Einfluss der miR-130b auf die Cholesterin-Biosynthese in Granulosa- 
und Kumuluszellen festgestellt werden.  In der molekulare Analyse konnte in pre-miR-
130b transfizierten Zellen eine geringere mRNA- und Proteinexpression detektiert 
werden. Im Gegensatz dazu zeigte sich  eine höhere Expression in anti-miR-130b 
tranfizierten Zellen im Vergleich zur Kontrollgruppe.  
Der Einfluss von miR-130b in Präimplantationsembryonen wurde durch eine 
Überexpression und eine Unterdrückung der miR-130b während des Zygotenstadiums 
untersucht. Die Embryonen wurden am Tag 8 im Blastozystenstadium gesammelt und 
deren Phenotypen wurden in bestimmten Zeitintervallen bestimmt. Für alle Embryonen 
die mit miR-130b Precursor, Inhibitor, Scramble und nicht injizierte Zygoten behandelt 
wurden, konnte eine erste Teilungsrate um 75 bis 80% beobachtet werden (p > 0,05). 
Nach 72 Stunden erreichten 68% der Precursor, 58% der Inhibitor und 65% der 
Scramble sowie 69% der nicht injizierten behandelt Zygoten das 8-Zell-Stadium. 16% 
der Precursor, 28% der Inhibitor und 19% der Scramble sowie 18% nicht injizierten 
Zygoten verblieben im 4-Zell-Stadium.  
Dennoch konnte eine reduzierte Morularate (p ≤ 0,05) bei Inhibitor injizierten Zygoten 
im Vergleich zur nicht injizierten Kontrollgruppe beobachtet werden. Die Anzahl an 
Embryonen die das Blastozystenstadium erreicht hatten, war bei Precursor injizierten 
Zygoten mit 22% höher als bei Inhibitor injizierten (14%). Scramble injizierte (19%) 
und nicht injizierten Zygoten (20%) zeigten keinen Unterschied. Des Weiteren konnte 
eine signifikant verringerte Blastozystenentwicklung bei Inhibitor injizierten Zygoten (p 
≤ 0,05) beobachtet werden.  
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Zusammenfassend zeigt die vorliegende Studie, dass miR-130b während der Maturation 
boviner Oozyten und Granulosazellproliferation eine bedeutende Funktion einnimmt. 
Die hohe Expression der miR-130b in Granulosazellen der antralen Follikel führte zur 
Proliferation der Granulosazellen und einer erhöhten Stoffwechselaktivität. Während 
der in vitro Oozytenmaturation konnte miR-130b als ein wichtiges Transkript 
identifiziert werden, das die Oozyten  sowohl bei der Maturation als auch bei der 
Blastozystenbildung unterstützt. Der mögliche Einfluss der miR-130b auf die 
Stoffwechselaktivität der Oozyten konnte zu einer erhöhten mitochondrialen Aktivität 
geführt haben. Alle analysierten Daten zeigten, dass die Transkiption der miR-130b 
während der bovinen Oozytenmaturation und Granulosazellproliferation benötigt wird. 
Des Weiteren könnte eine hohe Expression der miR-130b im Morula- und 
Blastozytenstadium einen bedeutenden Einfluss auf die Implantation des Embryos 
haben.  
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